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AcCoA / Acetyl-CoA (Acetyl-) coenzyme A 
ARFRP1 ADP-ribosylation factor-related protein 1 
(a trans-Golgi-associated small GTPase) 
Cryo-EM Cryogenic electron microscopy 
EPR Electropositive Region 
ES Ribosomal RNA expansion segments 
Gag Major capsid protein of the Saccharomyces cerevisiae virus L-A 
GNAT GCN5-related N-acetyltransferase superfamily 
HAT Histone acetyl transferase 
HRV 3C Human rhinovirus 3C protease / recognition site 
IMAC Immobilized metal affinity chromatography 
KAT Lysine acetyl transferase 
MALDI-TOF MS Matrix-assisted laser desorption/ionization – time-of-flight – mass spectrometry 
MetAP Methionine aminopeptidase 
NAA/Naa Nα-acetyltransferase gene/protein, respectively.  
NAT N-terminal acetyltransferase (enzyme that the catalyzes the Nt-acetylation) 
Nt-acetylation N-terminal acetylation (also known as Nα-acetylation) 
pI Isoelectric point 
PE Ribosome nascent polypetide exit tunnel 
PTM Post-translational modification 
SEC Size-exclusion chromatography 
yArl3 ADP-ribosylation factor-like protein 3 from S. cerevisieae 
(the yeast ortholog of human ARFRP1) 
X-ray X-radiation, a form of high-energy electromagnetic radiation. 
 
The above list represents only frequently occurring abbreviations that are beneficial for text comprehension. 
Further abbreviations are found in the materials and methods sections or defined upon first use.  
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1 Introduction 
1.1 The ‘missing’ genetic information in eukaryotic genomes 
The Human Genome Project finished its goal of obtaining a highly accurate sequence of the vast 
majority of the euchromatic1 human genome in 2004 (International Human Genome Sequencing 
2004). The 2.85 billion nucleotides of the haploid human genome encode only 20,000–25,000 
protein-coding genes, which is approximately one fifth of the number that was originally envisaged 
(Council 1988; Antequera and Bird 1993; Liang et al. 2000). Similarly, other eukaryotic genomes 
contain only a limited number of genes, e.g. ~13,600 in Drosophila melanogaster (Adams et al. 
2000), ~25,500 in Arabidopsis thaliana (Arabidopsis Genome 2000) and roughly 6000 genes in 
Saccharomyces cerevisiae (Goffeau et al. 1996). A central question that has to be answered is how 
such limited number of genes can lead to the development and functionality of a living being as 
complex as a human. 
Nilsen and Graveley (2010) have concluded that the ‘missing’ genetic information is in large part 
provided by alternative splicing. During the splicing reaction, eukaryotic gene transcripts are 
processed and assembled into mature mRNA through excision of non-coding introns. Alternative 
splicing patterns determine the inclusion of different exons in the mRNA, giving rise to multiple 
protein isoforms that differ in sequence and subsequently have different chemical and biological 
properties (Black 2003). 
Approximately 92–95% of human multiexon gene transcripts undergo alternative splicing (Pan et al. 
2008; Wang et al. 2008). Through analysis of RNA sequencing data, Hu et al. (2015) concluded that 
the expression of alternate transcripts is mostly tissue specific and estimated that there are more than 
200,000 mRNA transcripts with protein-coding potential, which correspond to roughly ten variants 
per annotated human gene. However, it is still debated to which extent alternative splicing contributes 
to protein diversity (Chaudhary et al. 2019). Weatheritt, Sterne-Weiler, and Blencowe (2016) 
suggested that a majority of splice variants are translated, and that specific cellular functions like cell 
cycle control are subject to alternative splicing-dependent modulation of translation output. 
Furthermore, Yang et al. (2016) showed that alternative splicing can produce protein isoforms with 
vastly different protein-protein interaction profiles. However, another proteomic study suggests that 
there is only a single dominant protein isoform for the vast majority of protein-coding genes, 
irrespective of tissue or cell type (Ezkurdia et al. 2015). After reviewing the current evidence, Tress, 
Abascal, and Valencia (2017) conclude that alternative splicing may not be the key to proteome 
complexity. 
 
1 The euchromatic genome (~2.88 Gb) covers about 93.5% of overall human genome (~3.08 Gbs) (International 
Human Genome Sequencing 2004). Euchromatin represent the lightly packed chromatin, which is enriched in 
genes and more actively transcribed than heterochromatin. 
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1.2 Post-translational modifications — a major source of protein diversity? 
The second route of proteome expansion is achieved through post-translational modifications 
(PTMs), which are covalent modifications that occur after the translation of mRNA into proteins or, 
in some cases, even during the translation process (co-translational modification). The nascent or 
folded proteins are subjected to a variety of enzyme-catalyzed modifications on their side chains or 
backbones. PTMs can be divided into two categories: enzyme-catalyzed covalent additions of a 
chemical group to a side chain or backbone of a protein and covalent cleavage of peptide backbones 
either by proteases or by autocatalytic cleavage. Fifteen out of the twenty common proteogenic amino 
acids are post-translationally modified. The five most common types are phosphorylation, 
glycosylation, acylation, alkylation and oxidation (Walsh, Garneau-Tsodikova, and Gatto 2005). In 
total, about 5% of the genome of higher eukaryotes encodes enzymes that carry out PTMs (Walsh, 
Garneau-Tsodikova, and Gatto 2005). 
The most actively researched PTM type is phosphorylation, which was already discovered sixty years 
ago (Fischer et al. 1959). Kinases, the enzymes that catalyze the phosphorylation reaction, form a 
superfamily of more than 500 members, which is termed the kinome (Manning et al. 2002). Protein 
phosphorylation is a reversible PTM, which is tightly controlled by phosphatase enzymes. This 
reversibility is consistent with the importance of kinases and phosphatases in receptor-mediated 
signal transduction and cell cycle control (Hunter 1995). Other reversible PTMs include 
glycosylation, alkylation, lysine-acylation and disulfide formation.  
In the literature, different terms have been used to describe the highly related, but chemically 
different, protein molecules that are derived from a single gene, including the terms: protein forms, 
protein isoforms, protein species and protein variants. However, the terms “variants” and “isoforms” 
were intended to describe proteins derived from distinct DNA or RNA and the term “protein species” 
does not distinguish between proteins originating from different genes and those originating from a 
single gene. Thus a new term, ‘proteoform’, was proposed to designate all of the different molecular 
forms in which the protein product of a single gene can be found, including changes due to genetic 
variations, alternatively spliced RNA transcripts and post-translational modifications (Smith, 
Kelleher, and Consortium for Top Down 2013). 
The question of how many proteoforms are created from the roughly 20,000 human genes is hard to 
answer. The theoretical number of proteoforms created through post-translational modifications is 
2n, where n is the number of PTMs (Aebersold et al. 2018). This calculation works for site-specific 
PTMs that are binary, like phosphorylation and acetylation. However, lysine residues can be 
unmodified, acetylated or methylated at three different levels: mono-, di- and trimethylated (Wang 
and Liu 2017) and thus lysines can exist in five different states. Aebersold et al. (2018) used the 
specific example of the human histone H4, for which the 58 SwissProt-annotated PTM modifications 
at seventeen different sites would yield more than 1010 theoretical proteoforms. Even when using the 
13 most common PTM sites from the literature, plus an allelic variant (E64Q), the authors calculate 
more than 98,000 possible proteoforms for histone H4. However, in an extensive mass spectrometry 
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project only 74 proteoforms were reported, and only 21 unambiguously (Dang et al. 2014). Thus, 
even though the potential complexity of the proteome is enormous, the few available studies suggest 
that only a fraction of this complexity is used. 
1.3 Protein acetylation 
Protein acetylation is one of the major PTMs in eukaryotes, in which the acetyl group from acetyl 
coenzyme A (acetyl-CoA) is transferred to either the protein Nα-terminus or the ε-amino group of a 
lysine side chain (Drazic et al. 2016) (see Fig. 1). The modification of the N-terminal amino group 
(N-terminal acetylation or Nt-acetylation) is catalyzed by N-terminal acetyltransferases (NATs) and 
is considered to be irreversible as no Nt-deacetylase has thus far been identified. The catalytic 
subunits of NATs belong to the GCN5-related N-acetyltransferase (GNAT) superfamily (Vetting et 
al. 2005) (see section 1.8). Protein acetylation of lysine ε-amino groups is catalyzed by lysine 
acetyltransferases (KATs), which were originally named histone acetyltransferases (HATs), because 
they were the first proteins for which a reversible acetylation of the ε-amino group was identified 
(Allfrey, Faulkner, and Mirsky 1964). KATs can be grouped into three major families GCN5, 
CBP/p300 and MYST, which are reviewed by Berndsen and Denu (2008). The removal of the acetyl 
groups is catalyzed by lysine deacetylases (KDACs), which belong to two different families; Zn2+-
dependent histone deacetylases and NAD+-dependent sirtuin deacetylases (Choudhary et al. 2014).  
 
 
Fig. 1 Schematic overview of acetylation and deacetylation. (A) Transfer of an acetyl group from acetyl-
CoA to the N-terminal amino group of a polypeptide, catalyzed by N-terminal acetyltransferases (NATs). (B) 
Reversible acetylation of the ε-amino group of a lysine residue by lysine acetyltransferases (KATs). The 
deacetylation of lysine residues is catalyzed by lysine deacetylases (KDACs). Adapted from (Drazic et al. 2016). 
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1.4 Evolutionary development of N-terminal acetylation 
N-terminal acetylation occurs in all kingdoms of life, but the frequency increases dramatically with 
the complexity of the organism. In E. coli, five proteins have long been known to be N-terminally 
acetylated, three of them being ribosomal proteins from the small or large ribosomal subunit 
(Gordiyenko et al. 2008). These proteins, with N-termini Ala-His-, Ala-Arg-, and Ser-Ile- are each 
acetylated by a separate, specific N-terminal acetyltransferase (Yoshikawa et al. 1987; Tanka et al. 
1989). In bacteria and eukaryotic organelles, the initiator methionine of nascent chains is Nα-
terminally formylated. The formyl moiety is co-translationally removed by a ribosome-bound 
peptide deformylase (Piatkov et al. 2015). The resulting methionine can be cleaved off subsequently 
by methionine aminopeptidases (MetAPs), if the subsequent residue at position 2 is not larger than 
valine (Frottin et al. 2006). Only then can the N-termini be acetylated by their dedicated N-terminal 
acetyltransferase. Both peptide deformylase and MetAP compete for the same binding site close to 
the exit tunnel of the E. coli ribosome. Their extremely fast association and dissociation kinetics 
allow them to frequently sample the ribosome and ensure processing of nascent chains after their 
emergence, followed by later maturation events, including chaperone recruitment and folding 
(Sandikci et al. 2013). A recent proteomics study has now identified a total of 31 N-terminally 
acetylated proteins in E. coli (Schmidt et al. 2016), comprising less than 1% of the E. coli genome2 
(Grenier et al. 2014). 
In archaea, acetylated N-termini are far more common, affecting about 15% of the proteins (Falb et 
al. 2006). The haloarchaeal N-terminal acetyltransferase(s) reveal a narrow substrate specificity, 
which is limited to N-termini starting with Ala or Ser, resembling the activity of the eukaryotic NatA 
complex (see below). Consequently, they also require the prior removal of the initial methionine by 
MetAP. Many proteins are only partially Nt-acetylated and complete acetylation is seen in only half 
of the acetylated proteins (Falb et al. 2006). Another archaea, the crenarchaeote Sulfolobus 
solfataricus, revealed a more relaxed substrate specificity and its single NAT, ssArd1, was able to 
acetylate Ala-, Ser- and Thr-, and also Met-Glu- amino termini (Mackay et al. 2007). The authors 
suggest that ssArd1 represents an ancestral form of the eukaryotic NATs and that the latter have 
evolved a complex NAT machinery, that contains multiple NAT paralogs with a much more 
restricted substrate specificity. 
In the lower eukaryote Saccharomyces cerevisiae, about 50% and in humans about 80% to 90% of 
all proteins are completely or partially Nt-acetylated (Polevoda and Sherman 2003; Arnesen et al. 
2009; Van Damme, Hole, et al. 2011). Arnesen et al. (2009) found that only 12% of yeast proteins 
are fully acetylated at their N-terminus, whereas 45% are partially acetylated and 43% are non-
acetylated. In contrast, 76% of human proteins are fully acetylated, 8% partially acetylated and 16% 
non-acetylated. 
 
2 The E. coli genome contains approximately 4,096 genes (https://www.uniprot.org/proteomes/UP000029103). 
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1.5 The eukaryotic NAT machinery 
Eukaryotes have at least five different highly conserved NATs, termed NatA to NatE, suggesting an 
increase in complexity of the NAT machinery during evolution (Rathore et al. 2016). Higher 
eukaryotes additionally express NatF and plants and animals even possess a seventh, kingdom-
specific NAT: Naa70 (Dinh et al. 2015) or Naa80, respectively (Drazic et al. 2018).  
Rathore et al. (2016) suggested that all six major eukaryotic N-terminal acetyltransferases were 
present in the Last Eukaryotic Common Ancestor (LECA), i.e. NAT diversification did not occur in 
the eukaryotes. However some NATs were secondarily lost during evolution: for example, NatF is 
absent in S. cerevisiae (Van Damme, Hole, et al. 2011). 
The eukaryotic NATs differ from each other in terms of subunit composition and substrate specificity 
(Table 1). Each NAT consists of at least a unique catalytic subunit and up to two auxiliary subunits 
that contribute to substrate specificity or mediate NAT-ribosome interactions (Aksnes et al. 2016). 
A simplified nomenclature for N-terminal acetyltransferase genes was introduced in 2009: The 
symbol NAA/Naa (Nα-acetyltransferase) was assigned to each gene/protein of the corresponding 
NAT complex (Polevoda, Arnesen, and Sherman 2009). For example, the NatC complex, analyzed 
in this thesis, consists of the catalytic subunit Naa30 and two auxiliary subunits Naa35 and Naa38. 
Orthologous genes have the same name, e.g. hNaa30 (human), yNaa30 (yeast, S. cerevisiae), and are 
assigned not only by their sequence similarity but also by their substrate specificity, i.e. they acetylate 
the same set of proteins. Each NAT recognizes a specific subset of protein N-termini, depending 
mainly on the amino acid sequence of the first two amino acids. 
Table 1 Composition and substrate specificity of eukaryotic NATs Adapted from (Ree, Varland, and 
Arnesen 2018). aAmino acids are listed according to in vivo Nt-acetylation specificity. bNatF is located at the 
Golgi-membrane and performs post-translational Nt-acetylation. Common subunit names are given in 
parentheses. 
 NatA NatB NatC NatD NatE NatFb NatG NatH 
Prevalence All eukaryotes 
















Naa50 (Nat5) Naa60 Naa70 Naa80 
         
Auxiliary 
subunit 




— Naa10 — — — 
   Naa38 
(Mak31) 
 Naa15    












































(β- and γ- 
actin) 
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The NatA complex, which consists of the catalytic subunit Naa10 and the auxiliary subunit Naa15, 
co-translationally acetylates N-termini that bear a small amino acid after the initiator methionine is 
removed by methionine aminopeptidases3 (Arnesen et al. 2005; Arnesen et al. 2009; Liszczak et al. 
2013). NatA is the major NAT in view of the number of its potential substrates, which represent 46% 
of the human proteome (Fig. 2B), of which 83% is (partially or fully) Nt-acetylated and 17% is 
unacetylated. Thus, NatA is estimated to Nt-acetylate 38% (Fig. 2A) of the human proteome and an 
estimated 8% of potential NatA substrates are not acetylated (Ree, Varland, and Arnesen 2018). 
Notably, purified monomeric Naa10 has been shown to post-translationally acetylate acidic N-
termini (Asp- or Glu-) in vitro with β- (DDDI-) and γ-actin (EEEI-) being the most prominent 
substrates (Van Damme, Evjenth, et al. 2011; Liszczak et al. 2013). 
 
Fig. 2 The human Nt-acetylome. Adapted from Ree, Varland, and Arnesen (2018). (A) Prevalence of Nt-
acetylation in humans predicted by combining experimental data on all SwissProt entries (version 57.8.), based 
on the occurrence of the first two amino acids. (B) NAT substrate class and frequency. (C) N-terminal amino 
acid frequency. 
The NatB complex is formed by the catalytic subunit Naa20 and the auxiliary subunit Naa25. It co-
translationally acetylates N-termini starting with methionine, followed by an acidic residue (MD-, 
ME-) or their amide (MN-, MQ) (Starheim et al. 2008; Van Damme et al. 2012). NatB substrates 
 
3 The aminopeptidase removes methionine when it precedes a small amino acid with a gyration radius of 1.29 
Å or less, i.e. Ala, Cys, Gly, Pro, Ser, Thr or Val (Sherman, Stewart, and Tsunasawa 1985). 
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represent 21% of the human proteome (Fig. 2A) and almost every protein of this substrate class is 
acetylated (Fig. 2B, C). 
The heterotrimeric NatC complex, whose structure and function are the focus of this thesis, is 
composed of a catalytic subunit Naa30, a large auxiliary subunit Naa35 and a small auxiliary subunit 
Naa38. Polevoda and Sherman (2001) showed that deletion of any of the three subunits in yeast 
strains results in a lack of Nt-acetylation of a NatC substrate in vivo. 
NatC acetylates protein N-termini starting with methionine, followed by a hydrophobic amino acid 
(ML-, MI-, MF-, MW-) (Tercero, Dinman, and Wickner 1993; Polevoda et al. 1999; Kimura et al. 
2000; Polevoda and Sherman 2001; Starheim et al. 2009). Behnia et al. (2004) have shown that the 
N-terminus of the S. cerevisiae GTPase yArl3 (starting with MF-) is Nt-acetylated by NatC. They 
also showed that the human ortholog of yArl3, Arf-related protein 1 (ARFRP1), interacts with hSys1 
and that the alanine substitution of its tyrosine at position 2 disrupts this interaction, suggesting that 
MY-termini are additional targets of NatC. Human NatC has been shown to additionally acetylate 
MM-, MV-, MK- and MH-termini in vivo (Van Damme et al. 2016).  
Starheim et al. (2009) purified an MBP-tagged human Naa30 subunit which displayed N-terminal 
acetyltransferase activity toward ML- termini, suggesting that in humans, NatC activity and substrate 
specificity are at least in part contained within the catalytic core alone. They also showed that hNaa30 
knockdown cells (HeLa and CAL-62) demonstrated a stronger phenotype – a fragmentation of the 
Golgi stack – than hNaa35 and hNaa38 knockdown cells, suggesting that Naa30 has an additional 
function independent of Naa35 and Naa38. Also the Arabidopsis thaliana ortholog of Naa30, 
atNaa30 can functionally replace yeast Naa30, Naa35 and Naa38 (Pesaresi et al. 2003). While an 
atNaa30 mutant showed a decreased synthesis of the PSII core proteins D1 and CP47, resulting in 
decreased photosynthesis, no phenotype was observed for an atNaa35 mutant. These results indicate 
that Naa30 function does not strictly require NatC complex formation in higher eukaryotes, as it does 
in yeast. 
The monomeric NatD (Naa40) was identified as a highly selective NAT that Nt-acetylates the SG-
sequence of histones H4 and H2A in all species from yeast to mammals (Song et al. 2003; Hole et 
al. 2011). N-termini starting with serine are also typical NatA substrates. However, Mullen et al. 
(1989) found that the Nt-acetylation of histones H4 and H2A is not affected in S. cerevisiae Naa10 
or Naa15 mutant strains. 
NatE is composed of the catalytic subunit Naa50 and both NatA subunits Naa10 and Naa15 (Gautschi 
et al. 2003; Arnesen et al. 2006). Gautschi et al. (2003) were the first to notice that yeast NatA binds 
to another NAT, Naa50, forming a trimeric complex in a 1:1:1 ratio with Naa10 and Naa15. However, 
they observed no phenotype for a ΔNaa50 yeast strain, compared to ΔNaa10 or ΔNaa15 mutant 
strains, which show temperature sensitivity and reduced mating efficiency. However, yeast Naa50 
lacks the optimal acetyl-CoA binding motif (Arnesen et al. 2006) and is enzymatically inactive (Deng 
et al. 2019). A recent cryo-EM structure of the yeast NatA/Naa50 complex showed that yeast Naa50 
contributes to the NatA-ribosome interaction (Knorr et al. 2019).  
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Arnesen et al. (2006) demonstrated that the same heterotrimeric assembly (Naa10/Naa15/Naa50) 
exists in H. sapiens and, in contrast to yNaa50, is catalytically active. Uncomplexed human Naa50 
has been shown to efficiently acetylate ML- and MI- termini, thus partly overlapping with NatC 
substrate specificity, implying a functional redundancy; however a phenylalanine at position 2 led to 
a dramatic increase in the Km value for Naa50, in contrast to NatC (Evjenth et al. 2009). Due to the 
distinct NAT activity of Naa50, which is different from NatA, it is named NatE. Arnesen et al. (2006) 
furthermore showed that uncomplexed Naa50 also has a low lysine acetyltransferase (KAT) activity 
in vitro: it can Nϵ-acetylate histone H4 and also auto-acetylates three of its own lysines, albeit at a 
rate 2000 times slower than its NAT activity. They showed that Naa50 autoacetylation leads to an 
increased enzyme specificity toward NAT substrates, but decreased KAT activity. Van Damme et 
al. (2015) showed that ectopic expression of human Naa50 in S. cerevisiae resulted in Nt-acetylation 
of N-termini, starting with MK, MV, MA, MY, MF, ML, MS, and MT. The identification of 
acetylated iMet followed by a small residue (MA, MS, MT, MV), revealed a kinetic competition 
between Naa50 and methionine aminopeptidases (MetAPs). The authors have shown in vitro that Nt-
acetylated iMet cannot be removed by human MetAP2 and thus Naa50-mediated Nt-acetylation may 
act to retain the iMet of proteins, which are normally processed by MetAPs. They conclude that the 
physical association of Naa50 with the NatA complex might confer an ideal positioning to enable 
the two NATs to Nt-acetylate the very same N-termini, either with or without their iMet processed. 
Deng et al. (2019) showed that NatA/Naa50 complex formation enables a catalytic crosstalk between 
the Naa10 and Naa50 subunits, significantly increasing the catalytic efficiency of hsNaa50 in 
comparison to its uncomplexed state by dramatically increasing its substrate binding affinity. The 
catalytic efficiency of NatA was only slightly increased upon binding of Naa50. 
Naa60 (NatF) is only present in higher eukaryotes, where it contributes to the higher abundance of 
Nt-acetylation compared to lower eukaryotes. Like NatC and NatE, NatF can process Met-starting 
N-termini, with a preference for MK-, MA, MV- and MM- sequences (Van Damme, Hole, et al. 
2011). Aksnes et al. (2015) showed that Naa60 differs from all other NATs, as it is anchored to the 
cytosolic side of the Golgi, where it specifically acetylates transmembrane proteins, with a preference 
for cytosol-facing N-termini. 
Together NatC, E and F substrates cover ca. 28% of the human proteome (Fig. 2B), with 
approximately 75% of the potential substrates being partially or fully Nt-acetylated (Fig. 2A,C) (Ree, 
Varland, and Arnesen 2018). 
A seventh NAT, Naa70 (NatG), was recently discovered in A. thaliana (Dinh et al. 2015). AtNaa70 
is located in the chloroplast, where it acetylates iMet and non-Met starting substrates, with a 
preference for M-, A-, S-, or T-starting N-termini. Furthermore, the authors also detected an Nϵ-
acetylation activity of AtNaa70 on three internal lysines, similar to the autoacetylation activity 
observed for hsNaa50.  
Finally, Drazic et al. (2018) recently discovered Naa80, which is responsible for the post-
translational Nt-acetylation of processed actin in animals. Unprocessed cytosolic β- (MDDD-) or γ-
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actin (MEEE-) N-termini are co-translationally Nt-acetylated by NatB (Van Damme et al. 2012). 
Rubenstein and Martin (1983) have shown that the N-terminal acetyl group is removed by a still 
unknown acetylmethionine aminopeptidase. Finally, the new N-termini (DDD-/EEE-) are post-
translationally acetylated by the newly discovered Naa80, leading to the mature β- (Ac-DDD-) or γ-
actin (Ac-EEE-). 
1.6 Co-translational Nt-acetylation at the ribosome 
Gautschi et al. (2003) first revealed that NatA (Naa10/Naa15) is quantitatively anchored to ribosomes 
via Naa15. By using chemical peptide crosslinking, they showed that Naa15 contacts the nascent 
chain, when about 40 amino acids have emerged from the exit tunnel (resembling a total length of 
the nascent chain of ca. 80 amino acids). They furthermore identified a direct interaction of Naa50 
with NatA, which is thus also placed in close proximity to the ribosomal exit tunnel. Neither Naa10 
nor Naa50 alone were able to bind to ribosomes without Naa15. Thus, the function of the NatA 
auxiliary subunit Naa15 seems to be the guidance of the growing peptide chain to the catalytic subunit 
Naa10 and, possibly, also Naa50, for co-translational acetylation of their corresponding substrates. 
 
Fig. 3 Subunit composition and location of the NAT machinery Adapted from Aksnes et al. (2016). The 
catalytic subunits are typically associated with up to two auxiliary subunits that contribute to NAT complex activity 
through ribosome anchoring, complex stabilization and/or modulation of substrate specificity. 
Later, ribosome interaction was demonstrated for all major eukaryotic NATs, NatA to NatE 
(Polevoda et al. 2008; Polevoda, Hoskins, and Sherman 2009; Hole et al. 2011), except for NatF, 
which specifically associates with Golgi membranes and acetylates transmembrane proteins (Aksnes 
et al. 2015) (see Fig. 3). Furthermore, Polevoda et al. (2008) constructed yeast strains with deletions 
of the NAT auxiliary subunits and could show that, in contrast to NatA, the catalytic subunit of NatC, 
Naa30, also binds in the absence of its auxiliary subunits Naa35 and Naa38. Moreover, they 
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identified the ribosomal proteins uL14 and uL23 to be associated with NatA. Both proteins are 
located in close proximity to the ribosomal exit tunnel. A recent cryo-EM structure of the 
NatA/Naa50-ribosome complex (Knorr et al. 2019) showed that both Naa15 and Naa50 interact with 
ribosomal RNA expansion segments, which positions NatA/Naa50 dynamically in close proximity 
to the ribosomal exit tunnel. 
1.7 Diverse functions of N-terminal acetylation 
Originally, it was thought that N-terminal acetylation might have a protective function towards 
proteolysis (Persson et al. 1985; Jornvall 1975), which was supported by initial experiments showing 
a stabilizing role of the acetylated N-termini (Hershko et al. 1984). In 2004, it was shown that proteins 
without a lysine can be degraded by the ubiquitin system via conjugation of the first ubiquitin moiety 
to the N-terminal residue, instead of the much more common conjugation to internal lysine residues 
(Ben-Saadon et al. 2004). Thus, Nt-acetylation had been proposed as a mechanism for blocking N-
terminal ubiquitination and therefore preventing degradation. However, the exact opposite function 
for Nt-acetylation has been identified as well: The Doa10 ubiquitin ligase specifically targets 
acetylated protein N-termini for subsequent proteasome-dependent degradation (Hwang, Shemorry, 
and Varshavsky 2010).  
Nt-acetylation furthermore affects membrane targeting and the subcellular location of proteins: Nt-
acetylation of α-synuclein was demonstrated to stabilize its N-terminal helix, which increased its 
affinity to lipid vesicles of moderate charge similar to synaptic vesicles (Dikiy and Eliezer 2014). 
The small GTPase ARFRP1 and its yeast counterpart yArl3 are both Nt-acetylated by the NatC 
complex. The acetylated N-termini bind directly to the trans-Golgi specific transmembrane protein 
hSys1/Sys1p, thus determining the localization of hARFRP1/yArl3 at the trans face of the Golgi 
apparatus (Behnia et al. 2004; Setty et al. 2004). Moreover, Starheim et al. (2009) showed that 
depletion of hNaa30 induces a fragmentation of the Golgi stack in HeLa and CAL-62 cells. 
Using an S. cerevisiae Naa30 mutant strain, Tercero and Wickner (1992) found that the MAK3 gene 
is necessary for N-terminal acetylation of the major capsid protein Gag of the yeast L-A virus and 
that this modification is necessary for viral particle assembly. Polevoda and Sherman (2001) showed 
that deletion of any NatC subunit in yeast results in lack of acetylation, diminished growth and the 
defective assembly of L-A viral particles. 
In 2011, the first human genetic disorder related to a NAT gene was identified. A point mutation 
within the X-linked NAA10, coding for the catalytic subunit of NatA, causes a missense mutation 
(S37P), which leads to a significant decrease of Nt-acetylation activity. The afflicted boys suffering 
from the associated Ogden syndrome had an aged appearance, craniofacial anomalies, hypotonia, 
global development delays, cardiac arrhythmias and died during infancy (Rope et al. 2011). 
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1.8 The structure of NAT enzymes 
During the last years, crystal structures of several Nα-acetyltransferases and NAT complexes have 
shed light on the structural mechanism of Nt-acetylation (Table 1). The structure of all major 
eukaryotic NATs, with the exception of the heterotrimeric NatC complex, have been solved in the 
presence of (acetyl-) coenzyme A and several different peptides, resembling their natural substrates  
Table 2 Published structures of N-terminal acetyltransferases. With PDB, Protein Data Bank and (EMD), 






Archaeal NAT complexes 
4LX9 Archaeal NAT bound to AcCoA 2.0 S. solfataricus (Liszczak and Marmorstein 2013 
     
 
NatA complex (Naa10/Naa15), Naa10 monomer, NatA-Naa50, NatA-HYPK, NatA-Ribsome 
4HNY Apo NatA complex 2.3 S. cerevisiae (Neubauer et al. 2012)a 
4HNX NatA bound to ppGpp 2.3 
4HNW NatA bound to Inositol Hexakisphosphate 2.8 
4KVX Naa10 bound to AcCoA 2.0 S. pombe (Liszczak et al. 2013) 
4KVM NatA bound to a bisubstrate analog 2.6 
4KVO NatA bound to AcCoA 3.2 
5C88 Apo Naa10 2.5 S. solfataricus (Chang and Hsu 2016) 
5NNP, 
5NNR 
NatA bound to HYPK-THB 2.6 
3.1 
C. thermophilum (Weyer et al. 2017) 
6C9M NatA complex 2.8 H. sapiens (Gottlieb and Marmorstein 2018) 
6C95 NatA bound to HYPK 3.2 
6HD7 Ribosome-NatA/Naa50 Cryo-EM structure 3.4 S. cerevisiae (Knorr et al. 2019) 
6O07 Dual enzyme NatA/Naa50 complex 2.7 S. cerevisiae (Deng et al. 2019) 
 
NatB complex (Naa20/Naa25) 
5K04 NatB bound to CoA and MES 2.4 C. albicans (Hong et al. 2017) 
5K18 NatB bound to bisubstrate inhibitor 2.7 
 
Naa40 (NatD) 
4U9V Naa40 bound to AcCoA 1.8 H. sapiens (Magin, Liszczak, and 
Marmorstein 2015) 4U9W Naa40 bound to H4/H2A peptide and CoA 2.5 
4UA3 Selenomethionine labeled Naa40 1.9 S. pombe 
 
Naa50 (NatE) 
3TFY Naa50 bound to substrate peptide and CoA 2.8 H. sapiens (Liszczak, Arnesen, and 
Marmorstein 2011) 
4X5K Naa50 with CoA and an acetylated peptide 2.5 H. sapiens (Reddi, Neubauer et al.  2014)a 
4XNH Naa50 (IP6) bound to a bisubstrate 2.1 S. cerevisiae (Dong, Neubauer et al. 2015)a 
 
Naa60 (NatF) 
5HGZ Naa60 bound to AcCoA 1.4 H. sapiens (Chen et al. 2016) 
5HH0 Naa60 bound to CoA 1.6 
5ICW Naa60 homodimer bound to CoA 2.0 H. sapiens (Stove et al. 2016) 
5ICV Naa60 bound to a bisubstrate analogue 1.5 
 
Naa80 (NatH) 
5WJD Naa80 bound to AcCoA 2.0 D. melanogaster (Goris et al. 2018) 
5WJE Naa80 bound to a bisubstrate analogue 1.8 
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The catalytic subunits of NATs belong to the GCN5-related N-acetyltransferase (GNAT) 
superfamily, which is an enormous superfamily of enzymes that uses acyl-CoAs (e.g. acetyl-CoA, 
propionyl-CoA and myristoyl-CoA) to acylate their cognate substrates. The superfamily includes, 
among others, Nα-terminal acetyltransferases (NATs), lysine acetyltransferases (KATs), 
aminoglycoside N-acetyltransferases (AACs), serotonin N-acetyltransferases (SNATs) and N-
myristoyl transferases (NMTs) (Vetting et al. 2005). 
All NATs share the structural GNAT domain (see Fig. 4), which is composed of an N-terminal strand 
(β1), followed by two helices (α1 and α2), three antiparallel strands (β2-β4), followed by a 
“signature” central helix (α3), a fifth strand (β5), a fourth helix (α4) and a final strand (β6) (Fig. 
4B,C) (Vetting et al. 2005). Beta strands four and five splay apart, as a result of a β-bulge in β4. 
The GNAT domain contains a central conserved CoA-binding motif, with the sequence Q/R-x-x-G-
x-G/A (where x is any amino acid) and is located in the β4–α3 loop (Lu, Berkey, and Casero 1996; 
Wolf et al. 1998). Substrate specificity of NAT enzymes is mediated by the N-terminal α1–loop–α2 
region and a C-terminal β-hairpin loop (β6–loop–β7) (Liszczak, Arnesen, and Marmorstein 2011; 
Liszczak et al. 2013). 
 
Fig. 4 NATs and KATs share a conserved GNAT fold. (A) Crystal structures of human Naa50 (left, PDB 
accession code 3TFY) and Tetrahymena thermophila Gcn5 (right, PDB code 1QSN) as representative of NAT 
or KAT enzymes, respectively. (B) Topology plot, showing the conserved GNAT-fold and the structural 
differences between NATs and KATs at the C-terminal end. 
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Liszczak, Arnesen, and Marmorstein (2011) solved the first crystal structure of an Nα-terminal 
acetyltransferase and showed that Naa50 can only accommodate an α-amino substrate and not a side 
chain lysine, which is acetylated by lysine acetyltransferases (KATs) like the histone 
acetyltransferase Gcn5. They have mapped the largest region of structural divergence between NATs 
and KATs to the C-terminal end of the two proteins (compare the two structures in Fig. 4). In 
hsNaa50, this region forms a β-hairpin (β6–loop–β7) containing a relatively long 14-residue loop, 
that blocks off part of the NAT substrate binding-site. In the KAT Gcn5, this region forms a loop–
helix–loop–strand motif, which facilitates the formation of a relatively wide substrate-binding site 
(Liszczak, Arnesen, and Marmorstein 2011; Rojas et al. 1999). 
As mentioned earlier, NatF/Naa60 differs from the ribosome-associated NatA to NatE as it 
specifically associates with Golgi membranes and acetylates transmembrane proteins. The 
subcellular location of Naa60 depends on a unique C-terminal membrane-integration region (Aksnes 
et al. 2015). 
 
Fig. 5 Comparison of the monomeric and dimeric states of Naa60 Monomeric human Naa60 (cyan) is bound 
to the bisubstrate analog CoA-Ac-MKAV. Homodimeric Naa60 (in green and gold) bound to CoA. A 
superposition of the two structures reveals the movements in the β6–β7 loop. The PDB accession codes for 
monomeric and dimeric hsNaa60 are 5ICW and 5IVC, respectively. 
The crystal structure of human Naa60 furthermore revealed the presence of two unique elongated 
loops within the conserved NAT region (Stove et al. 2016). The elongated β3–β4 loop folds back 
toward the enzyme core and is essential for protein stability. The β6–β7 loop of Naa60 hangs over 
the peptide binding site in a manner characteristic of all NATs. However, in Naa60, the β-hairpin 
structure of this loop contains two additional short strands, which the authors named β6’ and β7’. 
This loop mediates dimerization of hsNaa60 in the absence of substrate peptide (Fig. 5), a feature 
that has not been seen for any other NAT. The β6–β7 loops of both protomers extend in the active 
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sites of each other, thereby competing with peptide binding. Stove et al. (2016) suggest that this 
could be a way to regulate substrate specificity, as the affinity for a potential substrate would need 
to be higher than the affinity for the other protomer of the dimer.  
Liszczak et al. (2013) solved the structure of the heterodimeric Schizosaccharomyces pombe NatA 
complex, which is composed of the catalytic subunit Naa10 and the large auxiliary subunit Naa15. 
They showed that Naa15 adopts a ring-like topology, that wraps around Naa10 (Fig. 6, top). This 
interaction alters the catalytic activity of Naa10 for substrate-specific Nt-acetylation.  
The heterodimeric NatB complex (Naa20/Naa25) forms a very similar tertiary and quaternary 
structure (Hong et al. 2017) (Fig. 6, bottom) with the auxiliary subunit Naa25 forming a ‘horseshoe-
like deck’ that specifically hold its catalytic subunit Naa20. In contrast to NatA, the auxiliary subunit 
of NatB is essential for the solubility of its catalytic subunit Naa20. 
The α-helices in the NatA and NatB auxiliary subunits form several helical bundle tetratricopeptide 
repeats (TPR). The TPR motif adopts a basic helix-turn-helix fold and consists of 34 amino acids 
with a degenerate consensus sequence, containing small and large hydrophobic amino acids (Zeytuni 
and Zarivach 2012). These repeats form a tertiary structure, which is found in numerous proteins and 
serves as an interaction module and mediator for heteromeric complex formation. 
 
Fig. 6 Structures of the heterodimeric NatA and NatB complexes. Cartoon and surface presentations of 
Schizosaccharomyces pombe NatA (top) and Candida albicans NatB (bottom). NatA and NatB were both co-
crystallized with a bisubstrate analog, CoA-SASE and CoA-MDEV, respectively. The catalytic subunits of NatA 
and NatB, Naa10 and Naa20 (cyan), are surrounded by their corresponding auxiliary subunit Naa15 or Naa25, 
respectively. 
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Deng et al. (2019) recently solved the structure of the trimeric NatA/Naa50 complex which comprises 
subunits Naa10, Naa15 and Naa50 (see Fig. 7, left). They could show that NatA/Naa50 complex 
formation enables a catalytic crosstalk between the Naa10 and Naa50 subunits, significantly 
increasing the catalytic efficiency of hsNaa50 in comparison to its uncomplexed state, by drastically 
increasing its substrate binding affinity. The catalytic efficiency of NatA was only slightly increased 
upon binding of Naa50. They concluded that the physical association of Naa50 with the NatA 
complex might infer an ideal positioning to enable the two NATs to Nt-acetylate the very same N-
termini, either with or without their iMet processed. A recent cryo-EM structure of the trimeric 
NatA/Naa50 complex bound to the S. cerevisiae ribosome (Knorr et al. 2019), revealed that the 
trimeric NatA/Naa50 complex interacts with ribosomal RNA expansion segments via Naa15 and 
Naa50 (Fig. 7, right). Both catalytic subunits Naa10 and Naa50 are positioned dynamically in close 
proximity to the ribosomal exit tunnel. 
 
Fig. 7 Structures of heterotrimeric yeast NatA/Naa50 and the yNatA/Naa50-ribosome complex. Crystal 
structures of yeast NatA/Naa50 (PDB accession code 6O07, left). Molecular model of the NatA/Naa50-ribosome 
complex solved by cryo-EM (6HD7, right). The NatA/Naa50 complex binds to ribosomal RNA expansion 
segments (blue) near the nascent polypeptide exit tunnel (PE). 
As described in an earlier section (see section 1.5), NatA is the major NAT in eukaryotes and is 
estimated to Nt-acetylate 38% of the human proteome (Ree, Varland, and Arnesen 2018). In search 
for possible NatA regulators, Arnesen et al. (2010) identified the Huntingtin yeast two-hybrid protein 
K (HYPK) as a stable interactor of NatA. HYPK was first identified in a yeast two-hybrid screen as 
an interaction partner of Huntingtin protein, which is associated with the neurodegenerative 
Huntigton’s disease (Faber et al. 1998). HYPK was shown to be intrinsically disordered 
(Raychaudhuri et al. 2008) and Arnesen et al. (2010) demonstrated that NatA is required for the 
stability of HYPK and that both proteins prevent aggregation of the Huntingtin protein. Furthermore, 
HPYK is required for N-terminal acetylation of a known in vivo NatA substrate protein, PCNP 
(Arnesen et al. 2010). Recent studies of the Chaetomium thermophilum (Weyer et al. 2017) and 
human (Gottlieb and Marmorstein 2018) NatA/HYPK complexes, revealed that the HYPK C-
terminal region is responsible for high affinity association with the C-terminal part of the NatA 
auxiliary subunit Naa15 (see Fig. 8, right). The N-terminus of HYPK binds to the Naa10 active site 
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entrance and inhibits the NatA catalytic activity in vitro (Weyer et al. 2017; Gottlieb and 
Marmorstein 2018). Gottlieb and Marmorstein (2018) conclude, that while HYPK inhibits NatA 
activity in vitro, it likely plays a more nuanced regulatory role in vivo, where it functions as part of 
an hNatA substrate proofreading mechanism. 
 
Fig. 8 Structures of the heterotrimeric NatA/Naa50 and NatA/HYPK complexes Crystal structures of yeast 
NatA/Naa50 (left, PDB accession code 6O07) and human NatA in complex with the Huntington yeast two-hybrid 
protein (HYPK) (right, PDB code 6C96). 
Although HYPK and Naa50 bind to different NatA surfaces (compare both images in Fig. 8), they 
mediate NatA conformational changes, which prevent simultaneous binding of HYPK and Naa50 to 
NatA in humans and was confirmed by competitive pull-down studies. Thus, hHYPK binding blocks 
hNaa50 targeting to hNatA, thereby indirectly inhibiting the co-translational activity of hNatE. 
Gottlieb and Marmorstein (2018) suggest that an additional cellular protein might facilitate the 
simultaneous binding of HYPK and Naa50 to NatA in metazoans. 
1.9 General catalytic mechanism 
On the basis of many structural and functional studies of GNAT enzymes, a common general 
catalytic mechanism was identified, which involves the direct transfer of an acyl group from a donor 
substrate (usually acetyl CoA) to the amino group of an acceptor substrate (Fig. 9) (Salah Ud-Din, 
Tikhomirova, and Roujeinikova 2016).  
The first step of the catalytic mechanism usually involves the deprotonation of the amino group 
(-NH3+) of the acceptor substrate, which is mediated by an amino acid (usually Glu, Asp or Ser) near 
the active site that serves as a general base (B) and extracts a proton from the amino group of the 
peptide. 
Second, the deprotonated amino group attacks the carbonyl carbon of the enzyme bound AcCoA, 
forming a transient zwitterionic tetrahedral intermediate. The breakdown of the intermediate occurs 
through a proton transfer from a general acid (H-A), usually Tyr or Ser and may involve 
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deprotonation of the tetrahedral intermediate by a general base. Finally, the acetylate product is 
released. Deprotonation of the acceptor substrate may also occur via ordered water molecules. 
 
Fig. 9 General direct acetyl-transfer mechanism of GNAT superfamily members. B, general base (usually 
a Glu, Asp or Ser; H-A, general acid, usually Tyr or Ser). Adapted from (Salah Ud-Din, Tikhomirova, and 
Roujeinikova 2016) 
 
1.10 Objectives of this work 
The only major eukaryotic N-terminal acetyltransferase that has thus far eluded structural 
characterization is the heterotrimeric NatC complex, which consist of the catalytic subunit Naa30 
and the two auxiliary subunits Naa35 and Naa38. It is the only known NAT that strictly requires two 
auxiliary subunits for Nt-acetylation in vivo. The known substrate specificity profile of NatC includes 
methionine N-termini followed by a hydrophobic amino acid or lysine and partially overlaps those 
of NatE and NatF (see above). 
In order to obtain insights into the tertiary and quaternary assembly of NatC, its structure was solved 
by X-ray crystallography. To unravel the structural mechanism for substrate-specific recognition, 
additional structures of NatC in complex with its cognate substrates were determined. Independent 
biochemical studies with recombinant purified protein provided further insights into substrate 
specificity and catalysis, culminating into a reaction scheme for the catalytic mechanism of NatC. 
Finally, this work aimed to characterize the interaction of NatC with the ribosome and confirm 
ribosome binding patches on the NatC surface by co-sedimentation assays. 
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Coomassie® Brilliant Blue G 250 Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Copper(II) sulfate pentahydrate, puriss. Sigma-Aldrich, Inc. St. Louis, MO, USA 
5,5′-Dithiobis(2-nitrobenzoic acid) (DTNB), ≥98 % Sigma-Aldrich, Inc. St. Louis, MO, USA 
1,4-Dithiothreitol (DTT), ≥99 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Dimethyl sulfoxide (DMSO) New England Biolabs Inc., Ipswich, MA, USA 
Ethylenediamine tetraacetic acid (EDTA) disodium salt 
dihydrate, ≥99 % 
Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Ethylene glycol, for analysis EMSURE® Sigma-Aldrich, Inc. St. Louis, MO, USA 
Formaldehyde, 16% (w/v), methanol-free, Pierce™  Thermo Fisher Scientific, Waltham, MA, USA 
D(+)-Glucose monohydrate, for microbiology Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Glycerol, ≥99.5 % anhydrous Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Glycine, ≥99 %, for synthesis Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Guanidine hydrochloride, ≥99.5 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Imidazole, PUFFERAN® ≥99 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Iron(II) sulfate heptahydrate, ≥99 % Sigma-Aldrich, Inc. St. Louis, MO, USA 
L-Isoleucine,  ≥98% Sigma-Aldrich, Inc. St. Louis, MO, USA 
Isopropyl-β-D-thiogalactopyranoside (IPTG), ≥99 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
≥99.5% 
Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Hydrochloric acid, 32%, extra pure Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Kanamycin sulfate  ≥750 I.U./mg, for biochemistry Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
L-Leucine, ≥99.5% Sigma-Aldrich, Inc. St. Louis, MO, USA 
L-Lysine crystallized, ≥98.0% Sigma-Aldrich, Inc. St. Louis, MO, USA 
Magnesium sulfate, anhydrous Merck KGaA, Darmstadt, Germany 
Magnesium chloride, hexahydrate, ≥99.0% Sigma-Aldrich, Inc. St. Louis, MO, USA 
Manganese(II) chloride, tetrahydrate, ≥99.0% Sigma-Aldrich, Inc. St. Louis, MO, USA 
2-Mercaptoethanol, ≥99.0% Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Methanol, ≥ 99.8 % Th. Geyer GmbH & Co. KG, Renningen, Germany 
L-Phenylalanine, ≥99.0% Sigma-Aldrich, Inc. St. Louis, MO, USA 
Poly(ethylene glycol) BioUltra, 4,000 Sigma-Aldrich, Inc. St. Louis, MO, USA 
Ponceau S, for electrophoresis Merck KGaA, Darmstadt, Germany 
Potassium dihydrogen phosphate, ≥99 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
L-Selenomethionine, ≥97 % Merck KGaA, Darmstadt, Germany 
Silver nitrate solution 5% (w/v) Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Skim milk powder, for microbiology Sigma-Aldrich, Inc. St. Louis, MO, USA 
Sodium carbonate, anhydrous, ≥98 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Sodium chloride, ≥99.8 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Sodium citrate tribasic dihydrate, ≥99.5 % Sigma-Aldrich, Inc. St. Louis, MO, USA 
Sodium hydroxide, ≥98 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Sodium phosphate monobasic dihydrate, ≥99 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Sodium phosphate dibasic, ≥99 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Terrific broth, modified Melford Laboratories Ltd., Chelsworth, UK 
L-Threonine, ≥99.0% Sigma-Aldrich, Inc. St. Louis, MO, USA 
Trifluoroacetic acid (TFA), ≥99 % Sigma-Aldrich, Inc. St. Louis, MO, USA 
Tris-(hydroxymethyl)-aminomethan (TRIS), ≥99.9 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
Tween® 20, Ph. Eur. Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
L-Valine, ≥99.0% Sigma-Aldrich, Inc. St. Louis, MO, USA 
Zinc sulfate, heptahydrate, ≥99.5 % Carl Roth GmbH + Co. KG, Karlsruhe, Germany 
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2.4 Antibodies 
Monoclonal ANTI-FLAG® M2 antibody, mouse Sigma-Aldrich, Inc. St. Louis, MO, USA 
Anti-RPL7 antibody (ab72550), mouse Abcam plc, Cambridge, UK 
Goat IgG anti-Mouse IgG (H+L)-HRPO, MinX (115-035-003) 
Goat IgG anti-Rabbit IgG (H+L)-HRPO, MinX (111-035-003) 
DIANOVA GmbH, Hamburg Germany 
2.5 Enzymes 
Taq DNA polymerase with ThermoPol® Buffer 
Phusion® High-Fidelity DNA polymerase (2000 U/mL) with 
Phusion® HF Buffer 
Shrimp alkaline phosphatase (rSAP) 
T4 DNA Ligase with T4 DNA ligase Buffer 
Restriction Enzymes: BamHI-HF, MfeI-HF, NdeI, NotI, PvuI-
HF, XhoI, 
New England Biolabs Inc., Ipswich, MA, USA 
PreScission® protease for GST-tag removal GE Healthcare Life Sciences, Chicago, IL, USA 
Benzonase® endonuclease, >90%, 25 U/µL Merck KGaA, Darmstadt, Germany 
DNase I, grade II, from bovine pancreas Roche Diagnostics GmbH, Mannheim, Germany 
Endoproteinase Glu-C (S. aureus V8) Roche Diagnostics GmbH, Mannheim, Germany 
2.6 Bacterial strains  
E. coli BL21(DE3) New England Biolabs Inc., Ipswich, MA, USA 
2.7 Plasmids and cDNA clones 
pRSFDuet-1™ (Novagen) Merck KGaA, Darmstadt, Germany 
 
Table 3 cDNA clones 
Clone Manufacturer 
pRSFDuet-1™ (Novagen) Merck KGaA, Darmstadt, Germany 
 
E. coli clones from Dharmacon yeast ORF collection 
S. cerevisiae NAA35 (MAK10) 
Clone ID: YEL053C 
Accession: NM_001178868.3 / NP_010861.3 
Uniprot ID: Q02197 
Dharmacon, a Horizon Discovery Group Co., 
Cambridge, UK 
S. cerevisiae NAA30 (MAK3) 
Clone ID: YPR051W 
Accession: NM_001184148.1 / NP_015376.1 
Uniprot ID: Q03503 
S. cerevisiae NAA38 (MAK31 / LSM9 / SMX1) 
Clone ID: YCR020C-A 
Accession: NM_001178734.1 / NP_009948.1 
Uniprot ID: P23059 
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2.8 Peptides 
All peptides were synthesized by ProteoGenix (Schiltigheim, France) with a purity of ≥95% and with 
trifluoroacetic acid (TFA) exchanged for HCl. The first five amino acids of all peptides correspond 
to the N-terminal sequence of known NatA (SASEA), NatB (MDESV) or NatC (MFHLV, MYTLL 
and MLRFV) substrates as detailed in Table 4. The remaining C-terminal residues correspond to a 
short GS-linker followed by three arginine residues to increase solubility of the peptide. 
Table 4 Peptides used for co-crystallization and acetyltransferase assays. aAll peptides are decamers 
ending on the C-terminal five residues: GSRRR. 
N-terminal five 
residuesa 




SASEA Threonine-tRNA ligase (ThrRS) S. cerevisiae P04801 1076.1 
MDSEV Actin S. cerevisiae P60010 1192.3 
     
MYTLL ADP-ribosylation factor-related protein 1 (Arfrp1) H. sapiens Q13795 1252.5 




     
MFHLV ADP-ribosylation factor-like protein 3 (Arl3) S. cerevisiae Q02804 1258.5 
 
Arl3 variants with aromatic amino acid substitutions at position 2 
MYHLV Arl3 variant F2→Y - - 1274.61 
MWHLV 
Arl3 variant F2→W 
 
- - 1297.64 
 
Arl3 variants with alanine substitutions at positions 2, 3 and 4 
MAHLV Arl3 variant F2→A - - 1182.51 
MFALV Arl3 variant H3→A - - 1192.54 
MFHAV 
Arl3 variant L4→A 
 
- - 1216.41 
 
Arl3 variants with single amino acid substitution to Gag peptide at position 2, 3 or 4 
MLHLV Arl3 variant F2→L - - 1224.48 
MFRLV Arl3 variant H3→R - - 1277.65 
MFHFV 
Arl3 variant L4→F 
 
- - 1292.63 
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2.9 DNA oligonucleotides 
DNA oligonucleotides were ordered from Eurofins Genomics at a synthesis scale of 0.01 - 0.05 µmol 
in High Purity Salt Free (HPSF) quality. 
Table 5 Oligonucleotides for NatC expression vectors 
Name Sequence 5’ → 3’ 5‘ overhang 
Naa30 Fw 
GGC CGATCG AAGGAG ATATACC 
ATGGAAATAGTGTACAAGCCATTG 
RBS+PvuI 
Naa30 Rv GGC CTCGAG TTA TGTGGCCAGCCGGCC XhoI 
Naa30ΔC17 Rv 





















Naa35 Rv GGC GCGGCCGC TTATTTATAGCGGTCTTGC NotI 
Naa38 Fw  GGC CATATG GACATCTTGAAACTGTC NdeI 
Naa38 Rv GGC CAATTG CTAAACAATATTAGCCATCAATTC MfeI 
Naa38ΔC11 Fw CTGCAGGAGCTTACTTAGCAATTGGATATC Overlap for Site-
directed mutagenesis Naa38ΔC11 Rv GATATCCAATTGCTAAGTAAGCTCCTGCAG 
 
Table 6 Oligonucleotides for Naa35 ribosome binding mutants 
Name Sequence 5’ → 3’ 
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Table 7 Oligonucleotides for Naa30 and Naa35 mutants
Name Sequence 5’ → 3’ 
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2.10 Growth media 
Lysogeny broth (LB) medium was used for E. coli precultures and during transformations for cell 
recovery after heat shock treatment. LB medium consisted of 0.5% (w/v) yeast extract, 1% (w/v) 
tryptone, and 1 % (w/v) NaCl. TB medium (Melford Laboratories Ltd.) was used for E. coli 
expression cultures and consisted of 12 g/L casein digest peptone, 24 g/L yeast extract, 9.5 g/L 
K2HPO4, 2.2 g/L KH2PO4 and was supplemented with 0.4% (v/v) glycerol. M9 minimal medium was 
used for expression of Selenomethionine-labelled NatC and contained the components listed in Table 
8 to Table 10. 
Table 8 M9 minimal medium. Components were added according to the table order (i.e. top to bottom). 
Volume Solution Component c (final) 
~865.7 mL ddH2O (autoclaved)   
100 mL 10 × M9 salts 
Na2HPO4 100 mM 
KH2PO4 22 mM 
NaCl 8.56 mM 
20 mL 20% (w/v) glucose (filter sterilized) “ 0.4% (w/v) ≜ 4 g/L 
2 mL 1M MgSO4 (filter sterilized) “ 2 mM 
2 mL 5.0 g /20 mL NH4Cl (filter sterilized)  0.5 g/L ≜ 9.35 mM 
300 µL 1M CaCl2  0.3 mM 
10 mL 100× Trace elements 
EDTA, anhydrous 171 µM 
Fe2SO4 33 µM 
ZnCl2 / ZnSO4 3.7 µM 
CoSO4  / CoCl2 0.64 µM 
CuCl2 / CuSO4 0.74 µM 
H3BO3 1.62 µM 
MnCl2 81 µM 
 
Table 9 M9 salt solution (10× concentrate, pH 7.0-7.4) 
Salt / (substitute) MW (g/mol) β c (10× conc.) 
Na2HPO4 141.96 142 g/L 1 M 
KH2PO4 136.09 30 g/L 220 mM 
NaCl 58.44 5 g/L 85.6 mM 
 
Table 10 Trace element solution (100× concentrate) 
Salt / (substitute) MW (g/mol) β c (100× conc.) 
EDTA (anhydrous) 292.24 5 g/L 17.1 mM 
Fe2SO4 × 7 H2O 278.01 915.0 mg/L 3.3 mM 
 ZnSO4 × 7 H2O 287.56 105.5 mg/L 0.37 mM 
CoCl2 × 6 H2O 237.93 15.3 mg/L 64 µM 
CuSO4 × 5 H2O 249.69 18.6 mg/L 74 µM 
H3BO3 61.83 10 mg/L 162 µM 
MnCl2 × 4 H2O 197.91 1.6 g/L 8.1 mM 
 
 






Bruker Corporation, Billerica, MA, USA 
Rock maker Formulatrix, Bedford, MA, USA 
PyMOL, Version 2.3.1 Schrödinger, LLC. 
ImageJ, Version 1.52a (Schneider, Rasband, and Eliceiri 2012) 
Adxv, Version 1.9.14 https://www.scripps.edu/tainer/arvai/adxv.html 
Albula Dectris Ltd., Baden-Daettwil, Switzerland 
Phenix, Version 1.13-2998 Adams et al. (2010) 
 Phenix.refine (Afonine et al. 2012) 
 Phaser (McCoy et al. 2007) 
Geneious® 11.0.2 (Kearse et al. 2012) 
MXCuBE2 (Oscarsson et al. 2019) 
Coot/WinCoot, Version 0.8.9.1 (Emsley et al. 2010) 
iMOSFLM, Version 7.2.2 (Battye et al. 2011) 
XDS, Version Mar 15, 2019 (Kabsch 2010) 
 
HKL2Map (graphical user interface) 
 
(Pape and Schneider 2004) 




(Winn et al. 2011) 
 Freerflag (Brunger 1992) 
 Buccaneer (Cowtan 2006) 
 pdbcur 
Eugene Krissinel, European Bioinformatics Institute, Cambridge, 
UK. 
Martyn Winn, Daresbury Laboratory, UK - some additional 
keywords. 
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3 Methods 
3.1 Cloning of the NatC complex 
3.1.1 PCR reactions 
All routine PCR reactions were performed with the Phusion High-Fidelity DNA polymerase due to 
its 50× higher fidelity compared to Taq DNA polymerase.4 The final concentrations in a 50-µL 
reaction were: 1 U/50 µL Phusion DNA polymerase, 1× Phusion HF buffer, 200 µM dNTPs, 0.5 µM 
forward and reverse primer, 3% (v/v) DMSO and 20 pg/µL template DNA. The thermocycling 
conditions are displayed in Table 11. 
Site directed mutagenesis (SDM) was performed to make specific, targeted changes in double 
stranded plasmid DNA, including insertions, deletions and substitutions of DNA. For single base-
pair substitutions, the same reaction mix as for the routine PCR was used in a 20-µL reaction, except 
with a 100× higher final template DNA concentration of 2 ng/µL. For SDM reactions that aimed to 
substitute multiple subsequent base pairs, a two-step protocol was used. The reaction mix was split 
into 2×10 µL and 0.5 µM of either forward or reverse primer were added to the separate reactions. 
The thermocycler protocol was run for three cycles, after which the individual reactions were 
combined, and the protocol was continued for another 15 cycles. 
Colony PCR was used to determine the presence or absence of insert DNA in plasmid constructs. 
The final concentrations in a typical 20-µL reaction were: 0.5 U/20 µL Taq DNA polymerase5, 1× 
ThermoPol buffer, 200 µM dNTPs, 0.2 µM forward and reverse primer and 3 % (v/v) DMSO. A 
single colony was slightly touched with a sterile pipette tip, which was then resuspended in a PCR 
tube containing the complete PCR reaction mix. 
Table 11 Thermocycling conditions for different PCR applications  
 Routine PCR Site-directed mutagenesis Colony-PCR 
DNA Polymerase Phusion Phusion Taq 
Initial Denaturation 98 °C, 30 s 98 °C, 30 s 95 °C, 5 min 
Denaturation 98 °C, 10 s 98 °C, 10 s 95 °C, 20 s 
Annealing 45-72 °C, 20 s 45-72 °C, 20 s 45-68 °C, 30 s 
Extension 
72 °C, ~ 30-60 s 
(30 s/ 1000 bp) 
72 °C, ~ 3 min 
(30 s/ 1000 bp) 
68 °C, ~1-5 min 
(1 min/1000 bp) 
Number of cycles 30 
30 (one-step variant) 
3 and 15 (two-step variant) 
25 
Final extension 72 °C, 5 min 72 °C, 8 min 68 °C, 5 min 
 
4 https://international.neb.com/products/m0530-phusion-high-fidelity-dna-polymerase (Phusion DNA polymerase is 
provided at 2000 U/µL. 1 U (unit) is defined for Phusion DNA Polymerase as the amount of enzyme that will incorporate 
10 nmol of dNTP into acid insoluble material in 30 min at 74 °) 
5 Taq DNA polymerase is provided at 5000 U/µL. 1 U is defined as the amount of enzyme that will incorporate 15 nmol 
of dNTP into acid insoluble material in 30 min at 75 °C (https://international.neb.com/products/m0267-taq-dna-
polymerase-with-thermopol-buffer) 
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3.1.2 Enzymatic assembly of DNA using restriction digestion and ligation 
Classical enzymatic assembly using restriction digestion and ligation was used to insert DNA into 
expression vectors. 
Both the plasmid DNA and the insert were digested with the same set of restriction enzymes. A 
50 µL restriction digestion reaction was composed of 1 µg DNA, 1× Restriction buffer (typically 
NEB CutSmart buffer), and 1 µL of the selected restriction enzymes. The DNA was digested for 1-
2 h at 37°C. Afterwards 1 µL of shrimp alkaline phosphatase was added to the plasmid digestion 
reaction to dephosphorylate the plasmid for another 1 h at 37°C. Both the digested plasmid DNA and 
the digested, dephosphorylated vector DNA were purified with the Monarch® PCR & DNA Cleanup 
Kit. 
Afterwards purified insert and vector DNA were ligated with T4 DNA ligase. A 20 µL ligation 
reaction was composed of : 1× T4 DNA ligase buffer, 1 µL of T4 DNA ligase, 100 ng of vector DNA 
and a 5-fold molar excess of insert DNA. Ligations were carried out at room temperature for 1 h.  
3.1.3 Cloning of NatC constructs 
The first structures of the heterodimeric NatA (Liszczak et al. 2013) and NatB (Hong et al. 2017) 
complexes were obtained using bacterially expressed orthologous proteins from the yeast species 
Schizosaccharomyces pombe or Candida albicans, respectively. Thus, the yeast model organism 
Saccharomyces cerevisiae was chosen for a biochemical and structural characterization of the 
heterotrimeric NatC complex. In case of the NatA complex (Liszczak et al. 2013), a C-terminal 
truncation of a non-conserved regions of its catalytic subunit Naa10 led to a soluble, active complex, 
that could be purified and crystallized. A sequence alignment of Naa30 orthologs (Fig. S1) revealed 
a similar non-conserved region of seventeen amino acids and thus Naa30 was expressed as the C-
terminally truncated construct Naa30ΔC17. 
Genes encoding S. cerevisiae NatC subunits Naa30 (Uniprot ID: Q03503), Naa35 (Q02197) and 
Naa38 (P23059) were obtained from Dharmacon yeast ORF collection clones YPR051W, EL053C 
and YCR020C-A, respectively.  
The NatC complex, containing Naa30ΔC17 (residues 1-159), full-length Naa35 (residues 1-733) and 
Naa38 (residues 1-88) was cloned into the pRSFDuet-1 expression vector (Novagen), which contains 
two multiple cloning sites (MCS), each of which is preceded by a T7lac promotor and ribosome 
binding site (RBS). The genes encoding full-length Naa38 and Naa30ΔC17, were both cloned into 
the second multiple cloning site (MCS) of the pRSFDuet-1 vector. Naa38 was inserted using the 
restriction sites for NdeI and MfeI. Naa30ΔC17 was cloned behind Naa38, between the restriction 
sites for PvuI and XhoI. An additional RBS with a 7 bp spacer (AAGGAGATATACC) was added 
in front of the ATG start codon for Naa30ΔC17. DNA encoding full-length Naa35, preceded by the 
human rhinovirus 3C (HRV 3C) protease cleavage site (LEVLFQGP) was cloned in frame with the 
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sequence for the His-Tag (MGSSHHHHHHSQDP) in the first MCS of pRSFDuet-1, using the 
restriction sites for BamHI and NotI. For NatC-ribosome co-sedimentation assays, a Naa35 was 
cloned in the same manner, but with an additional sequence coding for a FLAG-tag (DYKDDDDK), 
inserted in between the HRV 3C coding sequence and the start codon. 
During purification of the NatC complex, a partial (proteolytic) degradation of the Naa38 subunit 
was observed. Using MALDI-MS, a mass difference of 1183 Da between the complete and partially 
degraded Naa38 protein species was determined. This difference corresponds to the C-terminal 
eleven residues (ANKVELMANIV) of Naa38. In order to ensure a homogenous NatC complex 
preparation, the Naa38 gene was shortened by 33 bp through site directed mutagenesis to encode for 
the truncated Naa38ΔC11 protein. 
All further NatC complex constructs contain Naa30ΔC17 (residues 1-159), full-length Naa35 
(residues 1-733) and Naa38ΔC11 (residues 1-77), which will be henceforth referred to as the “wild 
type” (WT) NatC complex. 
Two wild type NatC complexes with N-terminally truncated Naa35 subunits were created by 
replacing the full-length Naa35 gene with the coding sequence for Naa35ΔN17 or Naa35ΔN44 by 
restriction cloning using the BamHI and NotI restriction sites. 
All NatC mutant constructs used in the acetyltransferase assay and the NatC-ribosome co-
sedimentation assay are based on the WT NatC complex and were created by site-directed 
mutagenesis. 
3.2 Expression and purification of the NatC complex 
3.2.1 Preparation of chemically competent E. coli cells 
Chemically competent E. coli BL21(DE3) cells were prepared for use in the subsequent heat shock 
transformations (section 3.2.2). A single colony (plated on LB + 2% agar) was used to inoculate a 5 
mL LB culture and incubated overnight at 37°C on a rotary shaker. A 500 mL Erlenmeyer flask with 
100 mL of LB medium was inoculated with 1 mL of the overnight culture and grown at 37°C, 250 
rpm on a rotary shaker. After cells reached an OD600 of 0.6 to 0.8 they were transferred into two 50 
mL falcon tubes and incubated on ice for 10 min. Afterwards the cell cultures were centrifuged for 
10 min at 2600×g at 4°C and the cells were resuspended in 10 mL ice cold 0.1 M CaCl2/10% glycerol 
solution. After 15 min incubation on ice, the cells were centrifuged as before. The cell pellets were 
resuspended in 1 ml ice cold 0.1 M CaCl2/10% glycerol and 50 µL aliquots were prepared and 
transferred to -80°C.  
3.2.2 Transformation of chemically competent E. coli BL21(DE3) 
For the transformation of chemically competent E. coli BL21(D3) cells, 10 µL of a ligation reaction 
or 1 µL purified vector DNA was added to 50 µL competent cells and incubated on ice for 30 min. 
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The cells were heat shocked at 42°C for 45 s and immediately put back on ice for 5 min. 300 µL LB 
medium was added and the cell suspension was incubated for 1 h at 37°C, shaking at 1000 rpm. 
Afterwards the cells were centrifuged at 3000×g for 2 min, resuspended in 50 µL LB medium and 
plated on LB agar plates with 50 µg/mL Km. Agar plates were incubated overnight at 37 °C. 
3.2.3 Small-scale IPTG induction test 
A small-scale protein expression test was performed to screen several colonies in order to verify 
protein expression in different bacterial clones, to exclude clones that show no protein expression or 
to select clones that show a higher protein expression compared to other cultivated clones. Several 
single colonies were used to inoculate separate 5 mL LB medium cultures in 15 mL conical tubes. 
Cultures were grown to an optical density (OD600) of ~0.6 and then split into 2× 2.5 mL in separate 
15 mL conical tubes. 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to one of the 
fractions (+IPTG culture) incubated together with the non-induced fraction (-IPTG culture) for 
another 2 h at 37°C. 30 µL sample was taken from both -IPTG and +IPTG cultures, mixed with 10 
µL 4× SDS sample buffer (250 mM TRIS-HCl, pH 6.8, 10% (w/v) SDS, 30% glycerol, 10% (v/v) 2-
mercaptoethanol, 0.5% (w/v) bromophenol blue) and loaded on an SDS-PAGE. 
After Coomassie staining, lanes with -IPTG and +IPTG samples were analyzed visually for the 
presence of a protein band in the IPTG-induced sample at the expected molecular weight. The 
intensity of the recombinant protein band was compared between different bacterial clones. The 
clone that showed the strongest protein expression was selected and a glycerol stock was prepared 
by mixing 500 µL of glycerol with 1000 µL of the non-induced culture and stored in a cryogenic vial 
at -80 °C. 
3.2.4 Expression of the native NatC complex 
A pre-culture with 80 ml LB medium and 50 µg/mL kanamycin was inoculated by transferring ~ 50 
µL frozen glycerol stock with a sterile pipette tip. The culture was incubated overnight at 37 °C in a 
250 mL Erlenmeyer flask, shaking at 300 rpm.  
Protein expression was performed in 6×1 L TB medium with 50 µg/mL kanamycin, which was 
inoculated with 1% (v/v) of the preculture. Expression cultures were grown in 5L baffled Erlenmeyer 
flasks at 37°C, shaking at 110 rpm. At an OD600=0.6 the temperature was lowered to 18°C and 
cultures were induced with 100 µM isopropyl β-D-1-thiogalactopyranoside (IPTG) and incubated 
overnight. 
Bacterial cells were pelleted for 15 min at 4500 rpm (~3876 ×g) with a JLA-8.1000 rotor in an Avanti 
J-26 XP centrifuge (Beckman Coulter).  
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3.2.5 Expression of the selenomethionine-labeled NatC complex 
For the expression of selenomethionine-labeled proteins, a modified protocol from Van Duyne et al. 
(1993) was used, which relies on the feedback inhibition of methionine biosynthesis through addition 
of lysine, phenylalanine, threonine, isoleucine, leucine and valine, which are supplied together with 
selenomethionine to a M9 minimal medium culture before induction of protein expression (Doublie 
1997). 
A 5 mL LB medium preculture (with 50 µg/mL kanamycin) was inoculated from an E. coli 
BL21(DE3) glycerol stock carrying the pRSFDuet-1_NatC expression plasmid and grown at 37°C 
for ~6h. An overnight culture with 100 mL LB-medium (and 50 µg/mL Kan) was inoculated with 1 
mL of the preculture and grown at 37° in a 500 mL Erlenmeyer Flask. After approx. 24 h, 6×1L pre-
warmed, M9 minimal medium cultures were inoculated with 10 ml or 1% (v/v) of the overnight 
culture and grown at 37°C, 110 rpm. Final 1× M9 minimal medium was prepared by adding 1× M9 
salt solution, 4 g/L glucose, 2 mM MgSO4, 0.5 g/L NH4Cl, 0.3 mM CaCl2, 1× trace elements solution 
and antibiotics (i.e. 50 µg/mL kanamycin) to autoclaved ddH2O in the aforementioned order and as 
detailed in Table 8. 
The composition of 10× M9 salt solution and 10× trace element solution is described in Table 9 and 
Table 10, respectively. 
At mid-log phase (OD600 ≈ 0.6) the amino acid mixture detailed in Table 12 was added to all minimal 
medium cultures, which grew for another 15 min before induction with 100 µM isopropyl β-D-1-
thiogalactopyranoside (IPTG). The temperature was lowered to 18°C and the cultures were incubated 
overnight before harvesting the cells on the following day. The success of selenomethionine 
incorporation was examined by MALDI-MS. Selenomethionine-labeled NatC was purified, exactly 
like the native complex, but with the addition of 2.5 mM 2-mercaptoethanol to all purification buffers 
due to a higher oxidation sensitivity of selenium compared to sulfur, which can result in less stable 
crystals (Walden 2010). 
Table 12 Amino acid supplement (added per 1L of 1× M9 Minimal medium) 
Mass Amino acid 
100 mg L-lysine 
100 mg L-phenylalanine 
100 mg L-threonine 
50 mg L-isoleucine 
50 mg L-leucine 
50 mg L-valine 
50 mg L-selenomethionine 
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3.2.6 Purification of the NatC complex 
All subsequent purification steps were performed with cooled buffer solutions (~ 4–10 °C) or on ice. 
All buffer solutions were supplemented with 2.5 mM 2-mercaptoethanol, unless the proteins were 
intended for use in the colorimetric DTNB assay, in which case 2-mercaptoethanol was omitted from 
all buffers, due to the reaction of its thiol groups with the DTNB dye. Pellets were resuspended in a 
total of 120 mL Lysis Buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 10 mM Imidazole) and 
supplemented with 2 mL DNAse I solution (1 mg/mL in 1 M MgCl2, pH 6.5) and a spatula tip of 4-
(2-Aminoethyl)-benzolsulfonylfluorid hydrochloride (AEBSF, BioChemica). The cell suspension 
was lysed by passing it twice through a cell homogenizer (Model M-110L Microfluidizer Processor, 
Microfluidics). Afterward the cell lysate was centrifuged for 45 min at 35,000 rpm (~95834 ×g) in a 
Type 45 Ti rotor with a Optima™ L-100K Ultracentrifuge (Beckman Coulter) and the supernatant 
was passed through a 0.2 µm membrane filter (GE healthcare). The clarified supernatant (~ 200 mL) 
was supplemented with 1 mM MgCl2 (final concentration) and 40 µL Benzonase endonuclease 
(Merck) and incubated for ~ 30 min. Afterwards 6 mL resuspended nickel affinity agarose (GE 
Healthcare) (corresponding to ~ 3mL sedimented beads) was added to the supernatant and incubated 
for another 15 min. The supernatant, containing the nickel beads was transferred in 4×50 mL falcon 
tubes and centrifuged for 5 min at 500 × g and the supernatant was discarded. Nickel beads were 
washed by adding 50 mL Lysis buffer to each falcon, followed by centrifugation and discarding the 
supernatant. The washing step was repeated once more before finally resuspending the Ni2+ beads in 
10 mL Lysis buffer and transferring them into a glass column. Now beads were washed with 100 mL 
Wash Buffer (20 mM HEPES, pH 7.5, 300 mM NaCl, 25 mM Imidazole) using a peristaltic pump. 
The His-tagged NatC complex was eluted with Elution Buffer (20 mM HEPES, pH 7.5, 150 mM 
NaCl, 60 mM Imidazole). Buffer was exchanged with SEC buffer (20 mM HEPES, pH 7.5, 150 mM 
NaCl) using a centrifugal filter unit (Amicon Ultra-15, 50 kDa MWCO, Merck) to bring imidazole 
concentration below 1 mM. The 6×HIS-tag at the N-terminus of the Naa35 subunit of NatC was 
removed by cleavage at the human rhinovirus 3C (HRV 3C) protease cleavage site using PreScission 
protease (GE Healthcare). PreScission protease was added at a ratio of 1:100 (w/w) together with 10 
µL Benzonase endonuclease and 1 mM MgCl2 and incubated overnight at 4°C. The untagged NatC 
complex was loaded again on a Ni2+ column followed by a GSTrap column (GE Healthcare) to 
remove the GST-tagged PreScission protease. The column was washed with 100 mL SEC-Buffer 
and the untagged NatC complex was eluted with Lysis Buffer. The eluate was concentrated to ~ 2mL 
and loaded on a 26/600 Superdex 200 size exclusion column, equilibrated in SEC buffer. NatC 
complex-containing elution fractions were concentrated to ~ 10 mg/mL and snap frozen as 30-50 µL 
aliquots in liquid nitrogen. NatC concentrations were determined photometrically, using the sum of 
the molecular weights and molar extinction coefficients of all three subunits, as calculated with the 
ProtParam tool6 (ExPASy). For example, the HRV 3C digested NatC WT complex has a computed 
total molar extinction coefficient (assuming all cysteines are reduced) of 103,600 M-1 cm-1 (with 
 
6 https://web.expasy.org/protparam/ 
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Naa30dC17 = 21,890 M-1 cm-1, Naa35, cut = 81,710 M-1 cm-1 and Naa38 = 0 M-1 cm-1) and a total 
molecular weight of ≈111534 Da (with 18537 Da, 84457 Da and 8541 Da for Naa30dC17, Naa35 
and Naa38ΔC17, respectively). 
3.3 MALDI-TOF mass spectrometry 
A Matrix assisted laser desorption/ionization (MALDI) mass spectrometer with a time-of-flight 
(TOF) analyzer was used to verify the mass of purified protein constructs, to analyze the products of 
a partial proteolytic digest and to verify the N-terminal acetylation of NatC substrate peptides. 
Protein or peptide samples were diluted in 0.1% trifluoroacetic acid (TFA) to a final concentration 
of 10 µM. Similarly, up to five standards proteins or peptides were combined in 0.1% TFA with final 
concentrations ranging between 0.5-10 µM as indicated in Table 13. MALDI matrices were prepared 
by adding saturating amounts of α-Cyano-4-hydroxycinnamic acid (CHCA) or Sinapinic acid to a 
small volume (e.g. 50 µL) of 50% acetonitrile/0.05% TFA. Equal volumes (e.g. 2 µL + 2 µL) of 
prepared protein or peptide samples were mixed with saturated solution of the recommended matrix 
(see last column of Table 13). 0.5 µL of the sample/matrix mixture was spotted on a MALDI target 
plate (MSP 96 target ground steel BC plate, Bruker). Samples were allowed to dry completely, before 
loading the target plate into a mircoflex™ LRF MALDI-TOF mass spectrometer (Bruker). Peptides 
samples of 3495 Da (Insulin) or smaller were analyzed in Reflectron/Positive ion mode 
(RP_PepMix), whereas larger protein samples were analyzed in Linear/Positive ion modes 
LP_12kDa, LP_44kDa or LP_66kDa depending on the maximum molecular weight to be analyzed. 
The instrument was calibrated with the peptide or protein standard, before measuring unknown 
samples. Data was analyzed using the flexAnalysis3.4 software (Bruker). 
Table 13 Standard peptide and proteins for MS. Monoisotopic (mono) and average (ave) molecular weights 
and recommended matrices. CHCA, α-Cyano-4-hydroxycinnamic acid. 





or average (ave) 
Recommended 
 Matrix 
Bradykinin fragment 1-7 1.5 757.3997 (mono) CHCA 
Angiotensin II (human) 1 1,046.5423 (mono) CHCA 
P14R (synthetic peptide) 1 1,533.8582 (mono) CHCA 
ACTH fragment 18-39 (human) 0.5 2,465.1989 (mono) CHCA 
Insulin oxidized B chain (bovine) 2 to 5 3,494.6513 (mono) CHCA 
Insulin (bovine) 1 5,735 (ave) CHCA or sinapinic acid 
Cytochrome c (equine) 1 12,362 (ave) CHCA or sinapinic acid 
Apomyoglobin (equine) 1 16,952 (ave) CHCA or sinapinic acid 
Aldolase (rabbit muscle) 2 39,212 (ave) sinapinic acid 
Albumin (bovine serum) 10 66,430 (ave) sinapinic acid 
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3.4 Purification of yeast 80S ribosomes 
Yeast 80S ribosomes, used in the NatC-ribosome sedimentation assay, were purified by Ciara Lally7. 
The ribosome purification protocol was adapted from Magin et al. (2017). 
Saccharomyces cerevisiae strain YA2488 was plated-out on YPD-agar plates (1% yeast extract, 2% 
pepton, 2% agar, 2% glucose), and used to inoculate a 20 mL pre-culture of YPD (1% yeast extract, 
2% peptone, 2% glucose), which was incubated at 30ºC for 7 h. 8 L of YPD was inoculated with 
preculture to an OD600 of 0.001 and grown at 30ºC to an OD600 of 2 (stationary phase). 
The cells were pelleted at 8000 ×g, 5min, 4ºC, (Beckman Rotor JLA9.1000), resuspended in YP 
medium (1% yeast extract, 2% peptone, no glucose) and incubated for 10 min, 250 rpm, 30ºC, to 
ensure that all ribosomes would be in the “apo” form, without nascent chain or tRNA.  
The following cell lysis steps were all carried out at 4ºC: Cells were pelleted by centrifugation at 
8000 ×g, 5 min, 4ºC, (Beckman Rotor JLA9.1000) and resuspended in Buffer A (30mM HEPES, pH 
7.5, 50 mM KCl, 10 mM MgCl2, 8.5% sorbitol, 2 mM DTT, 0.5 mM EDTA). Cells were centrifuged 
again at 8000 ×g, 5 min, 4ºC, (Beckman Rotor JLA9.1000), the pellet was weighed and resuspended 
in lysis buffer (Buffer A + one cOmplete mini EDTA-free protease inhibitor tablet (Roche 
11836170001), 1 Unit/µl RNAsin (N261B, Promega), 800 µg/ml heparin) to a final concentration of 
200% (w/v). Glass beads (G8772 sigma) were added to the resuspension (such that there was an 
equal weight of glass beads to pellet), and lysis was performed by vortexing for 30 s, followed by 30 
s on ice, repeated 4 times. To obtain the yeast lysates, the resuspension was centrifuged at 9000 ×g, 
10 min, 4ºC (rotor Beckman TA-10.250), and the supernatant was collected. The absorbances at 260 
nm, and 280 nm were measured. 
To isolate the 80S monosomal ribosome fraction, yeast lysate (A260 = 200) was underlaid with 1 ml 
30% sucrose in 80S Buffer (20 mM HEPES, pH 7.6, 100 mM potassium acetate, 5mM MgCl2, 2 mM 
DTT) and centrifuged 70000 ×g, 18 h (Beckman ultracentrifuge, rotor mla80). The pellet was 
collected, and added at a concentration of A260 = 100, to the top of a 15-30% sucrose gradient, which 
was prepared by underlying 15% sucrose in 80S buffer with 30% sucrose in 80S buffer, and mixing 
(Gradient Master, BIOCOMP, short settings). The gradients were then spun at 23318 rpm, 6 h, using 
a SW32 Ti Beckman swing-out rotor, and then loaded to a polysome collector (LKB), which allowed 
isolation of the 80S peak, via monitoring the absorbance at 260 nm, at increasing levels of 
sedimentation.  
Fractions containing 80S monosomes were pooled and centrifuged at 43000 rpm, 14 h (Beckman 
MLA-80 rotor). The pellet containing the 80S yeast ribosomes were resuspended in 20 mM HEPES 
pH 7.6, 50 mM potassium acetate, 5 mM MgCl2, 2 mM DTT to give a final concentration of 2 µM.  
 
7Ciary Lally, Phd, Institute of Medical Physics and Biophysics - Charité, Charitéplatz 1, 10117 Berlin 
34      Methods 
 
3.5 NatC-ribosome sedimentation assay 
A sedimentation assay was performed to analyze the interaction between NatC and the yeast 
ribosome. The assay was adapted from the protocol described by Magin, Deng et al. (2017). NatC 
and ribosomes were combined to final concentrations of 1 µM and 0.8 µM, respectively in 80S Buffer 
(20 mM HEPES, pH 7.5, 50 mM KOAc, 5 mM Mg(OAc)2, 2 mM DTT, 0.003% (v/v) Tween-20). 
Tween-20 was added to reduce unspecific binding of NatC to plastic surfaces. 35 µL of the 
NatC/ribosome solution was underlaid with 80 µL of 80S Buffer supplemented with 30% (w/v) 
sucrose. Samples were centrifuged for 70 min at 95,000 rpm (352,769 ×g) in a pre-cooled (4°C), 
TLA-100 rotor (Beckman). The supernatant (i.e. 115 µl) was carefully removed and mixed with 
30 µL of 5× SDS sample buffer (250 mM TRIS-HCl, pH 6.8, 10% (w/v) SDS, 30% glycerol, 10% 
(v/v) 2-mercaptoethanol, 0.5% (w/v) bromophenol blue). The pellet was resuspended in 145 µL 
resuspension buffer (35 µL 80S Buffer, 80 µL 80S Buffer with 30% sucrose, 30 µL 5x SDS sample 
buffer) and run on an SDS-PAGE gel to analyze the amount of NatC that co-sedimented with the 
ribosome by silver staining and Western blot (sections 3.5.1 and 3.5.2, respectively).  
3.5.1 Silver staining 
For silver staining, SDS-PAGE gels were fixed for 30 min or overnight in Gel-fix (50% ethanol, 10% 
acetic acid). Afterwards gels were washed 3× 5 min (i.e. three times for 5 min intervals each) with 
Milli-Q water8. Gels were incubated for 1.5 min in Gel sensitizer (20 mg / 100 mL water) and 
afterwards washed 3× 30 s with Milli-Q water. Gels were then incubated in silver solution (0.2% 
(w/v) silver nitrate) for 25 min, followed by 2× 30s washes in 2-3 L Milli-Q water each. Gels were 
developed by incubating in developing solution (6 g Na2CO3, 2 ml Gel sensitizer, 50 µL of 37% 
(w/v) formaldehyde ad 100 mL water) until the desired level of staining is achieved (~ 1min). 
Development is stopped by discarding the developing solution and incubating in 6% acetic acid for 
10 min. Gels are finally washed for another 4×10 min. 
3.5.2 Western Blot, Ponceau S- and immunostaining 
Western blots were performed through “wet” electro-transfer using a tank blotting system. Proteins 
were transferred from SDS-PAGE gels to a 0.4 µm nitrocellulose membrane (GE Healthcare) in cold 
Transfer buffer (25 mM Tris Base, 192 mM glycine, 0.1 mM EDTA and 20% methanol) by running 
at 80 V for 1h (or 100 V for 1.5h if two blots were run simultaneously in the same tank blotting 
chamber). Afterwards gels were washed 2× 5 min with Milli-Q water and a Ponceau S staining was 
performed in order to verify that all lanes of the SDS-PAGE gel were transferred evenly onto the 
nitrocellulose membrane. To this end, the nitrocellulose membrane was incubated in Ponceau S 
solution (0.2% (w/v) Ponceau S in 3% acetic acid) for 1 min and washed with water to clear the 
 
8 Milli-Q® is a registered trademark of MilliporeSigma (Merck). Milli-Q water refers to any type of “ultrapure” 
water of “Type1” which has a resistivity at 25°C of 18.2 MΩ ∙ cm. 
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background. The membrane was washed in 1× TBST (20 mM Tris-HCL, pH 7.5, 150 mM NaCl, 
0.1% (v/v) Tween-20) for 2× 5 min. The membrane was then incubated in Blocking buffer (5% milk 
powder in TBST) for 1–2 h at room temperature or overnight at 4 °C. The membrane was then cut 
horizontally between the 55 and 70 kDa molecular weight marker bands of the PageRuler™ Plus 
Prestained Protein Ladder to allow incubation of the two membrane halves with different primary 
antibodies. The Blocking buffer was discarded and replaced with fresh Blocking buffer containing 
mouse, α-FLAG M2 (1:10,000) for incubation with the upper membrane half and rabbit, α-RPL7 
(1:3,000) for the lower membrane half. The primary antibody was incubated for 1-2 h or overnight 
at 4°C. The membrane was rinsed twice and washed for 2× 5 min with TBST. HRP (horseradish 
peroxidase)-conjugated secondary antibodies in fresh Blocking buffer (1:10,000) were added and 
incubated with the corresponding membrane halves for 1–2 h at room temperature. The membrane 
was again rinsed twice and washed for 2× 5 min with TBST, followed by a 2× 5 min wash with 
ddH2O. A working solution of SuperSignal™ West Dura Extended Duration Substrate 
(ThermoFisher) was prepared by mixing equal volumes of Stable Peroxide Solution and 
Luminol/Enhancer Solution (300 µL + 300 µL). The membrane was covered with working solution, 
placed in clear plastic wrap and chemiluminescence images were taken with the ImageQuant™ LAS 
4000 imaging system (GE Healthcare). Chemiluminescence intensities of protein bands were 
analyzed with ImageJ (Schneider, Rasband, and Eliceiri 2012). 
3.6 Acetyltransferase assay 
The acetyltransferase activity was determined using the Ellman method, adapted from Thompson et 
al. (2004). In Fig. 10, the NatC-catalyzed Nα-terminal acetylation (Nt-acetylation) reaction (1) is 
shown. The two substrates: acetyl-CoA and a short, ten-residue peptide are converted to the two 
products of the reaction: coenzyme A (CoA) and the N-terminal acetylated peptide. The employed 
assay is discontinuous, which means that the reaction is quenched at regular time intervals through 
the addition of the chaotropic guanidinium hydrochloride, which immediately denatures the enzyme. 
The Quenching buffer is supplemented with Ellman’s reagent (5,5-dithiobis(2-nitrobenzoic acid) or 
DTNB), which reacts with the thiol groups of CoA to produce the yellow 2-nitro-5-thiobenzoate 
(TNB2–) anion (2), whose concentration was determined using the Beer–Lambert law (𝐴 =
𝜀 × 𝑐 × 𝑙), with ε412 nm = 14150 M–1 cm–1. 
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Fig. 10 Separate reactions of the colorimetric acetyltransferase assay. (1) Nα-terminal acetylation of a 
protein/peptide N-terminal amino group catalyzed by Nα-terminal acetyltransferases (NAT). The acetyl group is 
transferred from acetyl coenzyme A (acetyl-CoA). (2) Coenzyme A (CoA) thiol groups react with 5,5-dithiobis(2-
nitrobenzoic acid) (DTNB or Ellman’s reagent) to produce the yellow 2-nitro-5-thiobenzoate anion (TNB2-) and 
CoA-TNB mixed disulfides. 
All acetylation reactions were carried out at 25 °C in Acetylation buffer (50 mM HEPES, pH 7.5, 
150 mM NaCl, 0.2 mM EDTA, 0.003% (v/v) Tween-20). Tween-20 was added to the buffer to reduce 
protein surface adsorption (Deechongkit et al. 2009). 
The substrate peptide kcat and Km parameters for wild type NatC (Naa30 1–159/ Naa35 full-length/ 
Naa38 1–77) or NatC mutants were determined using the yArl3 substrate peptide (MFHLVGSRRR), 
containing the N-terminal five residues of the Saccharomyces cerevisiae ADP-ribosylation factor-
like protein 3 (Arl3; Uniprot ID Q02804), followed by a GS-linker and a triple-arginine at the C-
terminus to facilitate peptide solubility. Reactions were carried out as duplicates at six different 
peptide concentrations, typically between 100 to 1500 µM. Acetyl-CoA was used at a fixed 
concentration of 500 µM (≥ 10× Km). Thus, a total of twelve individual reactions were carried out 
simultaneously using a 12-channel pipette. Individual reactions (110 µL total volume) were initiated 
by addition of 99 µL substrate solution to 11 µL enzyme solution with final NatC concentrations of 
50–2500 nM (50 nM for wild type NatC and more for NatC mutant complexes, that were catalytically 
deficient). The reactions were carried out for a total of 150 s (NatC wild type) up to 100 min (for 
catalytically impaired NatC mutant complexes). At regular time intervals, 20-µL aliquots were taken 
from the reaction and quenched in 40 µL Quenching buffer (3.2 M guanidinium-HCl, 5 mM EDTA, 
100 mM sodium phosphate, pH 6.8), containing freshly added 5,5-dithiobis(2-nitrobenzoic acid) 
(DTNB) at a final concentration of 0.5 mM. The free thiol groups (–SH) of CoA produced in the 
acetylation reaction react with DTNB to produce the yellow 2-nitro-5-thiobenzoate (TNB2–) anion. 
50 µl of the quenched reactions were transferred into 384-well plates and absorbances were measured 
at 412 nm with a M1000 Pro Microplate reader (Tecan), assuming ε = 14150 M–1 cm–1 (Riddles, 
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Blakeley, and Zerner 1983). Reaction background absorbances were determined for each reaction 
and subtracted from the absorbances of the individual reactions. Reaction background samples had 
the same composition as the reaction samples, but with enzyme added to the Quenching buffer 
aliquot, to account for the cysteine thiol groups of the enzyme. Moreover, plate background 
absorbances of each individual empty 384-well microplate were determined and subtracted from all 
reactions and reaction background absorbances, to account for plate-specific imperfections (micro-
scratches, impurities, etc.). 
Turnover of limiting substrate did not exceed 20%. Initial velocities were fitted by nonlinear least fit 
squares to the Michaelis-Menten equation (𝑣0 = 𝑣max[S]/(𝐾m+ [S])) using GraphPad, version 6, to 
determine kcat and Km parameters. Each complete acetylation assay was performed at least in triplicate 
and the average kcat and Km and s.d. were calculated from the individual values of the replicates. 
The Km of acetyl-CoA for wild type NatC was determined as described before, but with a fixed Arl3 
peptide concentration of 1.5 mM and 50–500 µM acetyl-CoA. 
3.6.1 Assay adaptations for different peptide substrates 
In addition to the Arl3 peptide (MFHLVGSRRR), kcat and Km parameters of various other substrate 
peptides were determined for wild type NatC. 
The NatA substrate peptide (SASEAGSRRR) containing the N-terminal five residues (after removal 
of the initiator methionine) of the S. cerevisiae Threonyl-tRNA synthetase (ThrRS) (Uniprot ID: 
P04801); and the NatB substrate peptide (MDSEVGSRRR) containing the N-terminal five residues 
of the S. cerevisiae Actin (Uniprot ID: P60010) were tested with wild type NatC. No activity could 
be measured for either NatA or NatB peptides under standard conditions and even after incubating 
for 2 h and using a large excess (2 µM) of wild type NatC. 
Arl3 peptides variants with substitutions at the second position (MWHLV-, MYHLV-, MLHLV-, 
MAHLV-(GSRRR)) were measured as described for the yArl3 peptide.  
The Gag peptide (MLRFVGSRRR), containing the N-terminal five residues of the Major capsid 
protein (Gag) of the S. cerevisiae virus L-A (Uniprot ID: P32503), represents another known NatC 
substrate (Tercero, Dinman, and Wickner 1993). Arl3/Gag-hybrid peptides are based on the yArl3 
peptide with single amino acid substitutions at position 3 or 4, replacing the yArl3 amino acid 
residues with the corresponding Gag peptide residues (MFRLVGSRRR and MFHFVGSRRR). The 
Gag peptide, Arl3/Gag-hybrid peptides and yArl3 variants with alanine substitutions at position 3 
(MFALVGSRRR) or position 4 (MFHAVGSRRR) showed a much higher catalytic efficiency and 
thus the acetyltransferase assay was correspondingly adapted. To account for the higher kcat, final 
NatC concentrations were lowered to 10-80 nM and total reaction times were as short as 60 s, with 
aliquots quenched every 15 s. 
To determine the low peptide Km values, peptide concentrations were lowered to between 30 µM to 
500 µM. Instead of measuring duplicates for six different concentrations, the lowest two 
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concentrations were measured in triplicates and the three highest concentrations were measured as 
duplicates (e.g. three times 30 µM and 60 µM and two times 100, 200 and 300 µM). The total reaction 
volume was increased to up to 226 µL, so that larger aliquots of 72 µL could be taken. The aliquots 
were quenched in half the volume (36 µL) of 2× Quenching buffer (6.4 M guanidinium-HCl, 10 mM 
EDTA, 200 mM sodium phosphate, pH 6.8), giving a total volume of 108 µL. Two times 50 µl of 
each quenched reaction were transferred into separate wells of the 384-well microplates to obtain 
duplicate absorbance readings, which were averaged to reduce random errors. 
3.6.2 Determination of peptide concentrations 
Peptides were solubilized in Acetylation buffer to a concentration of approximately 5 mM, based on 
gravimetric analysis. However, since net peptide content can vary between 50-80% of the gross 
peptide weight and not all peptides were soluble to the same final concentration, peptide 
concentrations were determined photometrically from TNB2– product concentration, formed in an 
end-point acetylation reaction. For each peptide stock, five different dilutions (25 to 125 µM, based 
on gravimetric estimates) were incubated together with an excess of Coenzyme A (200 µM) and 
2 µM wild type NatC in Acetylation buffer. Reactions aliquots were quenched after 1.5 h and 2 h 
with a two-fold excess of Quenching buffer, containing 0.5 mM DTNB (final concentration). 
Absorbances were determined, background absorbances were subtracted and concentrations were 
calculated as described for the Michaelis-Menten assays. The average concentration of the five end-
point reactions was taken to calculate the net peptide concentrations of the peptide stock. The 2 h 
measurements did not show a significant increase of absorbance, compared to the 1.5 h 
measurements and both readings were within 5% of one another.  
3.6.3 Pathlength calculations for the acetyltransferase assay 
The TNB2- anion product concentration, was determined using the Beer–Lambert law (𝐴 =
𝜀 × 𝑐 × 𝑙), with ε412 nm= 14150 M–1 cm–1. Since the calculated product concentration is linearly 
dependent on the pathlength, an accurate determination of the latter is mandatory. As the absorbance 
was measured in 384-well microplates, the pathlength is equivalent to the height of the liquid in the 
well (ℎl). The liquid height is dependent on the shape of the well and the volume of the measured 
solution. The wells of the employed microplate (Cat. No. 781 162, Greiner Bio one) have the shape 
of a frustum of an (upside-down) pyramid with rounded lateral edges. The well height (ℎwell) was 
specified by the manufacturer as 11.5 mm and the top (𝑑top) and bottom (𝑑𝑏𝑜𝑡𝑡𝑜𝑚) diameters of the 
wells were given as 3.7 mm and 3.3 mm, respectively. A microscope image of the well top was taken 
to determine the top corner radius (𝑟c,top). Calibrating the image dimensions with the diameter of the 
well top, a corner radius of 𝑟c,top=1.0 mm was measured. Given the pyramidal shape of the well, the 
bottom and top corner radii are linearly correlated with the well diameter. Thus, the bottom corner 
radius was calculated as 𝑟c,bottom ≈ 0.89 mm. The rounded square areas of the well top and bottom 
were calculated with equations (1) and (2), respectively. Finally, the height of the liquid ℎl (i.e. the 
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pathlength) was calculated using the equation for the volume of a frustum, solved for ℎl (3). A 
detailed explanation for the derivation of these equations is given in the supplement (sections 10.9.1 
to 10.9.5). Moreover, the results from the final model for the shape of the well are compared to 
simpler geometrical description of the well shape in supplement sections 10.9.6 and 10.9.7. 
 𝐴top = 𝑑top
2 − 𝑟c,top
2 × (4 − π) (1) 





2 × (4 − π) (2) 














3.7 Crystallization of NatC 
Crystals of the NatC complex, containing subunits Naa30ΔC17 (residues 1–159), full-length Naa35 
(residues 1–733) and Naa38ΔC11 (residues 1–77) were obtained through vapor diffusion at 20 °C as 
detailed in Table 14. NatC protein solutions were diluted to concentrations between 5–5.8 mg/mL in 
SEC Buffer (20 mM HEPES, pH7.5, 150 mM NaCl, 2.5 mM 2-mercaptoethanol). The 
selenomethionine-labeled NatC protein was crystallized in its apo form. Coenzyme A (CoA) was 
added at a 1:3 molar ratio to all native NatC proteins. In addition to CoA, the substrate peptides 
MFHLVGSRRR or MLRFVGSRRR were added to two further crystallization setups at a molar ratio 
of 1:5 or 1:3 respectively. SeMet and native crystals were obtained by mixing protein solution in a 
1:1 mixture with well solution containing 14.5–16.5% PEG 4000, 150 mM ammonium iodide and 
100 mM sodium citrate, pH 6.1–6.4. 
Crystallization plates were setup either manually in a 24-well hanging-drop format by mixing 1 µL 
protein solution with 1 µL reservoir solution above a 1000-µL reservoir. Or plates were setup as 
sitting-drops in a 96-well format with a Crystal Gryphon dispensing robot (Art Robbins Instruments) 
by mixing 0.2 µL protein solution with 0.2 µL reservoir solution above an 80-µL reservoir. 
Although not mandatory, NatC crystal growth could be facilitated through micro seeding. A seed 
stock was prepared from NatC crystals of low quality (i.e. thin needles) grown in a 2-µL drop 
(hanging-drop setup, 24-well plate). The entire drop was transferred into 100 µl well solution and 
crushed with Seed Bead (Hampton) by vortexing for 1 min. The seed stock was diluted 1:100 in well 
solution to be used for microseeding. To this end, 0.5 µL seeding solution was admixed with a 2-µL 
drop in the 24-well format or < 0.2 µL was added on top of a 0.4-µL drop in the 96-well format using 
a 12-channel pipette. 
Diffraction quality crystals appeared after 12 – 48 h and required another five days to reach maximum 
dimensions. Crystals were soaked for approx. 10 s in well solution containing 20 % (v/v) glycerol or 
20 % (v/v) ethylene glycol and quick frozen in liquid nitrogen. 
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Table 14 NatC crystallization conditions. WT, wild type (Naa30ΔC17, Naa35, Naa38ΔC17). Arl3, peptide 
with the sequence MFHLVGSRR. Gag, peptide with the sequence MLRFVGSRRR. EG, ethylene glycol. aCoA 
















  Protein concentration 52 µM 45 µM 45 µM 45 µM 45 µM 
  Ligands 
 
- 
135 µM CoA 
 
135 µM CoA 
225 µM Arl3 
135 µM CoA 
135 µM Gag 
- 
  Buffer 20 mM HEPES, pH 7.5, 150 mM NaCl 
 
Reservoir solution 
  PEG 4000 14.5 % 16.5 % 16 % 14.5 % 15.5 % 
  pH (100 mM 
  sodium citrate) 
pH 6.1 pH 6.3 pH 6.2 pH 6.3 pH 6.4 
  Ammonium iodide 150 mM 150 mM 150 mM 150 mM 150 mM 
 
Crystallization setup 
  Method Sitting drop Sitting drop Sitting drop Hanging Drop Sitting drop 
  Format 96-well 96-well 96-well 24-well 96-well 
  Reservoir volume 80 µL 80 µL 80 µL 1 mL 80 µL 
  Drop Volume (µL) 0.2 + 0.2 0.2 + 0.2 0.2 + 0.2 1.0 + 1.0 0.2 + 0.2 
  Seed solution no no no 0.5 µL < 0.2 µL 
  Cryo-protectant 20 % EG 20 % EG 20 % glycerol 20 % EG 20 % EG 
 
3.8 Data collection 
All data sets were collected at the Macromolecular Crystallography (MX) beamlines BL14.1 at 
BESSY II in Berlin-Adlershof (Helmholtz-Zentrum Berlin für Materialien und Energie 2016). 
Beamline parameters are detailed in Table 15. The control software used was MxCuBE2 (Oscarsson 
et al. 2019). 
Table 15 BESSYII – BL14.1 Parameter. From Helmholtz-Zentrum Berlin für Materialien und Energie (2016) 
Source 7T-WLS-2 
Monochromator Si111-DCM with sagital bender 
Energy range 5 - 15.5 keV 
Energy resolution < 2 eV 
Flux 1.4 x 1011 (Photons/s/100 mA) 
Polarization Horizontal 
Divergence horizontal 1.5 mrad 
Divergence vertical 0.5 mrad 
Focus size (hor. x vert.) 150 x 100 µm² 
Experiment in vacuum no 
Temperature 90 - 293 K 
X-ray fluorescence detector Amptek XR123 SDD 
Pixel detector Pilatus 6M 
Sample manipulators CATS sample changer 
Goniometer 
Microdiffractometer MD2 with 
Minikappa goniometer MK3 
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A selenomethionine (SeMet)-labeled NatC protein crystal was mounted and an x-ray fluorescence 
(XRF) energy scan9 was performed (Fig. 11).  
 
Fig. 11 X-ray fluorescence scan of a SeMet-labeled NatC crystal 
The data was analyzed with the MXCube2-integrated software CHOOCH (Evans and Pettifer 2001) 
to obtain the anomalous scattering factors f’ and f’’ and to calculate the selenium (K-edge) peak 
(12.655 keV), inflection (12.653 keV) and remote (12.705 keV)10 energies. Afterwards, beamline 
energy was shifted to the selenium peak energy to perform a single-wavelength anomalous 
diffraction (SAD) experiment. An initial characterization of all SeMet-labeled NatC crystals was 
conducted by taking two diffraction images with an exposure time of 3 s and 90° apart from one 
another. The diffraction images were evaluated with the X-ray diffraction image viewers adxv 11 or 
albula12 (Dectris) to visually assess the quality of the crystal diffraction pattern, including maximal 
resolution, spot shape, mosaicity, anisotropic diffraction, multiple lattices and ice rings. The two 
images from the crystal with the best diffraction pattern (i.e. highest resolution, low anisotropy, low 
mosaicity, no ice rings, only one visible lattice) were analyzed with iMOSFLM (Battye et al. 2011) 
to index the diffraction spots and to calculate a data collection strategy. 
A dataset of the SeMet-labeled NatC crystal was taken at peak energy of 12.655 keV (0.9797 Å) and 
consisted of 3600 images, with 0.1° oscillation range and an exposure time of 0.2 s. Oscillation was 
started at the rotation angle recommended by iMOSFLM but extended to a total oscillation range of 
360°, in order to obtain a high multiplicity for SAD phasing. 
For the native NatC crystals, the wavelength was shifted to 13.5 keV (0.9184 Å) and an initial 
characterization was performed for all crystals as described for the SeMet-labeled crystals. The two 
test images were indexed with iMOSFLM and a data collection strategy was calculated. 
Datasets from all native NatC crystals were taken at 13.5 keV and consisted of 1100 to 1800 
images for crystals in space group P212121 and 3600 images for the crystal that grew in space group 
 
9 The x-ray energy was changed in a range close to the absorbance edge of the chosen element.  
10 The energy of the “remote” data set is usually taken 50 eV above peak energy ( “high energy remote”). 
11 Adxv - A program to display X-Ray diffraction images (https://www.scripps.edu/tainer/arvai/adxv.html) 
12 ALBULA software (https://www.dectris.com/products/albula-software) 
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P1 (see Table 16). Exposure time was between 0.3 s and 0.5 s at 0.1° oscillation range. Oscillation 
was started about 10° before the oscillation angle recommended by iMOSFLM and extended above 
the minimal recommendation for a complete dataset to a total of 110° to 180° for the native P212121 
crystals and to 360° for the P1 crystal, in order to increase the multiplicity for the native datasets as 
well. 















Space group P212121 P212121 P212121 P212121 P1 
Energy (eV) 12,655 13,500 12,500 13,500 13,500 
Wavelength (Å) 0.9797 0.9184 0.9184 0.9184 0.9184 
Number of images 3600 1800 1100 1800 3600 
Exposure time (s) 0.2 0.3 0.5 0.3 0.3 
Oscillation range (°) 0.1 0.1 0.1 0.1 0.1 
3.9 Data processing, model building and refinement 
3.9.1 Anomalous dataset 
The peak energy dataset from the SeMet-labeled NatC crystals was processed with XDS (Kabsch 
2010). The reflection file XDS_ASCII.HKL, containing the corrected intensities of all reflections (= 
“unmerged data”) was used for single-wavelength anomalous diffraction (SAD) phasing with 
SHELXC/D/E (Sheldrick 2010) using the HKL2Map (Pape and Schneider 2004) graphical user 
interface.  
SHELXC estimates the marker-atom structure factors FA and the phase shift α. The main marker 
atoms, that are present in the SeMet-labeled NatC crystals are the selenium atoms (Se) of the 
selenomethionine side chains (MSE).  In addition to Selenium, iodide atoms (present in the reservoir 
solution in the form of 150 mM ammonium iodide) provided additional anomalous signal. At the 
theoretical K-edge (~12.667 keV) of selenium, iodide has an anomalous scattering factor f’’, that is 
about 83% of the selenium scattering factor f’’ as calculated with the Anomalous Scattering server13 
and shown in Fig. 12. 
 
13 The Anomalous Scattering by Ethan A. Merritt (http://skuld.bmsc.washington.edu/scatter/) uses the 
subroutine library by Brennan and Cowan (1992) and the theoretical approximation developed by Cromer and 
Liberman (1981) to calculate f’ and f’’. 
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Fig. 12 Calculated atomic scattering factors for iodide and selenium. The graph was generated using the 
X-ray Anomalous Scattering server. 
SHELXC/D calculated 1000 possible solutions for the substructure with the best solution having a 
CCall of 47.2. For the best solution, 28 sites with occupancy > 0.2 were identified, which were three 
more than the 25 MSE residues present in the NatC construct, which could be attributed to the 
additional anomalous signal from coordinated iodide ions. From the substructure phases ϕA and the 
estimated phase shift α, the approximate phases for the macromolecule ϕT were calculated. Together 
with the observed structure factors FT, an initial electron-density map was calculated. SHELXE 
performed an iterative phase improvement by density modification, combined with an auto-tracing 
of a poly-Ala chain into the electron density. 
The phs-file, containing the electron density map produced by SHELXE, was converted to mtz-
format using the C-shell script phs2mtz14.  
FreeR flags were added to 5% of the reflections with the software FreeRflag (Brunger 1992) from 
the CCP4 suite (Winn et al. 2011), before performing an automated model building and refinement 
with Buccaneer (Cowtan 2006). 
Before performing any further refinement, the CORRECT step of XDS was repeated, in order to 
truncate the dataset to a resolution of 2.4 Å (Friedels law = false), so that the highest resolution shell 
shows a signal-to noise ratio (I/σ) of >1 and a Pearson correlation coefficient CC1/2 > 50% as written 
in the CORRECT.LP file. The new XDS_ASCII.HKL (truncated to 2.4 Å), was converted to CCP4’s 
mtz-format, containing the mean structure factor amplitudes and their standard deviations (= 
 
14 http://webapps.embl-hamburg.de/hkl2map/phs2mtz 
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“merged data”) using XDSconv. The FreeR flags already used during the automated model-building 
and refinement steps in Buccaneer were transferred to the mtz-file from XDS with CCP4’s FreeRflag 
software. 
The initial model (.pdb) obtained from buccaneer was then completed manually in Coot (Emsley et 
al. 2010) and refined against the truncated dataset using Phenix (Adams et al. 2010). 
The final model of the selenomethionine-substituted NatC complex (NatC-apo) complex contained 
the completely modeled Naa30ΔC17 (residues 1-159). No model could be built for two flexible loops 
in Naa35 (129-TTAG-132 and 376-EFESSI-381) and five residues at the Naa35 C-terminus 
(729-QDRYK-733). Two residues (1-ME-2) of Naa38 could not be modelled, due to the flexibility 
of the N-terminus. 
The anomalous density map from SHELXE was used to identify selenium atoms of the 
selenomethionine side chains to assist model building. Additional strong anomalous density was 
found in between well-ordered protein chains and attributed to coordinated iodide ions (the reservoir 
solution contains 150 mM ammonium iodide). At the theoretical selenium K-edge (~12.667 keV), 
iodide has an anomalous scattering factor f’’, that is about 83% of the selenium scattering factor f’’ 
as calculated with the Anomalous Scattering server15. Iodide occupancies were included in the 
refinement with Phenix. 
3.9.2 Native datasets 
Datasets of all native NatC crystals were processed with XDS (Friedel’s law = true) and truncated 
resolution ranges using the same criteria (I/σ >1 and CC1/2 > 50% for the highest resolution shell) as 
described for the SeMet dataset.  
The FreeR flags from the anomalous dataset was transferred to all native datasets belonging to the 
same space group (P212121) using CCP4s FreeRflag. New FreeR flags were generated for the native 
dataset that was indexed in space group P1, during generation of the merged dataset with XDSconv. 
Native NatC datasets were solved by molecular replacement (MR) using Phaser (McCoy et al. 2007). 
The refined structure of the SeMet-labeled NatC complex was used as an input model after removing 
all non-protein chains and replacing the selenomethionine with methionine residues using the Phenix 
software PDB tools. 
Phaser was set to look for one copy of NatC for the native datasets that crystallized in space group 
P212121 (identical to the SeMet crystal), which gave a unique and unambiguous solution. The unit 
cell of the native P1 crystal occupied almost exactly half the volume (50.71%) compared to the 
SeMet P212121 crystal, which contains four unit cells per asymmetric unit (z = 4). Thus, two copies 
 
15 The Anomalous Scattering by Ethan A. Merritt (http://skuld.bmsc.washington.edu/scatter/) 
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of NatC were expected to be found in P1 and Phaser gave a unique solution using this search 
parameter. 
Afterwards, several manual model building (Coot) and refinement (Phenix) rounds were performed 
to address the deviations of the protein backbone and amino acid side chains between the native and 
the SeMet crystals. A strong electron density was found at most of the iodide positions, observed in 
the SeMet structure and thus iodide ions were placed at these positions as well. A few additional 
iodides were placed at coordinates with strong spherical electron densities, next to well defined 
protein sidechains, that could not be explained by other components of the crystal buffer or reservoir 
solution (i.e. HEPES, citrate, PEG4000, glycerol, ethylene glycol, ammonium, sodium or chloride 
ions). Occupancies of iodides were refined for the native structures as well. 
A clear positive difference density was visible in the active center of the NatC structures that were 
co-crystallized with coenzyme A (NatC-CoA structure) and the structures that were co-crystallized 
with both CoA and a substrate peptide (NatC-CoA-MFHLV or NatC-CoA-MLRFV). Ligand 
occupancies were refined. Omit maps for coenzyme A, the different substrate peptides and a water 
molecule in the active site of the NatC complex were generated using phenix.polder (Liebschner et 
al. 2017).  
The final model of the NatC-CoA complex contained the completely modeled Naa30ΔC17 (residues 
1-159) and Naa38ΔC11 (residues 1-77) subunits and 724 out of the 733 residues of the full-length 
Naa35. The nine residues that are missing in the model are located at the Naa35 C-terminus (731-
RYL-733), in the α7-α8 loop (130-TA-131) and in the α16-α17 loop (376-EFES-379). 
To judge the accuracy of all NatC models, the Phenix integration of the validation program 
MolProbity (Chen et al. 2010) was used.  
3.10 Secondary structure annotations 
Secondary structure assignment for all NatC structures was done manually by comparing the outputs 
of different automatic assignment methods and evaluating them through a careful visual inspection 
of the model and electron density. Automatic assignments from the DSSP, STRIDE and KAKSI 
algorithms were obtained for the Coenzyme A-bound NatC structure using the 2Struc secondary 
structure server (Klose, Wallace, and Janes 2010)16. Prior to the analysis with the 2Struc secondary 
structure server, alternative side chains were removed from the PDB file, using the CCP4i tool 
pdbcur17. Afterwards, ATOM serial numbers were reset using Phenix’s PDB file editor. Moreover, 




18 SEQRES records contain the primary sequence of all polymeric molecules (i.e. proteins, peptides, and 
nucleic acids) that are present in the PDB entry (https://www.wwpdb.org/documentation/file-format-
content/format33/v3.3.html) 
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Secondary structure assignments from the PyMOLs dss algorithm were obtained through PyMOLs 
command line19. 
Initial HELIX and SHEET records were generated with the open-source DSSP-derived program 
ksdssp20, which is incorporated into the phenix.secondary_structure_restraints21 tool (Adams et al. 
2011). HELIX and SHEET lines were then manually adjusted after comparing the results of all four 
secondary structure assignment algorithms. Finally, HELIX and SHEET lines were added to the 
secondary structure section of the PDB file.22 Furthermore REMARKS 650 and 700 were added to 
indicate the author-provided secondary structure assignments for both helices and sheets, 
respectively. 
3.11 Sequence alignments and conservation analysis 
To analyze the residue-specific conservation of NatC, multiple sequence alignments (MSA) were 
generated separately for Naa30 (Fig. S1), Naa35 (Fig. S2) and Naa38 (Fig. S3). Global sequence 
alignment with free end gaps (Blosum45) were generated with Geneious 
(https://www.geneious.com/) and visualized using ESPript3.0 (http://espript.ibcp.fr/). Amino acid 
sequences of NatC orthologs were selected from six different species, covering different clades from 
the eukaryotic tree of life. Two species were selected from the Fungi kingdom: Saccharomyces 
cerevisiae (Sc) and the closely related Kluyveromyces lactis (Kl), which can assimilate lactose and 
convert it into lactic acid. The mouse-ear cress Arabidopsis thaliana (At) was selected as a model 
organism for the plant kingdom. Homo sapiens (Hs), the zebra fish Danio rerio (Dr) and the red flour 
beetle Tribolium castaneum (Tc) were selected for the holozoan clade, which includes animals and 
single-celled relatives, but excludes fungi.  
The degree of conservation (conservation score) of each amino acid was calculated with the ConSurf 
(Ashkenazy et al. 2016) web server23 using a user-provided multiple sequence alignment. To generate 
the MSA, NatC subunit orthologs were selected manually from eighteen different species across the 
eukaryotic tree of life, using the publication of Rathore et al. (2016) as a guide. The eighteen species 
are represented in a phylogenetic tree diagram in Fig. S4. 
 
19 Using the command: “iterate n. CA, print chain + ';' + resi + ';' + resn + ';' + alt + ';' + ss” 
20 Phenix’s kdssp can be executed from the Phenix Command Prompt Using the command: 
“phenix.secondary_structure_restraints model.pdb format=pdb” 
21 https://www.phenix-online.org/documentation/reference/secondary_structure_restraints.html 
22 A detailed description can be found in the secondary structure section of the Atomic Coordinate Entry Format 
document (Version 3.3, https://www.wwpdb.org/documentation/file-format-content/format33/sect5.html) 
23 http://consurf.tau.ac.il/ 
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3.12 Structure analysis methods 
The approximate Minimal Bounding Box (MBB) was calculated with the PyMOL script “Draw 
Protein Dimensions”, which calculates an Inertia Axis Aligned Bounding Box (IABB) and was 
written by Pablo Guardado Calvo24. 
Interfaces between the subunits Naa30, Naa35 and Naa38 were analyzed for the NatC-CoA structure 
using the PISA (Krissinel and Henrick 2007) web server25. Buried surface areas were also calculated 
by the PISA server. 
The structures of the three NatC subunits were compared against the complete PDB database using 
the DALI web server26 (Holm and Rosenström 2010). 
Structural superpositions and RMSD calculations for structures from different proteins (e.g. NAT 
homologs and DALI matches) were performed with the PyMOL command super27. To compute the 
Cα RMSD between two structures of the same protein (e.g. NatC-CoA vs. NatC-apo) the command 
fit28 was used. 
The diameters of the tunnels with a roughly spherical diameter were calculated with the PyMOL 
plugin Caver (Chovancova et al. 2012). Dimension of tunnels with elliptical cross section were 
determined by measuring the distance between pointer atoms, placed manually on the PyMOL-
generated Conolly surface29. 
The electrostatic surface potential of the NatC-CoA complex was calculated with the PyMOL APBS 
plugin (Jurrus et al. 2018)30. 
 
24 https://pymolwiki.org/index.php/Draw_Protein_Dimensions 
25 'Protein interfaces, surfaces and assemblies' service PISA at the European Bioinformatics Institute. 
(http://www.ebi.ac.uk/pdbe/prot_int/pistart.html)  
26 http://ekhidna2.biocenter.helsinki.fi/dali/ 
27 Super (https://pymolwiki.org/index.php/Super) performs a sequence-independent alignment and is the 
method of choice for structural alignment of two proteins with a low sequence similarity. 
28 Fit (https://pymolwiki.org/index.php/Fit. )will superimpose two models by aligning matching atoms, which 
need to have the exact same atom identifier (segi, chain, resn, resi, name and alt). Any deviations between 
atoms identifiers of the two structures, for example, alternate locations of amino acids, were removed 
beforehand. 
29 The Connolly surface, shown in the PyMOL surface representation, is the solvent/protein contact surface, 
which is traced out by surfaces of waters in contact with the protein (https://pymolwiki.org/index.php/Surface)  
30 APBS writes out the electrostatic potential in dimensionless units of kT/e, where k is the Boltzmann’s 
constant (1.381× 10−23 J⋅K-1 or 8.617×10−5 eV⋅K−1), T is the temperature of the calculation in K (default is 
298.15 K, i.e. 25°C) and e is the charge of an electron (1.60217646 × 10-19 C). 
 
48      Results 
 
4 Results 
4.1 Purification of the NatC complex 
To obtain sufficient amounts of the NatC complex for structural and biochemical studies, the three 
NatC subunits (Naa30, Naa35 and Naa38) from S. cerevisiae were co-expressed in E. coli using a 
single expression vector (see sections 3.13.1.1 and 3.2). Secondary structure predictions revealed a 
highly flexible C-terminus in Naa30. Moreover, sequence alignments of Naa30 paralogs (Fig. S1), 
showed that the corresponding C-terminal residues are not conserved, pointing to a non-essential role 
for catalysis. Since a deletion of similar non-conserved C-terminal residues of the Naa10 catalytic 
subunit was required for the crystallization of the NatA complex (Liszczak et al. 2013), a truncated 
construct was also used for Naa30 (Naa30ΔC17).  
Furthermore, during initial purification experiments, a partial proteolytic degradation of the smallest 
subunit, Naa38, was observed, as indicated by a double band on an SDS-PAGE gel (Fig. 13A). 
MALDI-MS analysis (see 3.3) of the degradation fragment demonstrated a mass difference of 1183.0 
Da, compared to full length Naa38, which is closest to the mass of the eleven C-terminal residues of 
Naa38 (Fig. 13B). 
 
Fig. 13 MALDI-MS analysis of the Naa38 partial proteolytic degradation. (A) Purified NatC complex with 
full-length Naa38 on a 4–12% SDS-PAGE gel, showing a clear double band (red circle) for the small subunit. 
(B) MALDI-MS of the purified NatC complex with partially degraded Naa38. The right peak corresponds to full-
length Naa38 and was used together with its doubly charged species (not seen on the plot) for calibration. The 
left peak corresponds to the partially degraded Naa38 subunit. A mass difference of 1183 Da between full-length 
and degraded Naa38 was measured. (C) 12% SDS-PAGE gel showing purified wild type NatC with truncated 
Naa38ΔC11, displaying only a single protein band (red circle). 
The presence of two Naa38 protein species results in an inhomogeneous NatC complex. Moreover, 
a partial proteolytic digest is indicative of an unstructured region in a protein and both factors 
decrease the likelihood of crystallization (McPherson and Gavira 2014). As for Naa30, the C-
terminus of Naa38 is not conserved (Fig. S2). Therefore, the eleven C-terminal residues were 
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truncated in the Naa38ΔC11 construct. After expression and purification, only a single protein band 
was visible for the Naa38ΔC11 subunit on the SDS-PAGE (Fig. 13C). Thus, all further NatC 
complex constructs contained subunits Naa30ΔC17 (residues 1–159), full-length Naa35 (residues 1–
733) and Naa38ΔC11 (residues 1–77), which will be henceforth referred to as the wild type NatC 
complex.  
In addition to suitable construct boundaries, a reproducible protein purification protocol needed to 
be established (see Fig. 14). To achieve this, the large auxiliary subunit Naa35 was equipped with an 
N-terminal 6×His-tag for affinity purification by Immobilized metal ion affinity chromatography 
(IMAC) (see 0). The remaining NatC subunits Naa30ΔC17 and Naa38ΔC11 were untagged, and co-
purified with Naa35, indicating that the three proteins form a stable complex. 
Following bacterial expression, Naa30ΔC17 and Naa38ΔC11 were in molar excess over the tagged 
Naa35 in the soluble fraction, because a large proportion of the untagged subunits passed the affinity 
material and appeared in the flow-through fraction (Fig. 14A). The excess amounts of Naa30ΔC17 
and Naa38ΔC11 allowed for the purification of a homogenous NatC complex, with a subunit ratio 
of 1:1:1. 
 
Fig. 14 Purification of the wild type NatC complex. (A) Samples loaded on a 4–12% gradient gel. Ni-IMAC, 
Ni2+-Immobilized metal ion affinity chromatography; SN, supernatant; FT, flow-through; *, Imidazole 
concentrations during wash and elution steps. HRV 3C, human rhinovirus 3C protease cleavage with fractions 
before (-cut) and after (+cut) digest. (B) Different amounts of purified NatC complex, loaded on a 12% gel, after 
a final size exclusion chromatography (SEC) polishing step with an S200 column. (C) aNaa35, cut refers to the 
full-length Naa35 subunit, with residues GP at the N-terminus, which remain after HRV 3C protease cleavage. 
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The majority of E. coli proteins were removed during a first washing step of the affinity column 
using low imidazole concentrations. When eluted from the column with higher imidazole 
concentrations, the NatC complex exhibited a 260/280-ratio of ≈1.4, which suggested a significant 
nucleic acid contamination with an extent of roughly 20%.31 An overnight endonuclease treatment 
in parallel to proteolytic cleavage of the 6×His-tag, followed by a second IMAC, allowed for the 
successful removal of the nucleic acid contaminants, resulting in a low 260/280 ratio of ≈ 0.6. During 
the final size exclusion chromatography (SEC) step, further E. coli protein contaminants were 
removed (Fig. 14B) and the 260/280 ratio was decreased to ≈ 0.5, which correspond to a protein 
purity of almost 100%. Furthermore, the S200 SEC profile (Fig. 14C) showed one symmetrical peak 
in the center of the chromatogram, indicating the presence of one uniform NatC complex species. 
NatC was typically concentrated to 10 mg/mL, but also higher concentration (up to 30 mg/mL) were 
stable and did not aggregate over time. The typical yield for a NatC complex purification was about 
1–3 mg NatC per liter of E. coli culture. A seleno-methionine substituted variant of the NatC complex 
was expressed as described in section 3.2.5, and purified in the same way as the WT NatC complex. 
In conclusion a stable heterotrimeric S. cerevisiae NatC complex could be purified to homogeneity 
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4.2 Structures of the apo and CoA-bound NatC complex 
4.2.1 Crystallization 
To obtain insights into the atomic structure of NatC, the purified selenomethionine-labeled NatC 
complex was crystallized through vapor diffusion in both hanging- and sitting-drop format. Also, 
native NatC complex was crystallized together with coenzyme A, a natural product of 
acetyltransferases. 
First crystals of the NatC complex were obtained in several conditions of an initial PEG screen, 
containing PEG 3350 or PEG 4000 with the pH varying from 5.6 to 8.5. These crystals grew as thin 
needles from a single nucleation center (Fig. 15, left). By fine screening the PEG concentration, 
buffer conditions and through the addition of different ammonium salts, plate-shaped crystals were 
obtained (Fig. 15, middle). These plates were initially thin and entangled, but were further increased 
in size by changing the drop and reservoir volumes, until thicker, single plates were obtained (Fig. 
15A, right). However, these plates diffracted X-rays to only about 8 Å. By further fine-tuning the 
conditions, crystals diffracting X-rays between 2.4–3.0 Å were obtained in a crystallization solution 
containing 14.5–16.5% PEG 4000, 150 mM ammonium iodide and 100 mM sodium citrate, pH 6.1–
6.3 (see 3.7). Under these conditions, both SeMet-labeled and native NatC protein, supplemented 
with CoA formed rod-shaped crystals, which appeared after 12–48 h and required another five days 
to reach their maximum dimensions (Fig. 15B). 
 
Fig. 15 Initial and diffraction quality crystals of the NatC complex (A) Early NatC crystals, forming needles 
and thin plates, diffracted to a resolution of about 8 Å only. (B) Rod-shaped, single, diffraction quality crystals of 
SeMet-labeled and native NatC-CoA protein. 
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4.2.2 Structure determination 
X-ray data were collected at BESSY as described in 3.8. The best selenomethionine-substituted NatC 
crystal (NatC-apo) diffracted X-rays to a maximum resolution of 2.4 Å and belongs to the 
orthorhombic space group P212121. The data collection statistics are listed in Table 17. 
Table 17 Data collection statistics for a crystal of selenomethionine-substituted and CoA-bound NatC. 
Values in parentheses are for highest-resolution shell. 
Data collection NatC-apo (SeMet) NatC-CoA (native) 
Space group P21 21 21 P21 21 21 
Cell dimensions   
   a, b, c (Å)  48.12 140.42 166.41 48.04 139.79 166.56 
   α, β, γ (°) 90 90 90 90 90 90 
Wavelength (Å) 0.9797 0.9184 
Resolution range (Å) 
46.23 - 2.40 
(2.48 - 2.40) 
45.43 - 2.45 (2.54 - 2.45) 
Completeness (%) 99.6 (97.9) 99.9 (99.4) 
Rsym (%) 12.8 (133.2) 14.8 (159.5) 
Redundancy 7.0 (6.4) 6.6 (6.8) 
I/σ (I) 11.3 (1.2) 10.9 (1.1) 
 
The crystallized selenomethionine (MSE)-labeled NatC construct contained 25 selenium (Se) atoms. 
In the initial substructure of the anomalous scatterers, 28 sites with occupancy > 0.2 were identified, 
some of them resulting from iodide atoms that also have a weak anomalous signal at the chosen peak 
wavelength of the K-absorption edge of selenium. Together, selenium and iodide delivered enough 
anomalous signal for successful experimental phasing by a single-wavelength anomalous diffraction 
(SAD) approach (see 3.9.1). 
Exemplary selections of the calculated electron maps including the anomalous signals are shown in 
Fig. 16A. Alpha-helices were clearly visible and their orientation could be traced. At some positions, 
it was even possible to discriminate between the three large aromatic side chains. For example, the 
hydroxyl group of Tyr472 was clearly visible (Fig. 16A, top). The experimental electron density map 
was used to automatically build a model for the entire NatC complex, that was then manually 
completed and refined to a Rwork/Rfree32 of 19.5% / 22.3% (see Table 18). Both R values are lower 
than the median R values of PDB structures with similar resolution (see Fig. 17B). Thus, the overall 
model provided a good explanation of the experimental data. 
 
32 Rwork and Rfree values measure the agreement between the model and the experimental diffraction data. To 
avoid an over-modeling of the data, a Rfree value is calculated for 5% of the reflections that are not included in 
the refinement. The better the model describes the data, the lower will be the R values. 
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Fig. 16 Data processing and model building of the SeMet-labeled NatC complex. (A) Selected examples 
of the final SHELX 2Fo-Fc map (1 σ) and anomalous map (6 σ). (B) Final model of NatC-apo (SeMet), built with 
COOT and refined with PHENIX. 
The native CoA-bound NatC complex diffracted X-rays to a resolution of 2.45 Å and crystallized in 
the same orthorhombic space group as the SeMet-labeled crystal. Data collection statistics are listed 
in Table 17. The refined structure of the SeMet-labeled NatC complex was used as an input model 
for solving the structure of the native NatC complex by molecular replacement (see 3.9.2).  
The final model of the NatC-CoA complex contained the completely modeled Naa30ΔC17 (residues 
1-159) and Naa38ΔC11 (residues 1-77) subunits and 724 out of the 733 residues of the full-length 
Naa35. It was refined to a Rwork/Rfree of 20.3% / 23.6% (see Table 18). 
Table 18 Refinement statistics of the apo and CoA-bound NatC structures. Values in parentheses are for 






Resolution range (Å) 46.23 – 2.40 (2.48 – 2.40) 45.43 – 2.45 (2.54 – 2.45) 
No. of reflections 85037 (8268) 42170 (4132) 
Rwork / Rfree (%)a 19.5 / 22.3 20.3 / 23.6 
No of atoms   
   Protein 7718 7806 
   Ligands 100 122 
   Water 181 190 
B factors (Å2)   
   Average 65.7 64.5 
   Protein 66.0 64.6 
   Ligands 72.5 79.4 
   Water 51.6 50.2 
RMSD   
   Bond lengths (Å) 0.004 0.004 
   Bond angles (°) 0.90 0.92 
Ramachandran plot (%)   
   Most favored 98.5 98.9 
   Allowed  1.5 1.1 
   Outlier 0 0 
Rotamer outliers (%) 0.3 0.5 
Clashscore 4.0 3.9 
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For both models, >98% of all residues were in the most favored region of the Ramachandran plot 
(Fig. 17A) (Ramachandran and Sasisekharan 1968) and less than 0.2% of were Ramachandran 
outliers (see Table 18). Moreover, less than 1% of all side chains were rotamer outliers and the 
models displayed a low clashscore33 compared to models of similar resolution (Fig. 17B), pointing 
to an excellent stereochemistry of the refined models. 
 
Fig. 17 Evaluation of the NatC-apo (SeMet) structure. (A) Ramachandran plot for all non-Pro/Gly residues, 
with favored residues in cyan and allowed residues in yellow. No residues fell in the disallowed region. (B) Data 
statistics for NatC-apo compared with 722 PDB structures of similar resolution. Values for NatC-CoA are printed 
in black and the upper and lower limit for each distribution of the PDB parameters is printed in red. The 
connecting polygon (black) shows were the NatC values fall in each distribution. 
  
 
33 The clashscore is defined as the number of overlaps (more than 0.4 Å) between non-hydrogen bonded atoms 
per 1000 atoms and should be as low as possible. 
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4.3 Overall structure of the NatC complex 
The root-mean-square deviation (RMSD) of the Cα atom positions between the selenomethionine-
substituted apo structure (NatC-apo) and NatC-CoA was only 0.231 Å for a total of 953 compared 
residues, and no difference in the overall secondary, tertiary and quaternary structure was observed. 
Therefore, the better-defined CoA-bound NatC structure is presented in the following. A cartoon-
representation gives an overview of both tertiary and quaternary structure of the NatC complex (Fig. 
18) and a topology (Fig. 19) plot shows the arrangement of secondary structure elements, especially 
of β-strands. 
 
Fig. 18 Overall structure of the native NatC complex, bound to CoA Cartoon representation of NatC-CoA 
with Naa30ΔC17 (pale cyan), Naa35 (wheat) and Naa38 (pale green), bound to coenzyme A (in purple). Naa30 
helices and sheets are labeled α1–α4 and β1–β7, respectively. Naa35 is labeled α1–α26 and β1–β5, with helix 
three (η3) being a short 3-10 helix and helix six (π6), being a short pi-helix. Naa38 is labeled with α1–α2 and 
β1–β5. 
The catalytic subunit Naa30 adopts the typical Gcn5-related N-acetyltransferase (GNAT) fold: an N-
terminal strand (β1), followed by two helices (α1 and α2), three antiparallel strands (β2-β4), followed 
by a “signature” central helix (α3), a fifth strand (β5), a fourth helix (α4) and a final strand (β6) 
(Vetting et al. 2005). The seventh β strand of Naa30 lies antiparallel in between β5 and β6 (see Fig. 
18 and Fig. 19). Naa30 also contains the conserved CoA-binding motif (GNAT motif A) with the 
sequence Q/R-x-x-G-x-G/A (where x is any amino acid), which is located in the β4–α3 loop (see 
Appendix, Fig. S1) (Lu, Berkey, and Casero 1996; Wolf et al. 1998).  
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The auxiliary subunit Naa35 is composed of 26 helices ranging from 5 to 45 residues in length. 
Among these is one five-residue long 310-helix (η3) and a seven residue π-helix (π6).34 Helix α21, 
together with the C-terminal end of helix 20 (Naa35 subunit) extrude by approx. 29 Å from the 
central body, forming an extension, which will be referred to as the “Naa35 tip” in this thesis.35 
The small auxiliary subunit Naa38 adopts the conserved Sm fold (Kambach et al. 1999), containing 
a N-terminal α-helix, followed by a strongly bent five-stranded β-sheet. Naa38 contains an additional 
short α-helix at the C-terminus. The five β-strands (β1-β5) of Naa38 interact with three short β-
strands (β1-β3) of subunit Naa35 to form a bifurcated, anti-parallel β-sheet. The first sheet of the 
bifurcated Naa35-Naa38 β-sheet consists of seven β-strands and the second sheet of five β-strands 
(Fig. 19).  
 
Fig. 19 Topology plot of NatC Manually drawn TOPS-like cartoon of NatC. Triangles represent β-strands, with 
smaller triangles indicating sheets with ≤6 residues. Adjacent triangles pointing in the same direction, indicate 
parallel β-strands; triangles facing in different directions indicate antiparallel β-strands. Circular symbols 




34 Helices are labeled separately for each subunit by their type (α, 310 or π) followed by the total helix number. 
35 The length of the Naa35 Tip is approximated by the Cα atom distance (28.9 Å) between Ala507, located in 
the α20–α21 loop and Leu529, located in helix α22. 
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A minimal bounding box was calculated for the CoA-bound NatC complex which reveals its 
approximate dimensions of 119 Å × 86 Å × 69 Å (Fig. 20A). The surface representation shows 
another remarkable feature of the NatC complex: two tunnels, which are located roughly at the center 
of the entire complex at the Naa30-Naa35 interface. The thiol group of coenzyme A is located in the 
“side tunnel”, which contains the active site of the catalytic subunit Naa30 (Fig. 20 B, C). The side 
tunnel is separated from the “central tunnel”, which is surrounded entirely by loop-regions of the 
subunits Naa30 and Naa35. The abundance of loop regions near the central tunnel indicates a large 
flexibility of this region, which may play a role in substrate binding and is further explored in section 
4.8.3. 
 
Fig. 20 Surface representation of NatC (A) NatC-CoA surrounded by its minimal bounding box, representing 
the dimensions of the complex. Helix α21 and the C-terminal end of α20 (Naa35 subunit) form the Naa35 Tip. 
(B) Zoom view, showing the central and side tunnel and surrounding loop regions. (C) Back view showing the 
CoA binding groove that connects directly to the end of the side tunnel, which harbors the active site. 
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4.4 NatC subunit interfaces 
The Naa35 subunit wraps around the catalytic Naa30 subunit in an open ring-like tertiary structure, 
that covers about three fourth of the circumference of the roughly spherical Naa30 subunit (interface 
1, Fig. 21). The Naa38 subunit is primarily tethered to the NatC complex by the N-terminus (residues 
1–64) and a short stretch of subunit Naa35 (residues 276–282, containing helix α12) forming 
interface 2 (Fig. 21). Both segments of Naa35 wrap around almost the entire circumference of Naa38, 
forming another ring-like tertiary structure. 
 
Fig. 21 NatC subunit interfaces. (A) Cartoon representation of NatC-CoA, showing the two main interface 
regions, enlarged in four different zoom views (1a,b and 2a,b). Key residues (stick format) are labeled in bold 
(highly conserved) and are underlined (completely conserved). Hydrogen bonds and salt bridges involving side 
chains are colored in black; backbone-backbone interactions are colored in red. The Naa30-Naa35 interface is 
divided into two partial interfaces, comprising residues 97–159 or residues 10–44 of subunit Naa30, 
respectively. Scissors symbols represent two Naa35 constructs boundaries.  
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The buried surface area between Naa30 and Naa38 is 1,890 Å2, while the interface between Naa35 
and Naa38 measures 1,970 Å2. There is only a minor interface of 260 Å2 between the catalytic subunit 
Naa30 and the small subunit Naa38. 
The first interface region comprises the C-terminal half of subunit Naa30 (residues 97-159) and 
different segments of Naa35, which are far apart in sequence. The most intimate interactions between 
the two subunits are made between α3 and the α4–loop–β6–loop–β7 segment of subunit Naa30 and 
α18, the α19-loop-α20 segment, the α22–α23-loop and helix α23 of subunit Naa35. For example, 
two hydrogen bonds are formed between the completely conserved arginines Arg137 and Arg140 in 
β6 of subunit Naa30 and the backbone carbonyl oxygens of Asp456 and Leu455 of subunit Naa35, 
respectively. The β6–β7 loop of Naa30, important for its enzymatic activity, forms one face of the 
central tunnel and shows only weak interactions with several other loops of the Naa35 subunit: Two 
hydrogen bonds are formed between the side chains of Asn147 (Naa30) and Gln106 (Naa35) and 
one additional hydrogen bond is formed between Arg143 of Naa30 and the carbonyl oxygen of 
Tyr105 (Naa35). As will be discusses later, the binding of the Gag peptide substrate induces a 
conformational switch of the β6–β7 loop, demonstrating its general flexibility. 
The second interface region comprises the N-terminal half of subunit Naa30, the Naa35 N-terminus 
and a short stretch of helix Naa35α12, plus the entire Naa38 subunit. As mentioned above, the N-
terminus of Naa35 is wrapped around almost the entire circumference of Naa38. The N-terminal 
alpha helix (α1) and the succeeding loop are not conserved among Naa35 orthologs and form very 
limited interactions with the adjacent Naa38 subunit. However, the subsequent β-strand (β1) of 
Naa35 is highly conserved and constitutes one end of the bifurcated Naa38-Naa35 β-sheet. The 
Naa35 β1-α2-loop-β2 segment forms a highly conserved, extremely hydrophobic interface with 
several Naa38 side chains, which are distributed almost throughout the entire primary sequence of 
Naa38. The second β-strand of Naa35 is located on the opposite site of Naa38 (compared to the β1-
strand) and forms the second end of the bifurcated Naa38-Naa35 β-sheet. An extended segment 
(loop-β2-loop-η3-loop) of Naa35 is sandwiched in between the two N-terminal helices α1 and α2 of 
Naa30 and the Naa38 subunit. The mainly hydrophobic interfaces between the three subunits involve 
highly or completely conserved residues from Naa30, Naa35 and Naa38. The third β-strand of Naa35 
represents the first strand of the bifurcated Naa35-Naa38 β-sheet and forms three backbone hydrogen 
bonds with Naa38. Two salt bridges are formed between the side chains of the completely conserved 
Asp61 (Naa35) and Arg22 (Naa38). This interaction is supported by Ser63 (Naa35) which is within 
hydrogen bonding distance of Glu44, Arg22 and Arg51 of Naa38. Finally, Arg51 (Naa38) is within 
hydrogen bonding distance of three backbone carbonyl oxygens of Gln276, Lys277 and Arg279 from 
the C-terminal end of the short α12 helix of Naa35. 
In summary, the auxiliary subunit Naa35 is a central assembly hub of the NatC complex, which forms 
extensive interactions with the catalytic subunit and the second auxiliary subunit Naa38. 
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4.4.1 The Naa35 N-terminus is critical for NatC integrity 
To test the significance of the Naa35 N-terminus for NatC integrity, structure-guided truncation 
constructs were designed (see 3.1.3). Wild type NatC (Naa30ΔC17, Naa38ΔC11, full-length Naa35) 
runs as a complex on a size exclusion chromatography (SEC) with all three subunits present, as 
shown by an SDS-PAGE gel (Fig. 22, left lane). A NatC complex lacking the first seventeen 
non-conserved residues of Naa35 (Naa35ΔN17) also runs as a complex on the SEC, with all three 
subunits visible on the subsequent SDS-PAGE gel (Fig. 22, middle lane). As shown in the previous 
section (4.4) this non-conserved N-terminal region of Naa35 (see sequence alignment in Fig. S3 of 
the appendix) forms very limited interactions with the adjacent Naa38 subunit. Thus, the non-
conserved N-terminal α1 helix of Naa35 is not essential for structural integrity of NatC. 
The Naa35ΔN44 construct additionally lacks the β1-α2-loop-β2 segment, which forms extensive 
hydrophobic interactions with Naa38 and participates in the common Naa35-Naa38 β-sheet. In line 
with the structural data, a NatC complex affinity purified via the Naa35ΔN44 subunit only forms a 
heterodimer with Naa30 (Fig. 22, right lane). Thus, the integrity of the heterotrimeric NatC complex 
is dependent on the N-terminal region of Naa35, except for its very first α1 helix. 
 
Fig. 22 The Naa35 N-terminus is critical for NatC integrity SDS-PAGE gel of purified NatC complexes 
containing full-length Naa35 (residues 1–733), Naa35ΔN17 (residues 18–733) or Naa35ΔN44 (residues 44–
733).  
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4.5 Comparison of NatC with heterodimeric NatA and NatB complexes 
A comparison of the heterotrimeric NatC complex with the heterodimeric NatA and NatB complexes 
shows remarkable differences in their tertiary and quaternary structures (Fig. 23). 
 
Fig. 23 Comparison of NatA, NatB and NatC complexes NatA (4KVO) and NatB (5K04) were superimposed 
with NatC using the corresponding catalytic subunits (cyan). Afterwards, the entire complexes were translated 
horizontally for a side-by-side comparison. The Cα RMSD between Naa30 and Naa10 is 1.2 Å (125 Cα atoms) 
and between Naa30 and Naa20 is 1.3 Å (116 Cα atoms). 
At its core, all NAT complexes have the evolutionary conserved catalytic subunit, with its conserved 
GNAT architecture (Vetting et al. 2005). In all three NAT complexes, the additional β7-strand lies 
antiparallel in between β5 and β6. However, while NatA and NatB contain a single related, auxiliary 
subunit (called Naa15 and Naa25, respectively), NatC contains two auxiliary subunits, Naa35 and 
Naa38, which have different folds. The α-helices in subunits Naa15 and Naa25 form thirteen or 
twelve so-called helical bundle tetratricopeptide repeats (TPR), respectively. The TPR motif adopts 
a basic helix-turn-helix fold and consists of 34 amino acids with a degenerate consensus sequence, 
containing small and large hydrophobic amino acids (Zeytuni and Zarivach 2012). These repeats 
form a tertiary structure, which is found in numerous proteins and serves as an interaction module 
and mediator for heteromeric complex formation. However, in contrast to NatA and NatB, a sequence 
analysis with the TPRpred server36 revealed no such motifs in NatC. Moreover, while TPR motifs 
typically consist of helices containing 12–15 residues (Zeytuni and Zarivach 2012), NatC has a very 
heterogenous distribution of helix lengths, with nine helices having 11 or fewer residues, three 
helices in the range of 12–15 residues and fourteen helices ranging from 16 to 45 residues. 
Strikingly, the relative position of the NatC auxiliary subunit compared to the catalytic subunit, is 
exactly opposite to the positions of the NatA and NatB auxiliary subunits. Whereas Naa15 and Naa25 
primarily engulf the N-terminal part of their catalytic subunits, Naa35 additionally encloses the C-
terminal half of Naa30. In NatA and NatB, the catalytic β6–β7 loop makes no contact with the 
 
36 https://toolkit.tuebingen.mpg.de/#/tools/tprpred 
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corresponding auxiliary subunit. In NatC, this loop-region, which is critical for binding of the peptide 
substrate (see 4.8.3), is in direct contact with the auxiliary subunit Naa35 (see 4.4). 
4.5.1 Comparison of the catalytic subunits α1-loop-α2 regions with their auxiliary subunit(s) 
While the monomeric NAT ortholog NatE is active on its own (Liszczak, Arnesen, and Marmorstein 
2011), the catalytic subunits of the heterodimeric (NatA, NatB) or heterotrimeric (NatC) NAT 
complexes require their corresponding auxiliary subunit(s) for proper catalytic function. The 
auxiliary subunits are necessary for a proper positioning of the α1–loop–α2 region for full catalytic 
activity for their native substrates. 
 
Fig. 24 Comparison of the α1–loop–α2 region of NatA, NatB and NatC complexes (A) Superposition of 
monomeric, uncomplexed S. pombe Naa10 (spNaa10-AcCoA) with the SpNaa10/Naa15 complex (SpNatA-
CoA). (B) Naa20/Naa25 complex from C. albicans (caNatB-CoA). (C) Naa30/Naa35/Naa38 complex from S. 
cerevisiae (scNatC-CoA). 
Liszczak et al. (2013) have solved the structure of both the uncomplexed, monomeric Naa10 and the 
Naa10/Naa15 complex. A superposition of the uncomplexed Naa10 with the Naa10/Naa15 complex 
(NatA) shows that the α1–loop–α2 region undergoes significant conformational changes in the 
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presence of its auxiliary subunit Naa15 (Fig. 24A), which results in large movements of Leu22, 
Glu24 and Tyr26 (left zoom view), all of which are essential for catalysis. The α1–loop–α2 region 
of complexed Naa10 makes multiple hydrophobic interactions with Naa15, in addition to a few 
hydrogen bonds. 
In the NatB (Naa20/Naa25) complex, similar interactions of the Naa20 α1–loop–α2 region with the 
auxiliary subunit Naa25 are found (Hong et al. 2017). Fig. 24B shows that the interface is dominated 
by hydrophobic interactions from both the α1 and α2 helices. 
In NatC, α2 of Naa30 is in contact with the two auxiliary subunits (Fig. 24C, described in detail in 
section 4.4). Most importantly, Tyr34 from Naa30 is placed in a hydrophobic pocket that is lined by 
residues from both Naa35 and Naa38. Additionally, Lys59 of Naa35 makes a hydrogen bond with 
the carbonyl oxygen backbone of Naa30, stabilizing the α1–loop–α2. 
In contrast to the NatA and NatB complexes, α1 of the catalytic subunit has no contact to any of the 
two auxiliary subunits but makes several intramolecular hydrophobic interactions with α2 and the β-
sheet. Moreover, Asp26 forms a hydrogen bound with Arg91 from the conserved CoA-binding motif 
(Q/R-x-x-G-x-G/A) in the β4–α3 loop. These comparisons show that although the overall 
architecture of the auxiliary subunits is completely different in the three NAT complexes, the regions 
important for catalysis in the catalytic subunit are stabilized in a similar fashion, e.g. similar 
mechanistic principles apply for all of the NAT complexes. 
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4.6 Structural comparisons of NatC 
A comparative analysis of the three NatC subunits structures with known structures from the PDB 
database was used to detect related protein folds that may not have been previously derived from 
multiple sequence alignments. Thus, although protein sequences can be altered over the time course 
of evolution, in particular when proteins adopt new functions, their 3-dimensional folds often remain 
conserved (Holm and Sander 1996). 
The structures of the three NatC subunits were compared against the complete PDB database using 
the DALI web server37 (Holm and Rosenström 2010) (see 3.12). The top-ranked match and a few 
additional matches with non-redundant protein sequences are summarized in Table 19. 
Table 19 Top structural similarities of NatC subunits to the PDB database. NatC-CoA was used as a query 
structure (DALI search). Selected non-redundant hits are shown. Z, DALI Z-score (significance of pairwise 
comparison); rmsd, root-mean-square-deviation of aligned Cα atoms in Å; lali, number of aligned positions; nres, 
residue number of the matched structure; %id sequence identity between aligned structures. Full species names 




Z rmsd lali nres %id PDB structure Res Species Author 
Selected Naa30 hits 
1 4lx9-A 22.7 1.6 149 157 27 
Archaeal Ard1 ortholog (ssNAT) 






12 4kvo-E 22.2 1.7 150 153 25 
NatA (Naa10/Naa15) complex 
bound to a AcCoA 
3.2 
S. pombe (Liszczak et al. 2013) 
70 4kvx-B 19.3 2.3 147 152 22 
Crystal structure of Naa10 
(Ard1) bound to AcCoA 
2.0 
Selected Naa35 hits 
1 3zxp-C 11.5 3.8 225 384 7 
Bro1 Domain-Containing Protein 
Brox; 
2.5 H. sapiens (Zhai et al. 2011) 
5 5mk1-B 11.1 3.8 214 358 4 
Tyrosine-Protein Phosphatase 
Non-Receptor Type 23 
2.5 H. sapiens (Gahloth et al. 2017) 
8 1zb1-A 11.0 3.9 207 367 8 Bro1 protein 2.0 S. cerevisiae (Kim et al. 2005) 
42 2r02-A 9.0 3.6 205 697 5 
Alix / Programmed Cell Death 6-
Interacting Protein; 
2.6 H. sapiens (Zhai et al. 2007) 
Selected Naa38 hits: 
1 3jcm-h 11.6 1.8 72 77 24 
Spliceosomal U4/U6.U5 tri-
snRNP (Cryo-EM structure) 
3.8 S. cerevisiae (Wan et al. 2016) 
3 4m7d-G 11.5 1.8 72 77 24 
Lsm2-8 complex bound to RNA 
fragment CGUUU 
2.6 
S. cerevisiae (Zhou et al. 2013) 
28 4m7a-G 11.0 1.7 69 74 23 
Lsm2-8 complex bound to RNA 
fragment CGUUUU 
2.8 
4.6.1 The Naa30 subunit adopts the typical Gcn5-related N-acetyltransferase (GNAT) fold 
The top hit for the Naa30 subunit is the archaeal Ard1 ortholog from Sulfolobus solfataricus 
(ssNAT), which is the only NAT enzyme identified in archaea and believed to be the ancestral NAT 
variant from which the eukaryotic NAT machinery evolved (Liszczak and Marmorstein 2013). 
 
37 http://ekhidna2.biocenter.helsinki.fi/dali/ 
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The RMSD of Cα atom positions (149 aligned atoms) between Naa30 and ssNAT is 1.6 Å. With a 
sequence identity of 27% and a Z-score38 of 22.7, ssNAT is considered a close homolog (Table 19). 
ssNAT and Naa30 contain the same number of secondary structure elements and have a very similar 
fold (Fig. 25, left). The greatest difference between the two structures is the extended β3–β4 loop 
found in ssNAT, which is the only non-conserved core region relative to eukaryotic NATs and has a 
limited stabilizing effect on the 3D fold of the ssNAT active site (Liszczak and Marmorstein 2013). 
 
Fig. 25 Selected DALI matches for the Naa30 subunit. Naa30 from the NatC-CoA structure was used for a 
structural alignment with the complete PDB database. A superposition of the best match (ssNAT) is shown on 
the left. A zoom view (right) of the α1–loop–α2 region with two additionally aligned strong DALI matches. 
The next best, non-redundant match for Naa30 is the Naa10 subunit of the Schizosaccharomyces 
pombe NatA (Naa10/Naa15) complex with an RMSD of 1.7 Å (over 150 Cα atoms). The same 
spNaa10 protein, in its uncomplexed monomeric form, has a significantly higher RMSD of 2.3 Å 
(147 Cα atoms), mostly due to significant changes in the α1–loop–α2 region of uncomplexed Naa10 
(Fig. 25, right). This region undergoes significant changes upon complex formation with Naa15 that 
are essential for catalysis. The α1–loop–α2 region of Naa30 adopts the same conformation as the 
complexed Naa10, as does the monomeric ssNAT, which is catalytically active without the aid of an 
auxiliary subunit (Liszczak et al. 2013) (Mackay et al. 2007). 
In summary, the catalytic subunit Naa30 takes up the conserved GNAT fold and is most similar to 
the monomeric archaeal ssArd1 ortholog, followed by the catalytic subunit Naa10 of the spNatA 
(Naa10/Naa15) complex. Through complex formation with Naa35, the catalytic α1–loop–α2 region 
of Naa30 is positioned in the same orientation as in the ssArd1 and spNatA structures, which most 
likely facilitates the proper catalytic function and/or substrate recognition of NatC. 
  
 
38 The similarity between structures is ranked by a “Z-score” (Holm et al. 2008). Significant similarities have 
a Z-score above 2 and usually correspond to similar folds. “Strong matches” have a sequence identity above 
20% or a Z-score above a cutoff that was empirically set to n/10−4, where n is the number of residues in the 
query structure. 
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4.6.2 Naa35 contains a fold reminiscent of the Bro1 domain 
DALI identified part of the Naa35 subunit to resemble the Bro1 domain of a variety of proteins. 
Among these Bro1 domain-containing proteins is the S. cerevisiae Bro1 protein (Kim et al. 2005) 
and three human proteins, including the mammalian ortholog of yeast Bro1, Alix (Zhai et al. 2007), 
which is also known as the programmed cell death 6-interacting protein (PDCD6IP) or the ALG-2-
interacting protein 1 (AIP1). Further hits include the Bro1 domains from the Bro1 Domain-
Containing Protein Brox (Zhai et al. 2011) and the Tyrosine-Protein Phosphatase Non-Receptor Type 
23 (Gahloth et al. 2017). 
 
Fig. 26 A segment of Naa35 exhibits structural similarity to the Bro1 domain. (A) Naa35 from NatC-CoA 
aligned with the Bro1 domain of the S. cerevisiae Bro1 protein. The Bro1 protein is shown on the right. A 
superposition (middle) shows only the aligned regions, which are colored in red (Naa35) or yellow (Bro1). A total 
of 207 residues out of 725 (Naa35) or 367 (Bro1) were aligned. (B) Zoom view showing the TPR-like pocket, 
which in Bro1 is filled by its N-terminal eight residues (right). In NatC, this pocket is occupied by helix α14. 
The aligned Naa35 segment comprises helices α15 to α19, the N-terminal half of α20, the C-terminal 
half of α22, as well as helices α25 and α26. The Cα atom RMSD between Naa35 and the different 
Bro1 domains is between 3.6 and 3.8 Å (Table 19). The sequence identity is only 4-8% and the Z-
score of 9–11.5 is well below the cutoff (≥ 68.4), suggesting only a distant relationship. 
The Bro1 domain of the yeast Bro1 protein was chosen for the alignment with the relevant segments 
of Naa35 and is shown in Fig. 26A. The Bro1 domain was first structurally characterized by (Kim et 
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al. 2005) for the identically named S. cerevisiae Bro1 protein. The domain contains a folded 
conserved core of nearly 370 residues which forms 14 α-helices and three β-sheets, which resembles 
a boomerang- or banana-shape. The bulk of the structure consists of an 11-helical solenoid. The Bro1 
domain shows limited similarity to the tetratricopeptide repeat domain (TPR), which was found to 
be present in NatA and NatB but could not be identified for NatC. However, whereas the helices in 
the Bro1 domain are typically 22-30 residue long, TPR repeats have much shorter helices of only 12-
15 residues (Zeytuni and Zarivach 2012). The N-terminal eight residues of Bro1 fill a TPR-like 
pocket on the convex side of Bro1, which is necessary for the stability of the Bro1 domain. In NatC, 
this pocket is filled by helix α14 (Fig. 26B). 
In summary, structural comparisons of the Naa35 subunit identified a variety of proteins with 
distantly related folds and apparently different functions. Possible implications are discussed in 
section 5.2. 
4.6.3 The Naa38 subunit resembles the fold of an Sm-like protein 
Even before Naa38 was identified as a part of the NatC complex (Polevoda and Sherman 2001), the 
protein was suggested to be a Sm-like protein based on protein sequence similarity (Séraphin 1995). 
The current structural work confirms the structural similarity of Naa38 with Sm-like proteins. With 
a RMSD of 1.8 Å, Naa38 is most similar to the Sm-like protein Lsm4. Out of the 72 aligned residues, 
17 are identical, which gives a sequence identity of 23.6%. With a Z-score of 11.6, Lsm4 is 
considered a strong match (Table 19). 
Lsm4 is part of a heptameric complex that consist of seven different Lsm proteins. Together, they 
form a heptameric, donut-shaped assembly (Zhou et al. 2013), which binds a specific small nuclear 
rRNA (snRNA), U6.39 This RNA-protein complex, referred to as “small nuclear ribonucleoprotein” 
(snRNP) is part of the spliceosome. 
In Fig. 27, Naa38 is superimposed (aligned over 69 Cα atoms with an RMSD of 1.7 Å) with the 
Lsm4 protein of the heptameric, doughnut-shaped Lsm2-8 ring (Zhou et al. 2013). Each Lsm protein 
adopts the highly conserved Sm fold (Kambach et al. 1999), which contains an N-terminal α-helix 
and an antiparallel β-sheet, with the order β4–β3–β2–β1–β5. The β-sheet of each Lsm protein is 
continued through intermolecular interactions of the β4 and β5 sheets of neighboring Lsm proteins 
(Fig. 27B, left). 
Naa38 exhibits the same five-stranded anti-parallel β-sheet as the Lsm proteins. However, the β–
sheet of Naa38 is extended by three short β-strands from the Naa35 subunit (Fig. 27B, right). 
One end of the Naa38 β-sheet is extend by the anti-parallel β1-strand of Naa35. The other end of the 
Naa38 β-sheet is completed by the parallel β3-strand of Naa35. 
 
39 The designation “U” reflects the large fraction of uracil nucleobases in these RNAs. 
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Fig. 27 Superposition of Naa38 with the yeast Lsm2-8 complex (A) Naa38 from NatC-CoA aligned with 
Lsm4 of the Lsm2-8 heptameric complex (PDB accession code 4M7A). (B) Comparison of the β-sheet topology 
of Lsm4 in contact with its neighboring Lsm units (Lsm7 and Lsm8) and the Naa35-Naa38 β-sheet. (C) 
Sequence alignment of all yeast Sm-like (Lsm) proteins and Naa38. 
In summary, structural comparisons of the Naa38 subunit confirmed the previously described 
similarity of Naa38 with Sm-like proteins (Séraphin 1995). However, the intermolecular β-sheet 
hydrogens bonds between Naa35 and Naa38, are located roughly at the same position as the 
intermolecular hydrogen bonds formed between neighboring Lsm subunits. Thus, these Naa38 
interfaces are not available for homo- or hetero-oligomerization with other Lsm proteins. 
Nevertheless, the structural similarity of Naa38 with the RNA-associated Lsm proteins might suggest 
that Naa38 is also capable of binding (small nuclear) RNA, which is further discussed in section 5.2. 
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4.7 Evolutionary conservation of the NatC complex 
A surface representation of NatC-CoA, colored according to the degree of conservation of the 
underlying amino acids is shown in Fig. 28. In contrast to a multiple sequence alignment, this 
representation allows for the identification of conserved residues not only proximate in sequence but 
also in three-dimensional space. Conserved surfaces, in turn, have often a conserved function. 
The conserved surfaces of NatC are located around the two prominent tunnels in the center of the 
NatC complex. CoA and the substrate peptide meet head-to head in the side tunnel, which contains 
the active site of the catalytic subunit Naa30 and is surrounded by the majority of conserved residues. 
Their role in substrate binding and catalytic activity will be explored in sections 4.8.2 to 4.8.3 and 
sections 4.10.3 to 4.10.4, respectively. 
The central tunnel is lined by loop regions from both Naa30 and Naa35, including the highly 
conserved catalytic α1–α2 and β6–β7 loops, which separate the two tunnels. While the majority of 
residues in this region are likely to be involved in substrate binding and catalytic function, the high 
degree of conservation indicates a broader function of the tunnel structure, which will be explored in 
section 4.9. 
 
Fig. 28 Amino acid conservation projected on the surface of NatC. Analyzed for the NatC-CoA structure 
with the ConSurf server. Variable regions are colored in cyan; average conservation is shown in white and 
completely conserved regions are highlighted in purple. Conservations scores were calculated separately for 
each NatC subunit using multiple sequence alignments (generated with MUSCLE) of amino acid sequences 
from 18 different species. Approximate positions of the Naa30 and Naa38 subunits are indicated by circles. 
  
70      Results 
 
4.8 Structures of the NatC complex bound to peptide ligands 
4.8.1 Structure determination 
To obtain further insights into substrate binding and the catalytic mechanism, NatC was co-
crystallized with Coenzyme A and a decameric peptide, containing the N-terminal five residues of 
either of two proteins known to be acetylated by the NatC complex, followed by a GS-linker and a 
triple-arginine at the C-terminus to facilitate peptide solubility. The first substrate peptide 
(MFHLVGSRRR) contains the N-terminal five residues of the Saccharomyces cerevisiae ADP-
ribosylation factor-like protein 3 (yArl3). N-terminal acetylation of yArl3 is required for its binding 
to the trans-Golgi specific transmembrane protein Sys1, thus determining the localization of yArl3 
at the trans face of the Golgi apparatus (Behnia et al. 2004; Setty et al. 2004). The second substrate 
(MLRFVGSRRR) contains the N-terminal five residues of the Major capsid protein (Gag) of the S. 
cerevisiae virus L-A, another known natural NatC substrate (Tercero, Dinman, and Wickner 1993). 
 
Fig. 29 Diffraction quality crystals of the NatC complex bound to CoA and peptide ligands. 
Crystals of both complexes were obtained using a crystallization solution containing 14.5– 
16.5% PEG 4000, 150 mM ammonium iodide and 100 mM sodium citrate, pH 6.2–6.3 (see 3.7). 
Both crystals appeared after 12 – 48 h and required another five days to reach their maximum 
dimensions (Fig. 29). The crystal comprising NatC bound to coenzyme A and the yArl3 peptide 
(NatC-CoA-MFHLV) diffracted X-rays to a maximum resolution of 2.99 Å and belongs to the 
orthorhombic space group P212121 with cell dimensions a=48.3 Å, b=139.7 Å, c=166.8 Å, 
α=β=γ=90°. The crystal with NatC bound to CoA and the Gag peptide (NatC-CoA-MLRFV) 
diffracted X-rays to a maximum resolution of 2.75 Å and belongs to the same space group with 
dimensions a=48.1 Å, b=134.9 Å, c=165.7 Å, α=β=γ=90°. Data collection statistics for both crystals 
are found in Table 20. 
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Table 20 Data collection statistics for crystals of NatC bound to CoA and the yArl3 or Gag peptide. Values 
in parentheses are for highest-resolution shell. 
Data collection NatC-CoA-MFHLV (native) NatC-CoA-MLRFV (native) 
Space group P21 21 21 P21 21 21 
Cell dimensions   
   a, b, c (Å)  48.30 139.72 166.82 48.14 134.93 165.74 
   α, β, γ (°) 90 90 90 90 90 90 
Wavelength (Å) 0.9184 0.9184 
Resolution range (Å) 45.65 – 2.99 (3.10 – 2.99) 43.41 – 2.75 (2.85 – 2.75) 
Completeness (%) 98.7 (98.6) 99.5 (96.0) 
Rsym (%) 16.6 (94.6) 19.4 (15.1) 
Redundancy 4.0 (4.2) 6.6 (6.6) 
I/σ (I) 8.4 (1.5) 9.3 (1.2) 
 
The structures of the peptide ligand-bound NatC complexes were solved by molecular replacement 
(see 3.9.2), using the refined structure of the SeMet-labeled NatC complex as an input model. The 
structures of NatC-CoA-MFHLV and NatC-CoA-MLRFV were refined to a Rwork/Rfree of 
19.9%/24.8% and 20.4%/24.8% , respectively (see Table 21).  
Table 21 Refinement statistics for NatC bound to CoA and the yArl3 or Gag peptide. Values in parentheses 
are for highest-resolution shell. aRfree was calculated for 5% of the reflection data. 
Refinement NatC-CoA-MFHLV (native) NatC-CoA-MLRFV (native) 
Resolution range (Å) 45.65 – 2.99 (3.10 – 2.99) 43.41 – 2.75 (2.85 – 2.75) 
No. of reflections 23299 (2274) 28783 (2749) 
Rwork / Rfree (%)a 19.9 / 24.8 20.4 / 24.8 
No of atoms   
   Protein 7753 7734 
   Ligands 86 84 
   Water 52 93 
B factors (Å2)   
   Average 63.8 67.4 
   Protein 63.9 67.6 
   Ligands 67.8 78.3 
   Water 40.0 44.4 
RMSD   
   Bond lengths (Å) 0.003 0.004 
   Bond angles (°) 0.86 0.85 
Ramachandran plot (%)   
   Most favored 98.6 98.5 
   Allowed  1.4 1.5 
   Outlier 0 0 
Rotamer outliers (%) 0.34 0.68 
Clashscore 3.8 5.4 
 
In Fig. 30, electron density maps (2Fo-Fc, contoured at 1 σ) for ligands in the active site are shown 
for all three ligand-bound structures (NatC-CoA, NatC-CoA-MFHLV and NatC-CoA-MLRFV) 
described in this work. The electron density was sufficient to model a coenzyme A molecule in all 
three structures. However, the electron density was clearly strongest for NatC-CoA-MFHLV, 
followed by NatC-CoA-MLRFV and weakest for NatC-CoA, which is partially reflected by the 
different ligand occupancies of 100%, 93% and 86% respectively. In the NatC-CoA structure, the 
adenosine diphosphate moiety, and the pantoic acid moiety of CoA are clearly identified in the 2Fo-
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FC map (Fig. 30, right part of the molecule). However, no electron density can be seen for the 
connecting β-alanine moiety (NH-CH2-CH2-CO) and the final β-mercapto-ethylamine (NH-CH2-
CH2-SH) moiety, except for the final thiol group, which is again clearly defined. The absence of 
electron density for parts of CoA is explained by a higher B-factor of the atoms in the corresponding 
region (Fig. 31). The electron density of the peptide ligands was sufficient to model the first four 
amino acids of the peptide 1-MFHLVGSRRR-10 and the first six residues of the peptide 
1-MLRFVGSRRR-10 in the NatC-CoA-MFHLV or NatC-CoA-MLRFV structures, respectively.  
 
Fig. 30 2Fo-Fc electron density maps for ligands in the active site of the NatC complex. 2Fo-Fc maps 
(contoured at 1σ) are shown for CoA, peptide ligands and a highly coordinated water molecule in the center of 
the active site (HOH1). Average ligand occupancies are written next to each ligand. 
Moreover, a clear electron density was visible for a tightly coordinated water molecule (red sphere) 
in the active site of the NatC complex. In all three structures, the B-factor of the water molecule was 
very similar to the average B-factor of surrounding macromolecule atoms (Fig. 31), indicating that 
this water is well coordinated. The tight coordination, together with the close proximity to the amino 
group of the peptide substrate, suggests a potential catalytic role of this water molecule. 
In contrast, the B-factors of CoA and peptide ligands are higher than those of the surrounding 
macromolecule atoms and thus ligand occupancies might be lower than estimated. However, at the 
given resolutions (2.5–3.0 Å), it is not possible to differentiate between a reduced ligand occupancy 
and a higher B-factor. The partial ligand occupancies are most likely a result of the relatively low 
ligand concentrations (135–225 µM) that were used in the crystallization setup (see Table 14, section 
3.7). To ensure full occupancy for all ligands, it thus advisable to use higher ligand concentrations 
(>10× Km) in future crystallization setups. 
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Fig. 31 Atomic displacement factors of ligands in the active site of the NatC complex. Ligand atoms are 
colored with a black-blue-red-yellow spectrum based on their B-factor. Average ligand B-factors are written next 
to the corresponding ligand. 
4.8.2 Peptide binding to the NatC complex 
The two peptide-bound NatC structures reveal the orientation of the peptide N-terminus in the center 
of the active site. Furthermore, they reveal how NatC establishes its substrate specificity toward 
protein N-termini that start with their initiator methionine, followed by a hydrophobic amino acid at 
position two. 
A detailed analysis of the interactions of the yArl3 peptide (MFHLVGSRRR) with the NatC complex 
(Fig. 32 B, left) reveals that the yArl3 peptide forms a total of five hydrogen bonds with Naa30, 
which are mostly mediated via the yArl3 peptide backbone. Thus, the yArl3 amine group of Met1 
forms a hydrogen bond with the backbone carbonyl oxygen of Glu118 and the Met1 carbonyl oxygen 
interacts with the hydroxyl group of Tyr145. The backbone amide of Phe2 forms a hydrogen bond 
with the carbonyl oxygen of Gly82 and the Phe2 carbonyl oxygen with Tyr31. The only hydrogen 
bond between a yArl3 side chain and Naa30 is formed between the imidazole ring of His3 and the 
carboxyl group of Glu29. 
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Fig. 32 The peptide binding site of NatC. (A) Superposition of NatC-apo, NatC-CoA, NatC-CoA-MFHLV and 
NatC-CoA-MLRFV showing the large conformational change of the β6-β7 loop in the NatC-CoA-MLRFV 
structure. (B) Interactions of the two peptide substrates (in orange): yArl3 (MFHLVGSRR) and Gag 
(MLRFVGSRR) with Naa30 and Naa35. The proposed catalytic water (HOH1) is shown as a sphere. Hydrogen 
bonds formed between two backbone chains are colored in red. Cation-π interactions are yellow and all other 
H-bonds are black. 
The Gag peptide (MLRFVGSRRR) with the N-terminal five residues from the S. cerevisiae L-A 
virus forms a total of six hydrogen bonds with Naa30 (Fig. 32 B, right). Like the yArl3 peptide, the 
Gag peptide Met1 amine group forms a hydrogen bond with the backbone carbonyl oxygen of 
Glu118 and the oxygen forms a hydrogen bond with the Tyr145 hydroxyl. The backbone amide of 
Leu2 also forms the hydrogen bond with Gly82 and its carbonyl oxygen forms an H-bond with Tyr31. 
The guanidyl group of Arg3 forms a hydrogen bond with the backbone carbonyl oxygen of Naa30 
Tyr144. Moreover, a cation-π interaction is formed between the Arg3 guanidyl group and the 
aromatic ring of Tyr144, in a parallel geometry. In contrast to the yArl3-bound structure, the carboxyl 
group of Glu29 in the Gag-bound structure forms a hydrogen bond with the backbone amide of Phe4. 
This hydrogen bond cannot be formed in the yArl3 structure because the bulky imidazole group of 
yArl3-His3 sterically hinders Glu29 from interacting with the fourth peptide backbone amide. Last 
but not least, one more hydrogen bond is formed for the Gag peptide between the carbonyl oxygen 
of Val5 and the imidazole ring of His51 from subunit Naa35. 
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In addition to hydrogen bonds, both substrate peptides exhibit hydrophobic interactions of their side 
chains with a large hydrophobic pocket in the NatC complex. One side of the hydrophobic ligand-
binding pocket is formed by the conserved Naa30 residues: Val35, Phe39, Tyr80 and, slightly further 
away, residues Tyr38 (Naa30) and Phe47 from Naa35. Both the Phe2 side chain of the yArl3 peptide 
and Leu2 side chain of the Gag peptide are positioned in this pocket. However, the hydrophobic 
pocket extends further and exhibits a second partially hydrophobic surface on the opposite side. This 
side is lined by the side chains of Naa30 residues Pro30 (its hydrophobic face) and Leu146 and the 
Naa35 residues Leu53, Leu60, Phe283 and the hydrophobic face of Pro284. This pocket is only 
explored by Phe4 of the Gag peptide, while the side chains of yArl3-Leu4 is positioned 4.7 Å away. 
In summary, both peptides interact with the catalytic subunit Naa30 through formation of multiple 
hydrogen bonds, four of which involve the backbone amides and carbonyl oxygen atoms of the first 
two residues of the peptide. Both their hydrophobic side chains at position two are positioned in a 
conserved hydrophobic pocket of the catalytic subunit. In comparison, the Gag peptide forms more 
interactions with NatC, including a cation-π interaction of Arg3 and an additional hydrogen of the 
fourth backbone nitrogen. In addition, Phe4 explores a second hydrophobic pocket and thus the Gag 
peptide of the L-A virus is likely to be the stronger binder, which is in line with the data from the 
acetyltransferase assays (see sections 4.10.3 and 4.10.4). 
4.8.3 Peptide ligand-induced conformational changes 
The NatC-CoA-MFHLV and NatC-CoA-MLRFV structures undergo significant structural changes in 
the catalytic α1–α2 loop compared to the NatC-CoA reference structure (Fig. 33 A). While almost 
no movement can be seen between the NatC-apo and NatC-CoA structures, binding of the yArl3 or 
Gag peptides induces a α1–α2 loop movement of 2.8 Å or 3.5 Å, respectively, compared to the 
ligand-free NatC-apo structure. Upon binding of the yArl3 ligand, the hydroxyl group of Ser28 (α1–
α2 loop) comes into hydrogen bonding distance with the carboxyl group of Glu148 (β6–β7 loop), 
thereby stabilizing catalytic residues of both loops and priming them for catalysis. 
However, the most significant structural rearrangements of the catalytic β6-β7 loop can be seen in 
the NatC-CoA-MLRFV structure. In all NatC structures, the Naa30 β6-β7 loop is in contact with 
subunit Naa35. In the NatC-CoA structure, two hydrogen bonds are formed between the conserved 
Asn147 of subunit Naa30 and Gln106 of subunit Naa35. Asn147 is stabilized by additional hydrogen 
bonds from Arg143 (Naa30) and Arg286 (Naa35). This interaction is almost identical in the yArl3 
peptide-bound NatC-CoA-MFHLV structure. However, in the Gag peptide-bound NatC-CoA-
MLRFV structure the β6–β7 loop undergoes large rearrangements, so that Glu148 takes up the 
position of Asn147 and forms two hydrogen bonds with Gln106. As a result, the conserved Asn147 
is now facing the α1–α2 loop. Compared to the NatC-apo structure, the side chain amide group has 
traversed a distance of 8.8 Å. Due to this structural rearrangement, the side chain of Asn147 can now 
form a bifurcated intramolecular hydrogen bonds with the hydroxyl group of Ser28 and the carboxyl 
group of Glu120, thereby stabilizing the entire β6–β7 loop.  
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The significant structural changes in the β6–β7 loop are a direct consequence of the binding of the 
Gag peptide (MLRFVGSRRR). The strongest driving force for this rearrangement can most likely 
be attributed to the Arg3 side chain of the peptide, as detailed in the previous section (4.8.2). In 
addition, the backbone amide of Gag-Phe4 forms a hydrogen bond with the carboxyl group of Glu29 
(loop α1–α2), which itself forms another hydrogen bond with the backbone amide of Leu146, thereby 
providing additional stability for the β6–β7 loop. 
 
Fig. 33 Peptide ligand-induced conformational changes (A) Mixed surface (Naa35) and cartoon/stick 
representation (Naa30), showing the structural rearrangements of the α1–α2 loop and the β6–β7 loop of Naa30 
upon ligand binding. (B) Surface projection of NatC, showing the effect of ligand binding on the shape and 
diameter of the central and side tunnel. 
The drastic rearrangements of the α1–α2 loop and particularly the β6–β7 loop upon binding of the 
Gag peptide can be viewed as an induced fit-mechanism, which, as will be shown in section 4.10.4, 
enhances the activity of the NatC complex toward this substrate. Furthermore, the peptide-induced 
conformational changes also effect the shape of the central tunnel and the side tunnel, which will be 
explained in detail in the following section. 
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4.9 Structural features close to the active site of the NatC complex 
A cross-sectional view through a surface representation of NatC reveals the location and dimensions 
of the two tunnels in the center of the NatC complex (Fig. 34). CoA and the substrate peptide meet 
head-to head in the side tunnel, which contains the active site of the catalytic subunit Naa30. The 
narrowest constriction of the side tunnel surrounds the peptide substrate. 
 
Fig. 34 Morphology of the NatC central and side tunnel (A) Cross-section through a surface projection of 
NatC-CoA, NatC-CoA-MFHLV and NatC-CoA-MLRFV, revealing the central and side tunnels. (B) Zoom views 
showing an overview (top) of the two tunnels, key residues separating the two tunnels and tunnel dimensions. 
Red spheres were generated for circular tunnels with the PyMOLCaver plugin (https://www.caver.cz/). 
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The central tunnel is roughly spherical and its radius at the narrowest point is approximately 4 Å in 
all structures. The side tunnel has a more elliptical cross-section with a height of ~5 Å and a width 
of ~ 13 Å at its narrowest constriction in both the NatC-CoA (Fig. 34, A1) as well as the NatC-apo 
structure (not shown). Upon peptide binding, the tunnel constricts further to ~7 Å in the NatC-CoA-
MFHLV structure (Fig. 34, A2) and 6 Å in the NatC-CoA-MLRFV (Fig. 34, A3) structure, 
respectively. 
The central tunnel and the side tunnel are separated from each other by side chains from the α1–α2 
and β6–β7 loop (Fig. 34, zoom views 1-3). In case of the NatC-CoA and NatC-apo structures, side 
chains Ser28 and Glu29 are within 4–5 Å proximity to Glu148 and Leu146, without forming 
significant interactions. Upon binding of the yArl3 ligand (NatC-CoA-MFHLV structure), the 
hydroxyl group of Ser28 is in hydrogen bonding distance with the carboxyl group of Glu148 (3.7 Å), 
thus closing the gap between the α1–α2 loop and the β6–β7 loop and reinforcing the separation of 
the central and side tunnel. Upon binding of the Gag peptide, the loops move even closer together, 
enabling the formation of a hydrogen bond between the side chain of Asn147 and the hydroxyl group 
of Ser28. 
Taken together, both the α1–α2 and the β6–β7 loop separate the central tunnel from the side tunnel 
and concurrently restrict their diameters. In the ligand-free or CoA-bound structures, no significant 
interactions are observed between the two loop regions. As shown in section 4.8.3, both loops can 
undergo significant movements upon peptide binding, showing their flexibility. It is thus conceivable 
that the two loops can open up even further and link the central and side tunnel completely, which 
may play an important role in the co-translational acetylation of nascent chain peptide substrates 
emerging from the ribosomal exit tunnel. This is further discussed in section 5.5.1. 
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4.10 Acetyltransferase activity of the NatC complex 
4.10.1 Design of active site mutants 
A structure-based mutagenesis approach was performed to study the catalytic mechanism of the NatC 
complex. To this end, several NatC constructs with single point mutations in the active site were 
designed. Conserved residues within a ~5 Å radius of the peptide N-terminus and the Coenzyme A 
thiol group were considered to participate in catalysis. Conserved residues were identified using a 
multiple sequence alignment for the catalytic subunit Naa30 (Fig. S1). 
A detailed view of the active site of the NatC-CoA-MLRFV structure can be seen in Fig. 35. The 
active site is surrounded by residues from the α1–α2 loop, β4, β5 and the β6-β7 loop of the catalytic 
subunit Naa30. Nearly all residues in proximity of the active site are completely conserved among 
NatC orthologs, emphasizing their importance for proper catalytic function. 
 
Fig. 35 The NatC active site with bound CoA and Gag peptide. (A) Detailed view of the active site of the 
NatC-CoA-MLRFV structure, bound to the Gag peptide (MFHLVGSRRR) and coenzyme A. Completely 
conserved residue are bold and underlined. The position of the proposed catalytic water (HOH1) is indicated by 
a red sphere. Hydrogen bond distances of HOH1 with surrounding residues are shown in red.  
A well-coordinated water molecule (red sphere) is positioned in the vicinity of the peptide substrate 
N-terminus. It is within hydrogen-bonding distance of the Met1 amino-terminus of the peptide 
substrate. The tight coordination and the vicinity to the peptide amino group indicated a function of 
this water molecule in electron transfer during the enzyme catalyzed transfer of the acetyl- moiety, 
which is further discussed in section 5.4. 
Additional evidence for the identification of catalytically important residues can be obtained by 
comparing Naa30 with catalytic subunits from known NAT paralogs, i.e. genes/proteins that are the 
results of a gene duplication events in the last common ancestor (LCA) (see Fig. 36). Residues that 
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are essential for the general catalytic function of all GNAT superfamily members should be highly 
conserved among paralogs. For example, Tyr30, Tyr130, Tyr140 and Tyr145 are almost entirely 
conserved among all NAT paralogs. Likewise, the coenzyme A binding motif RxxGxG/A is 
conserved across the entire GNAT superfamily as displayed in Fig. 36B. 
 
Fig. 36 Structural alignment of NAT paralogs. (A) Sequence logos40 of the catalytic subunits of five different 
NAT paralogs showing identical regions (α1–α2 loop, β4, β5 and β6-β7 loop) near the active site. Sequence 
logos were generated from multiple sequence alignments using corresponding orthologs from 18 different 
species. ●, mutational sensitive residues and +, substrate binding residues (as described in the respective 
publications for each NAT paralog). (B) Conserved acetyl coenzyme A binding motif RxxGxG/A. 
Residues that are responsible for a paralog-specific function, for example, different substrate 
specificities, should only be conserved among orthologs, i.e. genes/protein that are descended from 
the same ancestral sequence, separated by a speciation event. Two completely conserved Naa30 
residues (i.e. among Naa30 orthologs) are of particular interest, because they are specific for Naa30: 
Glu118 and Glu120 in the β5 strand. In all other NAT paralogs, the two glutamate positions are 
occupied by residues with different electrostatic properties. The position of Glu118 is occupied by a 
histidine residue in Naa10, Naa50 and Naa60 and a phenylalanine in Naa20, which have both been 
shown to be relevant for the catalytic activity in these paralogs. Similarly, Naa30 residue Glu120 is 
replaced by Arginine in Naa10 and Naa20. 
To unravel the catalytic mechanism and the paralog-specific properties of Naa30, nine different 
residues were selected for mutational studies: Leu27, Ser28, Glu29, Tyr80, Glu118, Glu120 and 
Glu145.  
 
40 “A sequence logo is a graphical display of a multiple sequence alignment consisting of color-coded stacks 
of letters representing amino acids at successive positions. Sequence logos provide a richer and more precise 
description of sequence similarity than consensus sequences and can rapidly reveal significant features of the 
alignment that could otherwise be difficult to perceive.” (https://prosite.expasy.org/sequence_logo.html). 
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Single point mutations (see Fig. 36A) were introduced in the wild type NatC construct and the mutant 
NatC complexes were purified as the wild type construct (see 3.2.6). Point mutations included alanine 
substitutions, E→Q substitutions and Y → F substitutions. Alanine substitutions affect both 
electrostatic (i.e. charge and polarity) and stereochemical (i.e. size) properties of the corresponding 
position in the structure. E→Q and Y→F mutations were intended to only affect the functional 
properties of the side chain, while roughly maintaining the size of the corresponding residue. 
4.10.2 Overview of the acetyltransferase assay 
In vitro activity assays were performed to kinetically characterize wild type NatC and a series of 
NatC mutants (see 3.6). To achieve this, N-terminal acetylation of model peptides was followed by 
the conversion of acetyl-CoA to CoA and quantified using a subsequent colorimetric reaction. A 
complete exemplary data analysis is shown in Fig. 37 for wild type NatC and one NatC mutant 
(Naa30_E118Q) using the yArl3 peptide as a substrate (MFHLVGSRRR). 
 
Fig. 37 Data analysis overview for the acetyltransferase assay. Data analysis is shown for wild type NatC 
and one exemplary NatC mutant (Naa30_E118Q). Enzyme reactions were carried out at six different peptide 
concentrations (89–1340 µM). In the chosen examples, the yArl3 peptide (MFHLVGSRRR) was used. The 
acetyl-CoA concentration was 500 µM. (A) Initial rate period of the reactions. Initial velocities (𝒗𝟎) are obtained 
from linear regressions ([𝑷] = 𝒗𝟎 × 𝒕). (B) Initial velocities plotted against peptide concentrations were fitted to 
the Michaelis-Menten equation (𝒗𝟎 = 𝒗𝐦𝐚𝐱[𝐒]/(𝑲𝐦 + [𝐒])). Replicates (n ≥ 3) are shown in different colors. (C) 
Catalytic parameters (𝑲𝐦, 𝒌𝐜𝐚𝐭) of all replicates, which were performed at varying enzyme concentrations. 
The first four data points of the reaction process are in the linear, initial rate period of the reaction 
(Fig. 37A). Initial reaction velocities (𝑣0), measured at six different peptide concentrations, are 
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plotted in Fig. 37B. The six data points were fitted to the Michaelis-Menten equation to obtain the 
catalytic parameters kcat and the Michaelis-Menten constant Km. Complete Michaelis-Menten kinetics 
were performed at least in triplicate (differently colored graphs in Fig. 37B) and the catalytic 
parameters Km and kcat of each replicate are summarized in tabular form (Fig. 37C). The complete 
Michaelis-Menten kinetics for all tested NatC constructs and all tested substrate peptides are 
summarized in Table 22 and Table 23, respectively. Additionally, all Michaelis-Menten plots are 
shown in the supplement (Fig. S7 - Fig. S12). 
4.10.3 Kinetic analysis of wild type and mutant NatC constructs 
The in vitro acetyltransferase assays were performed with the help of a former Master student, Mr. 
Linus Hopf, who has published parts of the Michaelis-Menten data in his Master thesis.41 
Table 22 Catalytic parameters for wild type and mutant NatC. Km values are calculated for the yArl3 
substrate peptide (MFHLVGSRRR). Acetyl-CoA was used at a fixed concentration of 500 µM (≥ 10× Km).  aWT, 
wild type NatC construct (Naa30ΔC17, full-length Naa35 and Naa38ΔC11). bThe acetyl CoA Km was calculated 
for wild type NatC (Km = 31±6 µM, n = 5). cThe Naa35 Tip1 mutant contains point mutations: K500A, K501A, 
K503A and  K504A.dThe NatC-Naa38 deletion consist of Naa30ΔC11 and full-length Naa35 only. Errors 
















   
 
   
   L27A 0.010 ± 0.005 0.0023 80 ± 20 0.53 4 
   S28A 1.8 ± 0.1 0.43 270 ± 30 1.9 3 
   E29A 0.24 ± 0.01 0.06 160 ± 30 1.1 4 
   E29Q 0.18 ± 0.02 0.04 250 ± 40 1.8 3 
   Y31F 0.45 ± 0.01 0.11 230 ± 50 1.6 3 
   Y80A 2.5 ± 0.3 0.59 550 ± 70 3.9 3 
   Y80F 1.68 ± 0.01 0.40 430 ± 60 3.0 3 
   E118A 0.40 ± 0.03 0.10 320 ± 30 2.3 3 
   E118Q 0.60 ± 0.02 0.14 430 ± 60 3.0 4 
   E120A 0.88 ± 0.04 0.21 260 ± 10 1.8 3 
   E120Q 1.01 ± 0.05 0.24 300 ± 60 2.1 4 
   Y130A 0.057 ± 0.002 0.01 200 ± 60 1.4 4 
   Y130F 0.084 ± 0.01 0.02 120 ± 20 0.80 4 





   
 
   
   F47A 2.3 ± 0.1 0.55 160 ± 10 1.1 3 
   K59A 2.2 ± 0.3 0.53 191 ± 8 1.3 3 
   E171A E172A 5.8 ± 0.5 1.4 660 ± 50 4.6 3 
   R406A 3.0 ± 0.1 0.70 120 ± 20 0.83 3 
   Tip1c 4.2 ± 0.4 1.0 175 ± 9 1.2 3 
          
Naa38 deletiond 0.27 ± 0.04 0.06 110 ± 10 0.75 3 
 
41 Hopf, Linus Valentin Moritz (2019), “Biochemical and mechanistic characterization of NatC”, submitted to 
the Department of Biology, Chemistry and Pharmacy of the Freie Universität Berlin 
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For the wild type NatC complex, a kcat of 4.2 ± 0.3 s-1 and a Km of 140 ± 20 µM were determined for 
the yArl3 peptide (MFHLVGSRRR). The kcat of the NatC complex is comparable to the published 
values for wild type NatA (Liszczak et al. 2013) and NatB (Hong et al. 2017), each measured with 
their cognate peptides substrates: for NatA, a kcat of 3.0 ± 0.5 s-1 and for NatB, a kcat of 2.7 ± 0.2 s-1 
were determined by the authors. The corresponding Km values are 340 ± 50 µM for NatA and 660 ± 
50 µM for NatB, and thus slightly higher compared to the Km determined for NatC and yArl3 peptide. 
Single point mutations at amino acid positions close to the active site of the Naa30 subunit were 
introduced to identify residues that are crucial for the catalytic activity of NatC. All mutations close 
to the active site of the Naa30 subunit led to a reduction of kcat of at least 40% (Fig. 38). The most 
significant reductions to ≤ 10% of wild type activity were seen for residues Leu27, Glu29, Tyr31, 
Glu118 and Tyr130, indicating their importance in the catalytic mechanism. The strongest increase 
in Km compared to wild type Naa30 was observed for residues Tyr80 and E118A, suggesting a crucial 
function of these residues in substrate binding. 
 
Fig. 38 Catalytic efficiency (kcat/Km) of NatC wild type and mutant constructs. The s.d. for the catalytic 
efficiency was calculated from the s.d. values of kcat and Km, considering the propagation of uncertainty42. 
Mutations in the large auxiliary subunit Naa35 had only a minor effect on the kcat. For example, the 
K59A mutant, which stabilizes the catalytic α1–α2 loop, lead to a roughly 50% reduction of the kcat. 
Phe47 from Naa35, that forms a distal end of the hydrophobic substrate-binding pocket, shows a 
roughly 45% reduction of the kcat. Interestingly, the double mutant E171A/E172A, located in a 
conserved loop near the C-terminal end of the MFHLVGSRRR peptide, displayed a 40% increased 
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kcat, coupled with a 4.6-fold increase in Km. Even though the peptides’ triple arginine tag could not 
be modeled due to missing electron density, electrostatic interactions of the arginine side chains with 
the negative charges of the 170-FEEED-174 loop are likely to increase the affinity of the peptide 
with the NatC complex. The disruption of the negative charge (E171A/E172A) thus resulted in an 
observed increase in Km. Arg406 stabilized the 170-FEEED-174 loop through cation-π interactions 
with Phe170 and two salt bridges with Glu174. The R406A mutant was designed to decrease the 
stability of the loop. However, no significant effect on either Km or kcat was observed, indicating that 
the conserved 170-FEEED-174 loop has no direct function for NatC catalysis. 
Interestingly, a NatC construct that was expressed and purified without its small auxiliary subunit 
Naa38 (ΔNaa38) showed a strong decrease in kcat to 6% of wild type activity, while the Km remained 
almost identical to WT. These data suggest that the small subunit has a direct impact on catalytic 
activity of the NatC complex. 
4.10.4 Analysis of the NatC substrate specificity 
By using a variety of substrate peptides in the acetyltransferase assay, the peptide specificity of the 
NatC complex was analyzed. The results are summarized in Table 23 and visualized in Fig. 39. NatC 
activity was tested for two peptides, which are native substrates of the NatA and NatB complex. The 
sequence SASEA corresponds to the N-terminus of the S. cerevisiae protein SytC after the removal 
of its initiator methionine by a methionine aminopeptidase (MetAP) and is a NatA substrate that is 
efficiently acetylated in S. cerevisiae (Arnesen et al. 2009). SASEA was also used for co-
crystallization as a peptide-CoA conjugate with the NatA complex (Liszczak et al. 2013). The 
sequence MDSEV corresponds to the yeast actin N-terminus, a NatB substrate, which was co-
crystallized as a peptide-CoA conjugate with the NatB complex (Hong et al. 2017). For both the 
NatA and NatB model peptides, no activity could by detected in the acetyltransferase assay for wild 
type NatC. 
A peptide with the N-terminal sequence of the human ortholog of yArl3, hARFRP1 (MYTLL) 
showed a comparable activity to yArl3, with a kcat of 3.2 ± 0.3 s-1 and a Km of 180 ± 40 µM. This 
suggests that the species-specific changes in the N-terminal sequences between the yeast Arl3 and 
the human ARFRP1 proteins are not the results of an adaption to their respective NatC ortholog. 
Three yArl3 peptide variants, substituting Phe2 with tyrosine (MYHLV), tryptophan (MWHLV) or 
leucine (MLHLV), were designed to analyze which hydrophobic amino acid is preferred at position 
two. While a F2W substitution lead to comparable kcat and Km values, the F2Y variant showed a 50% 
reduction in kcat and a 3.7-fold increase in Km, indicating a negative impact of the polar tyrosine 
hydroxyl group for binding to the hydrophobic pocket. An F2L substitution at position 2 (MLHLV) 
showed a 30% increase of the kcat compared to the wild type yArl3 peptide. However, the Km showed 
a five-fold increase to 730 ± 50 µM, suggesting that the small leucine at position 2 only explores a 
fraction of the hydrophobic peptide biding pocket of NatC, which seems to prefer bulky aromatic 
amino acids at the second position. Interestingly, an F2A variant showed a 50% decrease of the Km 
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compared to the wild type, suggesting that the reduced size of the alanine side chain allows the 
peptide to bind in a unique way, without exploring the hydrophobic pocket. However, a structural 
analysis would be necessary to determine the exact binding mode of this MAHLV peptide. 
Table 23 Catalytic parameters for wild type NatC with various substrate peptides. aN-terminal five residues 
of the decameric peptides ending on -GSRRR.. bAll normalizations are relative to wild type NatC catalytic 
parameters, generated with the Arl3 substrate. Where kcat is ND (not determined), activity could not be detected. 













MFHLV- Arl3 4.2 ± 0.3 1.0 140 ± 20 1.0 5 
           
MYTLL- Arfrp1 3.2 ± 0.3 0.77 180 ± 40 1.3 4 
MLRFV- Gag 12 ± 1 2.8 4 ± 3 0.030 4 
           
 Arl3 variants          
MYHLV- F2Y 2.5 ± 0.1 0.60 520 ± 60 3.7 4 
MWHLV- F2W 3.4 ± 0.4 0.80 140 ± 60 1.0 4 
MLHLV- F2L 5.6 ± 0.2 1.3 730 ± 50 5.1 3 
MAHLV- F2A 5.1 ± 0.3 1.2 80 ± 10 0.5 3 
MFALV- H3A 7.0 ± 0.5 1.7 4 ± 3 0.029 3 
MFHAV- L4A 8 ± 1 1.9 6 ± 5 0.044 4 
           
 Arl3/Gag hybrids          
MFRLV- H3R 9 ± 2 2.1 27 ± 2 0.19 4 
MFHFV- L4F 10 ± 1 2.5 28 ± 4 0.20 5 
           
SASEA- ThrRS (NatA substrate) ND       
MDSEV- Actin (NatB substrate) ND       
 
The Major capsid protein (Gag) of the S. cerevisiae virus L-A is another known native NatC substrate 
(Tercero, Dinman, and Wickner 1993). With a kcat of 12 ± 1 s-1, the turnover number of the Gag 
peptide (MLRFV) was 2.8-fold higher compared to the yArl3 peptide. In addition, the Km was 
reduced to 4 ± 3µM, which is at the detection limit of the colorimetric acetyltransferase assay. The 
strong reduction of the Km suggests a higher affinity of the Gag peptide toward the catalytic subunit 
of NatC. 
To identify the Gag peptide residues that convey the large increase in catalytic efficiency (kcat/Km) 
compared to yArl3, two yArl3/Gag hybrid peptides with single amino acid exchanges from Gag in a 
yArl3 background were designed and tested. Both, the H3R and the L4F yArl3/Gag hybrids showed 
marked increases in kcat and strongly reduced Km values to below 30 µM. This can be explained by 
the Gag-Naa30 ligand interactions, observed in the NatC-CoA-MLRFV structure, in which Arg3 
interacts with the β6–β7 loop and Phe4 with the opposite side of the extended hydrophobic pocket 
(Fig. 32, section 4.8.2). 
Interestingly, also the H3A and L4A yArl3 variants exhibited strong increases in kcat and strongly 
reduced Km values (< 10 µM). From the NatC-CoA-MFHLV structure, it is apparent, that the bulky 
imidazole group of yArl3-His3 sterically hinders Naa30-Glu29 from forming a hydrogen bound with 
the fourth peptide backbone amide. A smaller amino acid at peptide positions 3 or 4 is likely to give 
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Glu29 free access to interact with the substrate peptide thereby increasing the peptide affinity. Similar 
to the NatC-CoA-MLRFV structure, the Glu29 could in turn stabilize the catalytic β6–β7 loop, 
resulting in the observed increase of kcat.  
 
 
Fig. 39 Catalytic efficiency (kcat/Km) of wild type NatC with various substrates. The s.d. for the catalytic 
efficiency was calculated from the s.d. values of kcat and Km, considering the propagation of uncertainty. Arl3 
single amino acid substitutions in the Arl3 variants and Arl3/Gag hybrid peptides are written above each bar. 
Three peptides exhibited Km values at the lower detection limit of the employed colorimetric assay, resulting in 
very large catalytic efficiencies. Due to the large s.d. values of these datasets, the graph is cut a 50×10-3 µM s-
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4.11 Structure of the NatC_Naa30_L27A mutant 
4.11.1 Structure determination 
The NatC_Naa30_L27A mutant construct exhibited the lowest catalytic activity compared to the wild 
type NatC construct, with a more than 100-fold reduction of the kcat. The mutant was crystallized to 
assess if this mutation causes structural changes in the α1-α2 loop region, which could explain the 
reduced activity of this mutant.  
A single crystal of NatC_Naa30_L27A was obtained using a crystallization solution containing 
15.5% PEG 4000, 150 mM ammonium iodide and 100 mM sodium citrate, pH 6.4 (see 3.7). As with 
all other NatC constructs, the crystal grew at 20°C, appeared after 12 – 48 h and required roughly 
five days to reach maximum dimensions (Fig. 40). 
 
Fig. 40 Diffraction quality crystals of the apo NatC_Naa30_L27A mutant construct. 
The crystal of the NatC_Naa30_L27A mutant construct diffracted X-rays to a maximum resolution 
of 2.69 Å and belongs to the space group P1 with cell dimensions a=48.2 Å, b=89.5 Å, c=138.6 Å, 
α=85.1° β=80.9° γ=75.2°. The data collection statistics are found in Table 24.  
Table 24 Data collection statistics for a crystal of the NatC_Naa30_L27A mutant. Values in parentheses 
are for highest-resolution shell. 
Data collection NatC Naa30_L27A (native) 
Space group P1 
Cell dimensions  
   a, b, c (Å)  48.22 89.54 138.55 
   α, β, γ (°) 85.14 80.89 75.20 
Wavelength (Å) 0.9184 
Resolution range (Å) 46.14 - 2.69 (2.79 - 2.69) 
Completeness (%) 94.6 (86.4) 
Rsym (%) 8.541 (95.1) 
Redundancy 3.7 (3.4) 
I/σ (I) 11.6 (1.2) 
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The structure of the NatC_Naa30_L27A mutant was solved by molecular replacement using the 
refined structure of the SeMet-labeled NatC complex as an input model. The structure of 
NatC_Naa30_L27A was refined to a Rwork/Rfree of 19.8%/22.8% (see Table 25). The final model 
contains no Ramachandran outliers, with 98.7% of its residues located in the favored region. 
Table 25 Refinement statistics for the NatC_Naa30_L27A mutant structure. Values in parentheses are for 





Resolution range (Å) 46.14 - 2.69 (2.79 - 2.69) 
No. of reflections 58142 (5292) 
Rwork / Rfreea 19.8 / 22.8 
No of atoms  
   Protein 15451 
   Ligands 91 
   Water 182 
B factors (Å2)  
   Average 82.0 
   Protein 82.3 
   Ligands 92.5 
   Water 55.6 
RMSD  
   Bond lengths (Å) 0.004 
   Bond angles (°) 0.86 
Ramachandran plot (%)  
   Most favored 98.6 
   Allowed  1.4 
   Outlier 0 
Rotamer outliers (%) 0.4 
Clashscore 5.0 
 
The asymmetric unit of the NatC_Naa30_L27A crystal contained two independent copies of NatC, 
which are referred to as biological assemblies #1 and #2. The root-mean-square deviation of the Cα 
positions between the two biological assemblies is low (0.89 Å, over 950 compared Cα atoms), 
indicating an almost similar fold. 
In contrast to all other structures that crystallized in space group P212121, the NatC_Naa30_L27A 
construct crystallized in space group P1. There are no crystal contacts around the α1–α2 region, 
which contains the mutated Leu27 residue, in either the P1 (Fig. S6) or the P212121 (Fig. S5) 
structures. Thus, it is unlikely that the leucine-to-alanine substitution in the α1–α2 loop has a direct 
influence on the crystal packing. Thus, the appearance of a NatC crystal in space group P1 might be 
purely coincidental. 
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4.11.2 Conformational changes in the α1–loop–α2 region 
The reason for crystallizing the NatC_Naa30_L27A mutant, was to assess if the 100-fold reduction 
of the kcat compared to wild type NatC is caused by structural changes in the α1–loop–α2 region. A 
superposition of NatC_Naa30_L27A with NatC-apo and NatC-CoA reveals, however, that the side 
chain of the Ala27 substitution points in the same direction – toward the two alpha helices α1 and α2 
– as does the wild type Leu27 residue (Fig. 41, 1a). 
 
Fig. 41 Conformational changes in the Naa30 α1–α2 loop of the L27A mutant. (A) Superposition of 
NatC-apo, NatC-CoA and NatC_Naa30_L27A (assemblies #1 and #2) with zoom views (1a, b), showing the 
α1–α2 loop of the Naa30 catalytic subunit. Highly conserved residues are labeled in bold and completely 
conserved residues are underlined. The position of the L27 to alanine mutants is indicated by an arrow. 
The wild type L27 side chain is positioned in a hydrophobic pocket, composed of the residues Ile23, 
Tyr31, Tyr36 and Met83. Since the side chain of alanine is much smaller and less hydrophobic 
compared to the leucine, it is less restricted in its placement. As a result, the entire α1-α2 loop moves 
up to 4.4 Å in NatC_Naa30_L27A, as judged by the Ser28 Cα position (Fig. 41, 1b). 
However, it is unlikely that the slight shift of the α1–α2 loop is responsible for the drastic reduction 
of the catalytic efficiency of NatC_Naa30_L27A compared to wild type NatC. It is more likely that 
the amino-terminal methionine side chain of the peptide substrate needs to be stabilized by Leu27 
and Tyr145, which form a hydrophobic pocket that encompasses the methionine side chain (Fig. 35).  
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4.12 NatC-ribosome interactions 
Polevoda et al. (2008) showed that all major NATs, NatA, NatB, NatC and NatE are associated with 
mono- and polyribosomes. Using co-sedimentation assays with purified ribosomes and NatA, Magin 
et al. (2017) identified two conserved electropositive regions (EPR) in NatA that are responsible for 
its ribosome interaction. A recent cryo-EM structure of the NatA/Naa50-ribosome complex 
(comprising Naa10, Naa15 and Naa50) (Knorr et al. 2019) revealed that the complex interacts with 
ribosomal RNA expansion segments via its large auxiliary subunit Naa15 and Naa50. To identify the 
regions responsible for ribosome binding in NatC, the electrostatic surface potential of NatC was 
calculated (Fig. 42). 
 
Fig. 42 Electrostatic surface potential of NatC.The electrostatic surface potential (ESP) is projected on the 
surface of the NatC-CoA structure. Approximate positions of the Naa30 and Naa38 subunits are indicated by 
circles. 
Seven distinct electropositive regions were identified on the surface of NatC (Fig. 42). The 
previously described Naa35 tip region (α20–α21), that extends by approx. 29 Å from the central 
body, includes one of these electropositive regions (EPR1).  
EPR1 contains a total of eleven positively charged residues, starting with H496 and ending at R519 
(Fig. 43A). Due to the low overall sequence conservation of the large auxiliary subunit Naa35 (see 
Fig. S3, appendix), only two of the positively charged residues align perfectly (K511 and R519) 
among the eight different Naa35 orthologues. However, the overall positive charge of this region is 
conserved (Fig. 43B). 
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Fig. 43 Residues in the electropositive region EPR1 of NatC. (A) Electropositive region EPR1. Highly 
conserved residues are labeled in bold, with completely conserved residues underlined. (B) Sequence alignment 
of the Naa35 Tip region, using six different Naa35 orthologues with positively charged residues highlighted in 
blue. 
4.12.1 Characterization of the ribosome binding surfaces in NatC 
NatC-ribosome sedimentation assays were performed with the help of a former Master student, Mr. 
Linus Hopf, who has published part of the data in his Master thesis.43 
Three of the identified electropositive regions: EPR1, EPR2 and EPR4 were tested in ribosome 
sedimentation assays (Fig. 44A). The Naa35 tip region contains a total of eleven positively charged 
residues, from which two sets from opposite sides were selected for mutational studies (Fig. 44B). 
The NatC Tip1 construct contains alanine substitutions for Lys511, Arg515 and Arg519. In the Tip2 
construct, Lys500, Lys501, Lys503 and Lys504 were substituted with alanine residues. The EPR4 
patch lies in the middle of the two parallel helices α25 and α26. The corresponding Mid mutant 
construct contains alanine substitutions for Arg636, Lys681 and Lys688. Finally, EPR5 was selected 
as an electropositive patch, that is even more distant to the Naa35 Tip. The corresponding Distal 
mutant construct contains alanine substitutions for Lys696, Lys699 and Lys701. 
All NatC mutants tested in a ribosome co-sedimentation assay are based on the wild type NatC 
construct, with an additional FLAG-tag inserted that was used for quantification in Western blots 
(see 3.1). Purified NatC mutants were mixed with yeast ribosomes, underlaid with a sucrose cushion 
and subjected to ultracentrifugation. Supernatant and pellet fractions were separated on SDS-PAGE 
gels and analyzed by silver staining and western blot (see section 3.5).  
 
 
43 Hopf, Linus Valentin Moritz (2019), “Biochemical and mechanistic characterization of NatC”, submitted to 
the Department of Biology, Chemistry and Pharmacy of the Freie Universität Berlin 
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Fig. 44 NatC-ribosome co-sedimentation assay. (A) Electrostatic surface potential (ESP) projected on the 
surface of the NatC-CoA structure, showing three electropositive regions (EPR) on the back side of the NatC 
complex. (B) Cartoon presentation of NatC, showing the residues (colored in gold) of the four NatC mutant 
constructs, used in the sedimentation assays. All selected residues in the mutant constructs were substituted 
with alanine. (C) Silver stain gel of the supernatant (S) and pellet (P) fractions of the ribosome sedimentation 
assay. (D) Western blot of the sedimentation assay targeting the FLAG-tagged Naa35 subunit of NatC (Naa30 
and Naa38 are untagged) and the Rpl7 protein of the large subunit of the yeast ribosome. (E) Quantitative 
analysis of the Western blot. The proportion of NatC bound to the ribosome was calculated as the percentage 
of NatC in the pellet (P/S+P) divided by the percentage of ribosome in the pellet (P/S+P). Plots show mean 
values and error bars represent s.d. (n=2). The result of a one-way ANOVA analysis is represented, with ns = 
not significant and ***, P ≤ 0.001. 
The negative control without ribosomes (-Ribo) shows that NatC stays in the supernatant, whereas 
the opposite negative control (-NatC), shows the ribosomal proteins in the pellet fraction (Fig. 44C, 
D). In co-sedimentation experiments, a large fraction of wild type NatC co-sediments together with 
the ribosomes. The Mid and Distal mutants show no significant difference (Fig. 44E) compared to 
wild type NatC and are also found in the pellet fractions. In contrast, the Naa35 Tip mutants Tip1 
and Tip2 behave significantly different (P ≤ 0.01) compared to wild type NatC and are primarily 
found in the supernatant, indicating their inability to bind to the ribosome. 
In order to test if mutations in the Naa35 Tip region negatively affect the overall integrity of the NatC 
complex, the catalytic activity of the Tip1 mutant was analyzed. No significant difference in kcat and 
Km could be seen between the Tip1 mutant and wild type NatC (see Table 22, section 4.10.3). Thus, 
mutants in the Naa35 Tip are unlikely to affect the structural integrity of the NatC complex and the 
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observed loss of NatC-ribosome association is the result of the altered electrostatic properties of this 
region. 
The NatC-ribosome co-sedimentation assay clearly shows that the electropositive Naa35 tip region 
is necessary for association of NatC to the ribosome in vitro, most likely via the same RNA expansion 
segments that interact with the auxiliary subunit Naa15 of the NatA complex (Knorr et al. 2019). 
4.12.2 Movements of the Naa35 Tip region 
It was established in the previous section, that the Naa35 Tip region is required for the interaction of 
NatC with the ribosome. A comparison of the different NatC structures (Fig. 45A) reveals, that the 
tip region can undergo substantial movements, which could facilitate the interaction of NatC with 
the ribosome. Helix α21 rotates in two directions around a hinge point, located approximately at 
Glu525 (Fig. 45B). The angle formed between helices α20 and α21 varies up to 9° between different 
NatC structures. The second rotation is perpendicular to the first and measured between α21 in 
different NatC structures, which can rotate up to 12°. Atomic displacement factors (ADPs) of the 
Naa35 tip are significantly larger in the second biological assembly of NatC_Naa30_L27A compared 
to the other NatC structures (Fig. 45C). The larger flexibility of the Naa35 tip in biological assembly 
#2 is explained by a reduced number of crystal contacts. 
The large flexibility of the Naa35 tip region might be necessary to facilitate the NatC-ribosome 
interaction. 
 
Fig. 45 Movements of the Naa35 Tip region. (A) Superposition of NatC-apo, NatC-CoA and 
NatC_Naa30_L27A (assemblies #1 and #2). (B) Detailed view of the Naa35 tip movements. Angles were 
measure between helices α21 and α22 for all NatC structures. Additionally, the angle formed by α21 in 
assembly#1 and the same helix in assembly #2 was determined. (C) Heat maps, showing the atomic 
displacement parameters (ADP) on the surface of NatC-CoA and NatC_Naa30_L27A (#1 and #2). 
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5 Discussion 
The family of Nα-terminal acetyltransferases mediates the acetylation of N-termini in a wide range 
of target proteins. This irreversible post-translational modification is co-translationally attached and 
is of tremendous biological importance since it modifies the stability of these proteins, controls their 
interaction with binding partners and influences their functionality. 
In yeast and mammals, NATs comprise a family of five proteins or protein complexes, whose 
members modify N-termini in target proteins with different consensus recognition sequences. To 
reveal the catalytic mechanism and substrate specificity, several structures from single NATs and 
heteromeric NAT complexes have been determined in the presence and absence of their cognate 
substrates (Liszczak, Arnesen, and Marmorstein 2011; Liszczak et al. 2013; Magin, Liszczak, and 
Marmorstein 2015; Chen et al. 2016; Stove et al. 2016; Hong et al. 2017; Goris et al. 2018). Most 
recently, a cryo-EM structure of NatA/Naa50 in complex with the ribosome has been presented 
(Knorr et al. 2019). 
The only major eukaryotic NAT that has thus far eluded structural characterization, is the 
heterotrimeric NatC complex, consisting of the catalytic subunit Naa30 and the two auxiliary 
subunits Naa35 and Naa38. In this work, five structures of the Saccharomyces cerevisiae NatC 
complex in the absence and presence of CoA and two peptide substrates have been elucidated. These 
structures provide insights into the highly intertwined architecture of the NatC subunits and into their 
evolutionary origin. Furthermore, the structures show how N-terminal substrates with the NatC-
specific consensus sequence are recognized at the interface of two NatC subunits and provide insights 
into the catalytic machinery of NatC and, consequently, the catalytic mechanism of NatC and other 
Nat complexes. Finally, by comparing the NatC structure to the ribosome-bound NatA structure, a 
model for the ribosome-bound NatC complex is presented, which provides structural insights into N-
terminal acetylation during translation. 
5.1 Architecture of the NatC complex 
The structural analyses in this thesis show that the large auxiliary subunit Naa35 is the central 
assembly hub of NatC and forms extensive interactions with the catalytic subunit Naa30 and the 
small auxiliary subunit Naa38. Naa35 wraps around Naa30 in an open ring-like tertiary structure and 
covers about three fourth of its circumference. Naa38 is primarily tethered to NatC by the N-terminus 
of Naa35, which wraps around almost the entire circumference of Naa38, forming another ring-like 
tertiary structure (Fig. 18). 
The interactions between the NatC subunits are evolutionary conserved among NatC orthologs and 
comprise a mixture of hydrophobic and hydrophilic interactions (Fig. 21). Here it was shown, that 
the N-terminal β1–α2–loop–β2 segment of Naa35 forms extensive hydrophobic interactions with 
Naa38 and participates in the common Naa35/Naa38 β-sheet. In accordance with the involvement of 
the Naa35 N-terminus in the NatC structure, deletion of its first 44 residues disrupted the interaction 
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with Naa38. Most strikingly, the architecture of the NatC complex completely differs from that of 
the heterodimeric NAT complexes NatA and NatB (Fig. 23) (Liszczak et al. 2013; Hong et al. 2017). 
Most importantly, the relative position of the NatC auxiliary subunit compared to the catalytic 
subunit is exactly opposite to the positions of the NatA and NatB auxiliary subunits. Whereas Naa15 
and Naa25 primarily engulf the N-terminal part of their catalytic subunits, Naa35 additionally 
encloses the C-terminal half of Naa30. In NatA and NatB, the catalytic β6–β7 loop makes no contact 
with the corresponding auxiliary subunit. In NatC, this loop-region, which is critical for binding of 
the peptide substrate is in direct contact with the auxiliary subunit Naa35. 
5.2 Evolutionary relation of NatC subunits 
A detailed structural analysis of the individual subunits revealed expected and surprising 
evolutionary relationships of the individual NatC subunits that are discussed in the following. 
As predicted from sequence comparisons, the catalytic subunit Naa30 is closely related to the 
catalytic subunits of NAT paralogs. Indeed, Naa30 adopts the typical Gcn5-related N-
acetyltransferase (GNAT) fold, containing a central acetyl-CoA binding region (Vetting et al. 2005; 
Lu, Berkey, and Casero 1996; Wolf et al. 1998). 
As shown in section 4.6.2, part of the Naa35 subunit structurally resembles the Bro1 domain of 
several proteins. This includes the Bro1 domain of the S. cerevisiae Bro1 protein (Kim et al. 2005) 
and its mammalian ortholog Alix (Zhai et al. 2007). 
 
Fig. 46 Absence of a Snf7 interface in the Bro1-like domain of Naa35. (A) Part of the Naa35 subunit of NatC 
(red region in the NatC-CoA structure), resembles a large fraction of the Bro1 domain of the S. cerevisiae Bro1 
protein (yellow region of the Bro1 structure). A hydrophobic patch in the Bro1 protein (containing residues L336 
and I144) is responsible for its association with the Snf7 component of the ESCRT-III complex. (B) A 
superposition of NatC-CoA and Bro1 reveals that the corresponding region in NatC is not accessible for 
intermolecular interactions. 
Yeast Bro1 is a cytoplasmic protein that associates with endosomes by binding to the Snf7 
component of the ESCRT-III complex (Odorizzi et al. 2003). The ESCRT (endosomal sorting 
complex required for transport) pathway is a key mediator of multivesicular body (MVB) biogenesis 
at the endosome. MVBs deliver cargo destined for degradation to the yeast vacuole or mammalian 
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lysosome (Henne, Buchkovich, and Emr 2011). Kim et al. (2005) have identified a hydrophobic 
patch in the Bro1 domain which is necessary for binding to Snf7. The corresponding region in NatC 
partly overlaps with the electropositive EPR2 patch (Fig. 42, section 4.12) and is additionally covered 
by the α23–α24 loop region of Naa35 (Fig. 46). It is therefore unlikely that NatC can associate in a 
similar manner to Bro1 with the ESCRT complex at the endosomes. 
The structure of the NatC complex revealed, that Naa38 adopts the conserved Sm fold (Kambach et 
al. 1999) which contains a strongly bent five-stranded β-sheet. In the NatC complex, the five Naa38 
β-strands are extended on both sides by three short β-strands from the Naa35 subunit, forming a 
bifurcated, anti-parallel β-sheet (see Fig. 19, section 4.3). Within the Sm-like proteins, Lsm4 exhibits 
the highest structural similarity to Naa38. Lsm4 is part of a heptameric donut-shaped assembly that 
consist of seven different Lsm proteins and binds the small nuclear RNA (snRNA) U6 (Zhou et al. 
2013) which is part of the spliceosome. 
The structural similarity of Naa38 with the RNA-associated Lsm proteins may suggest that Naa38 
can also assemble into multimeric structures and/or bind RNA. However, as shown in section 4.6.3, 
Naa38 forms tight interactions with Naa35. The intermolecular β-sheet hydrogens bonds between 
Naa35 and Naa38 are roughly located at the same position as the intermolecular hydrogen bonds 
formed between neighboring Lsm subunits and thus, these Naa38 interfaces are not available for 
homo- or hetero-oligomerization with other Lsm proteins (see Fig. 27). 
The second question relates to the possible interaction of a Naa38 with RNA. This may be relevant 
since NatA was shown to contact the ribosomal RNA extension segments (Knorr et al. 2019) (see 
section 5.5 for further discussion), and thus, the Naa38 subunit may have evolved to mediate this 
RNA interaction in NatC. Séraphin and coworkers found that Naa38 is more divergent compared to 
other yeast Lsm proteins and lacks a conserved R-G/C motif in the C-terminal part (Séraphin 1995). 
In a co-immunoprecipitation experiment, tagged Lsm-constructs, including Naa38, were introduced 
into yeast cells, to analyze their ability to bind snRNAs. However, for Naa38, none of the snRNAs 
(U1, U2, U4, U5 or U6) was identified. 
By comparing the snRNA-bound LSm2-8 ring with the NatC structure solved in this work, a potential 
Naa38-RNA interaction may still be envisaged: In the Lsm2-8 ring, the U6 snRNA is bound in a 
positively charged groove on the inside of the ring (Fig. 47A). The uracil bases of the U6 snRNA are 
each recognized by conserved residues from two sequence motifs DxXxN and IRGX (Fig. 47B). The 
DxXxN but not the IRGX motif is also conserved in Naa38. 
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Fig. 47 Absence of U6S sRNA recognition motifs in NatC (A) Electrostatic surface potential projected on the 
Lsm2-8 heptameric complex (PDB accession code 4M7A). (B) Protein sequence alignment of yeast Lsm 
paralogs in comparison with Naa38. (C) U6 sRNA recognition by Lsm2-8 (top row). NatC-CoA complex showing 
the theoretical position of U6 sRNA from the Lsm2-8 structure, generated by superposition of Naa38 with Lsm4 
(bottom row). Both complexes are projected with their surface charge (left), with differently colored subunits 
(middle) and in cartoon/stick presentation (right).  
In analogy to the snRNA-bound Lsm4 subunit, a superposition with Naa38 reveals a potential RNA 
binding site in NatC (Fig. 47C). Interestingly, an RNA base would neatly fit into a pocket formed at 
the interface between subunits Naa35 and Naa38. However, this pocket is surrounded by 
hydrophobic and positively charged residues and has thus different electrostatic properties compared 
to the electropositive binding groove in the Lsm2-8 complex. 
The tight incorporation of Naa38 in the NatC complex, its unfavorable electrostatic charge properties 
and the absence of coordinating residues from the IRGX motif strongly indicate that Naa38 is unable 
to bind RNA. 
Starheim et al. (2009) found that, while all the human NatC subunits localize to the cytoplasm, Naa38 
is also significantly enriched in the nucleus. They concluded that Naa38 may have a nuclear role 
linked to RNA processing independent of the NatC complex. However, even if monomeric Naa38 
should exists in the nucleus, its overall low isoelectric point of 5.1 (see Fig. 42, section 4.12) suggest 
that it has a negative net charge in the cell, which makes its interaction with RNA less likely. 
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5.3 Insights into NatC substrate recognition and specificity 
While NatA and NatD, require removal of the substrate initiator methionine prior to Nt-acetylation, 
NatB, NatC, NatE and NatF acetylate the N-terminal methionine with further specificity determined 
by the second amino acid (Ree, Varland, and Arnesen 2018). The NatB complex has the unique 
ability to Nt-acetylate methionines followed by an acidic residue (MD-, ME-) or their amide (MN-, 
MQ) (Starheim et al. 2008; Van Damme et al. 2012). In contrast, the substrate specificity profile of 
NatC, NatE and NatF is partially overlapping and includes methionine N-termini followed by a 
hydrophobic amino acid (ML-, MI-, MV-, MY-, MF-, MW-) or lysine (MK-) (compare Table 1, 
section 1.5). 
To obtain insights into the substrate recognition of NatC, two structures have been solved in complex 
with coenzyme A and two different peptides representing the N-terminal five residues of cognate, 
well-characterized NatC substrates. The first peptide represents the N-terminus (MFHLV-) of the 
small GTPase S. cerevisiae Arl3, whose N-terminal acetylation is required for its binding to the trans-
Golgi specific transmembrane protein Sys1, thus determining the localization of yArl3 at the trans 
face of the Golgi apparatus (Behnia et al. 2004; Setty et al. 2004). The second substrate contains the 
N-terminal five residues (MLRFV) of the Major capsid protein (Gag) of the S. cerevisiae virus L-A. 
Nt-acetylation of Gag was shown to be required for viral particle assembly (Tercero, Dinman, and 
Wickner 1993). Both peptides interact with the catalytic subunit Naa30 through formation of multiple 
hydrogen bonds with the peptide backbone (see 4.8.2). The N-terminal methionine, which determines 
one part of the substrate specificity of NatC, NatE and NatF, is sandwiched in between L27 and 
Y145. The L27A mutant resulted in the strongest reduction of kcat to an almost undetectable activity 
(see Table 22, section 4.10.3). In the peptide-free NatC structures, Leu27 is positioned in a 
hydrophobic pocket in between helices α1 and α2. While binding of the yArl3 peptide induces only 
minor movements of the α1–α2 loop, binding of the Gag peptide induces a flipping movement of 
Leu27, which facilitates its interaction with the peptide’s Met1. The hydrophobic side chains at 
position 2 of yArl3 (Phe) and Gag (Leu) are both positioned in a conserved hydrophobic pocket of 
the catalytic subunit (Fig. 32, section 4.8.2). Tyr80 of the Naa30 subunit contributes to the formation 
of the hydrophobic pocket and a Y80A mutant exhibited an approximately four times higher Km 
compared to wild type NatC, emphasizing its importance for substrate recognition. Tyr80 is 
conserved among NAT paralogs NatC, NatE and NatF, all of which acetylate methionine N-termini 
followed by a hydrophobic residue. In contrast, NatA and NatB – which prefer polar or charged 
residues at position two, respectively, have both a histidine at the corresponding position. 
While the substrate’s first two amino acids are the major determinants for the specificity of most 
NATs, amino acid residues at positions 3 and 4 of yArl3 and Gag also contribute to the interaction 
with NatC. When comparing the two peptides, Gag forms more interactions with NatC, including a 
side chain interaction of Gag-Arg3 and a main chain interaction of residue 4. Additionally, Gag-Phe4 
explores the distal end of the hydrophobic substrate binding pocket. As a result, Gag peptide binding 
induced drastic rearrangements of the α1–α2 and particularly the β6–β7 loop which can be viewed 
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as an induced fit-mechanism. Consequently, the Gag peptide displayed a greatly increased catalytic 
efficiency, compared to the yArl3 peptide. While NatC wild type catalytic parameters for yArl3 are 
very similar to the values seen for other NATs (Liszczak et al. 2013; Hong et al. 2017), the Gag 
peptide displays an almost three times higher activity and a low micromolar Michaelis-Menten 
constant (Km) (see Table 23, section 4.10.4). As a result, the catalytic efficiency is more than one 
order of magnitude above the activity observed for the yArl3 peptide. 
The high affinity of the Gag-peptide is likely an evolutionary adaption related to the viral origin of 
the Gag protein. The major coat protein Gag is encoded by the L-A double-stranded (ds) RNA virus 
of S. cerevisiae. Since the L-A virus lacks the outer virion layer which is typical for retroviruses, 
they do not have an extracellular phase in their life cycle and are only transferred by yeast cell-cell 
mating (Wickner, Fujimura, and Esteban 2013). Terecero and coworkers have shown that NatC 
recognizes the N-terminal four residues of the L-A virus Gag protein, which is necessary for viral 
assembly (Tercero, Riles, and Wickner 1992; Tercero and Wickner 1992; Tercero, Dinman, and 
Wickner 1993). Since N-terminal acetylation is a requirement for viral particle assembly, the N-
terminal sequence of Gag is under strong evolutionary pressure, which explains the excellent 
catalytic efficiency observed for this substrate. Moreover, it is shown here that the N-terminal four 
residues make indeed the strongest contribution to Gag binding. A surface representation of the NatC 
substrate binding pocket reveals that residues 2-3 fill the entire extended substrate pocket that is 
formed in the Naa30-Naa35 interface (see Fig. 50, top left). 
 
Fig. 48 Comparison between substrate recognition of NatC, NatE and NatF.(A) Surface projection of NatC-
CoA-MLRFV, Naa50-Co-Ac-MGLP (3TFY) and Naa60-Co-Ac-MKAV (5ICV), showing the active site with bound 
peptide substrate (NatC) or bisubstrate analogs (Naa50 and Naa50), respectively. (B) Electrostatic surface 
potential of the active sites. 
Even though the substrate pocket is lined by several conserved hydrophobic amino acids (Fig. 32, 
section 4.8.2), the electrostatic surface potential (see Fig. 50, bottom left) reveals a strongly negative 
surface charge, which is likely to contribute to the NatC substrate selectivity. Indeed, both yArl3 and 
Gag have a positively charged residue at position 3, which interact with Naa30 side chains. 
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Even though NatC, NatE and NatF share substantially overlapping substrate specificity (Table 1, 
section 1.5), a comparison of their substrate pockets reveals strong differences in the corresponding 
electrostatic surface potentials (see Fig. 50, bottom row). Since NatF is localized to the Golgi-
membrane, where it specifically acetylates transmembrane proteins (Aksnes et al. 2015), the 
functional redundancy with NatC and NatE is likely to be minor. The opposite charge properties of 
the NatC and NatE pockets are likely to result in different substrate selectivity, which is not only 
inferred by the second position, but also subsequent positions of the peptide N-terminus. 
5.4 Catalytic mechanism of NatC 
On the basis of the structure-function studies presented in this work, a catalytic mechanism for the 
NatC complex was developed, which is presented in the following and compared against related 
NAT orthologs in the subsequent section (see 5.4.1). Different views of the active site of ligand-
bound Naa30 show the residues that are involved in the catalytic mechanism (Fig. 49 A-C). Since no 
structure of NatC in complex with acetyl-CoA was produced in this work, the Naa10-AcCoA 
structure was aligned with Naa30, to show the approximate position of the acetyl-group in the 
proposed catalytic mechanism (Fig. 49 A). Based on this information, a reaction scheme was 
proposed (Fig. 49). 
 
Fig. 49 Proposed catalytic mechanism for the NatC complex. (A) N-terminal acetylation in NatC starts with 
the deprotonation of the peptide amino terminus by the general base Glu118 and is mediated through an ordered 
water molecule. The activated amino group attacks the carbonyl oxygen of the enzyme-bound acetyl-CoA, 
resulting in a transient tetrahedral intermediate, which is stabilized by the backbone amide of Leu84 (oxyanion 
hole). The AcCoA molecule in the active site is obtained from a superposition of the Naa10-AcCoA structure 
(4KVX) with Naa30 (RMSD = 0.98Å over Cα 100 atoms) and shows the approximate location of the oxyanion 
in the tetrahedral intermediate. (B) Tyr130 serves as a general acid and donates a proton to break the thioester 
bond of the tetrahedral intermediate. (C) Glu29 is likely to act as a second general base, which deprotonates 
the acetylated peptide at the former amino terminus. (D) Complete mechanism for NatC-catalyzed transfer of 
an acetyl group from AcCoA to a peptide amino nitrogen. 
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Deprotonation of the peptide amino group 
The first step of the proposed catalytic mechanism involves the deprotonation of the amino group of 
the acceptor substrate peptide by a general base44, which in case of NatC, is likely mediated via a 
coordinated water molecule. In all NatC structures, a clear electron density for a water molecule was 
visible in the active site (see Fig. 30, section 4.8.1). The B-factor of the water molecule was similar 
to the average B-factor of surrounding macromolecule atoms (Fig. 31, section 4.8.1), indicating that 
this water is tightly coordinated. This coordination, together with the close vicinity to the amino 
group of the peptide substrate, suggests a potential role of this water molecule in catalysis. 
The proposed catalytic water (red sphere, Fig. 49A), is positioned 3.3 Å away from the peptide amino 
group and coordinated by the hydroxyl group of the Tyr80 side chain, the backbone carbonyl oxygen 
of Ile81 and the carboxyl group of the Glu118 side chain. Glu118 is likely to serve as the general 
base, as E118A or E118Q substitutions result in a ~90% reduction of the kcat compared to wild type 
Naa30. Y80A or Y80F led to a ~50% reduced kcat, which supports the prosed role of Tyr80 in 
coordinating the catalytic water. 
Nucleophilic attack on the carbonyl carbon of acetyl-CoA 
In a second step, the activated (i.e. deprotonated) peptide amino group performs a nucleophilic attack 
on the carbonyl carbon of the enzyme bound acetyl coenzyme A (AcCoA), resulting in a transient 
zwitterionic tetrahedral intermediate (third step of Fig. 49 D). Simultaneously, the resultant negative 
charge on the carbonyl oxygen (oxyanion) is most probably stabilized by the backbone amide of 
Leu84.  
Proton transfer and breakdown of the tetrahedral intermediate 
The breakdown of the intermediate is likely to occur through a proton transfer from Tyr130, which 
serves as the general acid (Fig. 49B). At the same time, the electron pair of the oxyanion flips over 
to form the double bond of the carbonyl oxygen, thereby breaking the thioester bond of the CoA-
intermediate. In acetyltransferase assays, Y130A and Y130F mutants exhibited an extremely reduced 
kcat, corresponding to ~1-2% of wild type NatC turn over numbers, while showing no significant 
changes in Km, emphasizing the crucial role of Tyr130. 
Second deprotonation of the peptide amide 
After the nucleophilic attack, the nitrogen atom of the former peptide carries a positive charge and 
needs to remove its excess hydrogen atom.  
The most likely candidate for this second deprotonation step is the highly conserved Glu29, which 
would represent the second general base. E29A and E29Q mutants exhibited a strongly reduced kcat, 
corresponding to ~4-6% of wild type NatC turn over numbers and no other function has been 
 
44 General base catalysis refers to the partial proton abstraction by a proton acceptor and can be performed by 
the unprotonated forms of Asp, Glu, His, Tyr, Cys, Lys. The same amino acids can act as general acids in their 
protonated form (http://faculty.smu.edu/svik/5310/5310lectures/lect14.html). 
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assigned for this residue in the catalytic mechanism. In the NatC-CoA-MLRFV structure, the amino 
group of the substrate peptide and the carboxyl group of Glu29 are about 9 Å apart. However, Glu29 
is part of the flexible α1–α2 loop, which allows for large movements of the loop residues. 
Furthermore, it is possible that the acetylated peptide encounters Glu29 during the product 
dissociation process. 
In summary, N-terminal acetylation in NatC starts with the deprotonation of the peptide amino 
terminus by the general base Glu118 and is mediated through an ordered water molecule. The 
activated amino group attacks the carbonyl oxygen of the enzyme-bound acetyl-CoA, resulting in a 
transient tetrahedral intermediate, which is most probably stabilized by the backbone amide of 
Leu84. Tyr130 serves as a general acid and donates a proton to break the thioester bond of the 
tetrahedral intermediate. Finally, Glu29 is likely to act as a second general base, which deprotonates 
the acetylated peptide at the former amino terminus. 
5.4.1 Comparison of the catalytic mechanism 
The active site of Naa30 is now compared to catalytic subunits from the following NAT paralogs: S. 
pombe NatA (Liszczak et al. 2013), C. albicans NatB (Hong et al. 2017) human Naa50 (Liszczak, 
Arnesen, and Marmorstein 2011) and human Naa60 (Stove et al. 2016). A superposition of scNaa30 
with these NAT structures shows the highest structural similarities with the complexed catalytic 
subunits of NatA and NatB. Only two active side residues are universally conserved among the major 
eukaryotic NAT paralogs Naa10, Naa20, Naa30, Naa50 and Naa60 (Rathore et al. 2016) (see Fig. 
36, section 4.10.1), which correspond to Tyr130 and Tyr145 in scNaa30 (Fig. 50). In addition, Tyr31 
is completely conserved in all paralogs except Naa20 in which it is either a tyrosine or a 
phenylalanine. 
Tyr31 and Tyr145 form hydrogen bonds with the peptide backbone and phenylalanine substitutions 
(Y31F, Y145F) showed significant reductions in kcat (Table 22, section 4.10.3). Similar strong or 
total losses of catalytic activity for corresponding residues in NAT paralogs were also observed by 
others for S. pombe NatA (Liszczak et al. 2013), hsNaa50 (Liszczak, Arnesen, and Marmorstein 
2011) and hsNaa60 (Stove et al. 2016; Chen et al. 2016). In C. albicans NatB, Tyr31 is replaced by 
a phenylalanine (F27), which makes a hydrophobic interaction instead of a hydrogen bond with the 
substrate backbone (Hong et al. 2017). 
In the present work, Glu118 is proposed to deprotonate the peptide amino group via a well-ordered 
water molecule in the center of the active site. Liszczak, Arnesen, and Marmorstein (2011) have 
identified a similar well-ordered water molecule for hsNaa50 (Fig. 50C) and proposed that the nearby 
Y73 and H112 cooperate in the deprotonation of the amino group via the observed water molecule. 
In Naa60, an identical catalytic water and an equal pair of amino acids (Y97 and H138) are present 
and thus the same mechanism was suggested for proton abstraction from the peptide amino terminus 
(Stove et al. 2016; Chen et al. 2016). A glutamate was also suggested to function as the general base 
in the GNAT histone acetyltransferase Gcn5 from S. cerevisiae (Trievel et al. 1999). 
5.4  Catalytic mechanism of NatC      103 
 
 
Fig. 50 Comparison of the active sites of NatC, NatE and NatF. Superposition of NatC-CoA-MLRFV, spNatA-
CoA-Ac-SASE (4KVM), caNatB-CoA-Ac-MDSE (5K18), Naa50-CoA-Ac-MGLP (3TFY) and Naa60-CoA-Ac-
MKAV (5ICV). For simplicity, only the NatC CoA (purple) and Gag peptide (orange) are shown. (A) View of the 
active site. The catalytic water in Naa30, Naa50 and Naa60 is shown as a sphere. Hydrogen bonds show the 
coordination of the water in Naa30 (red lines) and the NatC Gag substrate peptide (black lines), respectively. 
(B) 90° rotated view, showing the coordination of the Met1 residue. Additional hydrogen-bonding involving the 
α1-α2 loop, β6–β7 loop, β5 and one backbone amide of the substrate peptide (F4) are shown for NatC. 
In the catalytic mechanism proposed here, Tyr130 in NatC was suggested to serve as a general acid 
for the breakdown of the tetrahedral intermediate. Even though Tyr130 is completely conserved in 
all major eukaryotic NATs, very few mutational studies are available, except for the NatB complex, 
where a mutation to phenylalanine reduced the kcat to 4% of wild type activity, with only a minor 
increase of the Km (Hong et al. 2017). Thus, Tyr130 is crucial for catalysis in NatC and potentially 
in all major NATs. The catalytic mechanism proposed in this work now assigns a potential role to 
this highly conserved tyrosine. 
Glu29 in NatC was suggested to act as a second general base. In NatA, the corresponding glutamate 
(E24) showed similar strong reductions in kcat with negligible effects on Km (Liszczak et al. 2013). 
However, a mutation of the corresponding glutamate in NatB (E25A) increased its enzymatic activity 
by ~60% (Hong et al. 2017). Given the observed differences for Glu29 in different NAT paralogs 
and its large distance from the peptide amino group, the function of Glu29 in the final deprotonation 
step remain elusive. 
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5.5 NatC-ribosome interaction 
Gautschi et al. (2003) first revealed that NatA is quantitatively anchored to ribosomes via the 
auxiliary subunit Naa15 to enable co-translational Nt-acetylation of NatA substrates. Polevoda et al. 
(2008) showed that all major NATs, e.g. NatA, NatB, NatC and NatE, are associated with mono- and 
polyribosomes. The authors furthermore showed ribosomal proteins uL23 and uL14 to associate with 
NatA in pulldown experiments. Both proteins are located in close proximity to the ribosomal exit 
tunnel. Using co-sedimentation assays with purified ribosomes and NatA, Magin et al. (2017) 
identified two conserved electropositive regions (EPR) in NatA, that are responsible for its ribosome 
interaction. A recent cryo-EM structure of the trimeric NatA/Naa50 complex (comprising Naa10, 
Naa15 and Naa50) bound to the S. cerevisiae ribosome (Knorr et al. 2019) revealed that the trimeric 
NatA/Naa50 complex interacts with ribosomal RNA expansion segments via its large auxiliary 
subunit Naa15 and Naa50 (Fig. 51A). The authors have identified four interaction sites on the 
ribosome, all of which contain ribosomal RNA. One interaction is formed between Naa15 and rRNA 
helices H24 and H47 (Fig. 51, colored in green) close to the peptide exit tunnel (PE). All other 
interactions are formed with RNA expansion segments (ES) (Fig. 51, colored in blue) which are 
specific for eukaryotic ribosomes. Thus, Naa15 interacts with ES27a and ES39a, whereas Naa50 
binds ES7a. The catalytic Naa10 does not form contacts with the ribosome and is positioned 
dynamically in close proximity to the ribosomal exit tunnel (Knorr et al. 2019). 
In this work, NatC-sedimentation assays showed that the electropositive Naa35 tip region is 
necessary for association of NatC with the ribosome in vitro. Thus, it is conceivable that NatC also 
interacts with negatively charged ribosomal RNAs. In order to obtain first insight into the possible 
interactions of NatC with the ribosome, two different superpositions of NatC with the NatA/Naa50-
ribosome cryo-EM structure were generated: The catalytic subunit of NatC, Naa30, was aligned with 
either Naa10 (Fig. 51B) or Naa50 (Fig. 51C) of the trimeric NatA/Naa50 complex, both of which 
feature the conserved GNAT fold. 
The superposition of the two catalytic subunits, Naa10 and Naa30, reveals that large parts of the 
auxiliary subunit Naa35 would be in close contact with the surface of the ribosome, while exhibiting 
only minor clashes (Fig. 51B). Most importantly, the Naa35 Tip region would be in close proximity 
with ribosomal RNA, which is in line with its essential role in NatC-ribosome binding as established 
in this work. Interestingly, this putative interaction would involve rRNA helices H18-H20, which are 
not involved in binding of the NatA/Naa50 complex. 
The second possible superposition aligns Naa30 of NatC with Naa50 of the NatA/Naa50-ribosome 
complex (Fig. 51C). In this configuration, hardly any interaction between NatC and the ribosome 
was observed. Moreover, the Naa35 Tip is positioned far away from the ribosome surface. Therefore, 
this orientation is very unlikely to exist in vivo. 
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Fig. 51 Potential NatC-ribosome interfaces. (A) Molecular model of the NatA/Naa50-ribosome complex 
(6HD7) near the peptide exit tunnel (PE). The catalytic subunit Naa30 of the NatC-CoA-MLRFV structure was 
used for a superposition with either Naa10 (B) or Naa50 (C) in the NatA/Naa50-ribosome complex. The 
superpositions of Naa30 with either Naa10 or Naa15 are shown in the smaller boxes on the left. The 
NatA/Naa50-complex is omitted in the NatC-ribosome models for better clarity. The Naa35 Tip mutants are 
highlighted in gold. 
The secondary structure of the 28S rRNA of S. cerevisiae is shown in Fig. 52. Expansion segments 
involved in the NatA/Naa50-ribosome interaction are detailed in Fig. 52B and rRNA segements 
involved in putative NatC-ribosome interactions are detailed in Fig. 52C. 
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Fig. 52 Secondary structure of the 28S rRNA of S. cerevisiae. (A) Overview of the 28S rRNA (adapted from 
http://apollo.chemistry.gatech.edu/RibosomeGallery/). Expansion segments involved in the NatA/Naa50-
ribosome interaction are labeled in blue. Additional rRNA segments involved in the putative NatC-ribosome 
interaction are colored in red. Zoom views are shown in (B) and (C) respectively. 
Returning to the superposition of Naa30 with Naa10, more potential NatC-ribosome interactions can 
be predicted from the electrostatic surface potential of NatC. In addition to the electropositive region 
in the Naa35 Tip (EPR1), two more electropositive patches on the NatC surface are potential 
candidates for ribosome interactions (Fig. 53A). Both EPR2 and EPR3 could interact with the highly 
flexible ES27a RNA expansion segment, with EPR2 being the more likely candidate due to its larger 
dimensions and stronger conservation: EPR2 contains ionizable side chain groups from six basic 
residues of Naa30 and one from Naa35 (Fig. 53B). Three Naa30 residues are universally conserved 
(H72, R78 and K139) and two more Naa30 residues (R73 and K153) are highly conserved. In 
between these residues, electron density indicated the presence of a ligand which was attributed to 
two PEG molecules from the crystallization solution. It is conceivable that the PEG binding site 
overlaps with an RNA binding site in Naa30. 
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Fig. 53 Electrostatic surface potential of NatC reveals further putative ribosome interaction sites. (A) 
Superposition of Naa30 from NatC-CoA-MLRFV with Naa10 from the NatA/Naa50-ribosome complex. The 
electrostatic surface potential (ESP) is projected on the surface of NatC and reveals three electropositive regions 
(EPR) as potential ribosome binding sites. (B) Detailed view of EPR2 in the NatC-CoA structure. Highly 
conserved residues are labeled in bold, with completely conserved residues underlined. A 2Fo-Fc map, 
contoured at 1σ, is shown for the PEG and water molecules modeled near EPR2. 
In summary, the electropositive Naa35 tip region was shown to be crucial for NatC-ribosome 
interactions in vitro. A superposition of NatC with the NatA/Naa50-ribosome structure revealed 
ribosomal RNA helices H18-H20 as the potential binding site for the Naa35 tip region of NatC. The 
conserved EPR2 region in NatC was identified as another promising candidate for the putative 
interaction of NatC with the ribosomal expansion segment ES27a. Further NatC-ribosome 
sedimentation assays would be necessary to confirm whether or not EPR2 is involved in ribosome 
binding. 
5.5.1 Possible roles of the central tunnel for NatC interactions with the nascent chain 
In this work, another remarkable feature of the NatC complex was discovered: two tunnels, which 
are located roughly at the center of the entire complex at the Naa30-Naa35 interface (Fig. 34, section 
4.9). CoA and the substrate peptide meet head-to head in the side tunnel, which contains the active 
site of the catalytic subunit Naa30. The circular central tunnel is separated from the side tunnel by 
the α1-α2 loop and the β6-β7 loop and is constricted to 4 Å at its narrowest point. The side tunnel 
has a more elliptical cross-section with a height of ~5 Å and a width of ~ 13 Å in the peptide-free 
state. Upon peptide binding, the side tunnel becomes significantly constricted due to movements of 
the flexible α1-α2 and β6-β7 loops. 
This high degree of flexibility suggests that, conversely, the two loops can also open up further, fully 
connecting the central and side tunnel. The opposite site of the central tunnel is lined by four 
additional Naa35 loop regions, which further shows the expandability of this region. It is thus 
possible, that the central tunnel can accommodate the nascent polypeptide chain as it emerges from 
the ribosomal exit tunnel, directing its N-terminus to the center of the active site. The large flexibility 
of the central tunnel might be necessary to accommodate NatC substrates that contain a bulky 
hydrophobic amino acid at position two (e.g. MY-, MF- or MW-).  
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As outlined in a current review (Waudby, Dobson, and Christodoulou 2019), nascent polypeptide 
chains emerging from the exit tunnel will begin to fold and assemble their tertiary and quaternary 
structure during biosynthesis in a vectorial manner, starting at their N-terminus45. While simple 
secondary structures (e.g. small α helices) may form within the ribosomal exit tunnel (Bhushan et al. 
2010), tertiary structure formation can only occur upon reaching the exit tunnel vestibule (Kudva et 
al. 2018). Upon emerging from the exit tunnel, the nascent chain is exposed to the surface of the 
ribosome itself, which (i) constraints the nascent chain to regions adjacent to the exit tunnel (Cabrita 
et al. 2016) and (ii) slows down folding of the nascent chain (Kaiser et al. 2011). However, soon after 
the nascent chain emerges, it can collapse into a co-translational folding intermediate46 (Kelkar et al. 
2012). The supposed close proximity of NatC with the exit tunnel, would allow it to N-terminally 
acetylate its substrate before the nascent chain starts to collapse into a folding intermediate (e.g. the 
special case of the molten globule). The formation of the kinetic molten globule is initiated by a 
collapse of the unfolded protein chain and generally thought to be driven by hydrophobic interactions 
(i.e. hydrophobic collapse) (Udgaonkar 2013). Since some NatC substrates contain a bulky 
hydrophobic amino acid at position two (e.g. MY-, MF- or MW-), they are likely to collapse quickly 
(and consequently will be inaccessible for Nt-acetylation). It is possible that the structure of the NatC 
complex, especially of its central tunnel region, has evolved to accommodate and delay the collapse 
of the hydrophobic substrates until they have been Nt-acetylated by the catalytic subunit Naa30. 
 
45 Today protein folding is seen as a “parallel microscopic multi-pathway diffusion like process” (Dill and 
Chan 1997) along an energy landscape that resembles the movement of a ball down the surface of a “rugged” 
funnel, containing local minima that resemble non-native conformations. The bottom of the funnel represents 
the global minimum free energy state of the native folded protein. 
46 A specific type of folding intermediate is the (kinetic) ‘molten globule’, which is as compact as the native 
protein and may contain secondary structure elements, but has a fluctuating tertiary structure (Ohgushi and 
Wada 1983). 
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6 Conclusion 
Based on a structural and biochemical characterization of NatC, its structure, substrate preference, 
catalytic mechanism and ribosome interaction surfaces have been characterized in this work. Future 
studies need to address the exact binding modes of NatC on the ribosome to understand the detailed 
mechanism of co-translational Nt-acetylation of target substrates, for example, by cryo-EM analyses. 
Furthermore, based on the structural work, it may now be possible to design structure-based NatC 
mutants which specifically abrogate N-terminal acetylation of specific subsets of NatC substrates. 
This may provide exciting opportunities to further study the biological function of N-terminal 
acetylation in specific target proteins.  
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7 Summary 
N-terminal acetylation is one of the most abundant protein modifications in eukaryotes, affecting an 
estimated 80% of all human proteins and has diverse implications for the stability, folding, half-life, 
interaction ability and subcellular targeting of the acetylated protein. This irreversible modification 
is catalysed by a highly conserved family of N-terminal acetyltransferases (NATs). Eight different 
NATs have been described in eukaryotes so far, which differ in their substrate specificity, their 
subunit composition and their subcellular localization. The only major eukaryotic NAT that has thus 
far eluded structural determination, is the heterotrimeric NatC complex, consisting of the catalytic 
subunit Naa30 and the two auxiliary subunits Naa35 and Naa38. 
In this work, five structures of the Saccharomyces cerevisiae NatC complex in the absence and 
presence of CoA and two peptide substrates are presented. The structural analyses show that the large 
auxiliary subunit Naa35 is the central assembly hub of NatC that forms extensive interactions with 
the catalytic subunit Naa30 and the small auxiliary subunit Naa38. Thus, Naa35 wraps around Naa30 
in an open ring-like tertiary structure and its N-terminus embraces Naa38 around almost its entire 
circumference.  
Most strikingly, the architecture of the NatC complex completely differs from that of the 
heterodimeric NAT complexes NatA and NatB. Most importantly, the position of the NatC auxiliary 
subunit relative to the catalytic subunit shows the exact opposite arrangement seen in the NatA and 
NatB auxiliary subunits.  
NatC structures in complex with two cognate peptides corresponding to the N-terminus of yeast Arl3 
and the viral Gag protein provided structural insight into NatC substrate specificity and show that 
the peptides are bound in an elongated hydrophobic substrate binding pocket that is formed in 
between subunits Naa30 and Naa35. Binding of the high-affinity Gag peptide, but not of the Arl3 
peptide, resulted in large ligand-induced structural rearrangements of the substrate binding loop. 
Accordingly, in acetyltransferase assays, the Gag peptide displayed a 10-fold increased catalytic 
efficiency compared to Arl3. 
Based on a comprehensive structure-function study, a catalytic mechanism for the NatC complex 
was proposed. Finally, by comparing the NatC structure to the ribosome-bound NatA structure and 
supported by structure-based mutagenesis, a model for the ribosome-bound NatC complex is 
presented. 
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8 Zusammenfassung 
Die N-terminale Acetylierung ist eine der am häufigsten vorkommenden Proteinmodifizierungen in 
Eukaryoten, welche geschätzte 80% aller humanen Proteine betrifft und weitreichende 
Auswirkungen auf die Stabilität, Faltung, Lebensdauer, das Interaktionsvermögen und die 
subzelluläre Verteilung des acetylierten Proteins hat. Diese irreversible Modifikation wird von einer 
stark konservierten Familie N-terminaler Acetyltransferasen (NATs) katalysiert. Acht verschiedene 
NATs wurden bisher in Eukaryonten beschrieben, welche sich durch ihre Substratspezifität, 
Untereinheiten-Zusammensetzung und ihre subzelluläre Lokalisation unterscheiden. Die einzige 
eukaryotische N-terminale Acetyltransferase die bisher nicht strukturell charakterisiert werden 
konnte, ist der heterotrimere NatC-Komplex, welcher aus der katalytischen Untereinheit Naa30 und 
den beiden unterstützenden Untereinheiten Naa35 und Naa38 besteht. 
In dieser Arbeit werden fünf verschiedene Strukturen des Saccharomyces cerevisiae NatC-
Komplexes in Gegenwart und Abwesenheit von Coenzyme A und zwei Substratpeptiden vorgestellt. 
Die strukturelle Analyse zeigt, dass die große Neben-Untereinheit Naa35 die zentrale 
strukturgebende Funktion einnimmt und umfangreiche Interaktionen mit der katalytischen 
Untereinheit Naa30 und der kleinen Untereinheit Naa38 eingeht. Naa35 umhüllt auf diese Weise 
Naa30 in einer offen-ringförmigen Tertiärstruktur. In ähnlicher Weise wickelt sich der N-terminus 
von Naa35 fast vollständig um den gesamten Kreisumfang von Naa38. 
Zwei NatC Strukturen im Komplex mit Peptiden der natürlichen Substrate Arl3 (aus Hefe) und dem 
viralen Gag-Protein ermöglichen einen strukturellen Einblick in die Substratspezifität von NatC und 
zeigen weiterhin die Bindung der beiden Peptide in einer langgestreckten, hydrophoben Substrat-
Bindetasche, welche zwischen den beiden Untereinheiten Naa35 und Naa38 gebildet wird.   
Die Bindung des Gag-Peptides, aber nicht die von Arl3, resultiert in einer großen Ligand-induzierten 
strukturellen Neuordnung der Substrat-Bindeschlaufe. Demgemäß zeigt das Gag-Peptid eine 
zehnfach erhöhte katalytische Effizienz im Vergleich zu Arl3. 
Auf Basis der umfangreichen Struktur-Funktions-Studien wurde ein katalytischer Mechanismus für 
den NatC Komplex vorgeschlagen. Aufgrund des Vergleichs der NatC-Struktur mit der Ribosom-
gebundenen NatA-Struktur, unterstützt durch strukturbasierte Mutagenese, wird ein Modell für den 
Ribosomen-gebundenen NatC Komplex präsentiert. 
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10.3 Sequence alignments of Naa30, Naa35 and Naa38 orthologs 
 
Fig. S1 Sequence alignment of Naa30 orthologs. Sc, Saccharomyces cerevisiae; Kl, Kluyveromyces lactis; 
At, Arabidopsis thaliana; Tc, Tribolium castaneum; Dr, Danio rerio and Hs, Homo sapiens. Completely 
conserved residues are highlighted with red boxes, highly conserved residues with yellow boxes. Secondary 
structures assignments of ScNaa30 are shown on top. The conserved coenzyme A binding motif RxxGxG/A is 
annotated below.▲, CoA binding residues and +, Peptide binding residues, identified with the PISA server 
(https://www.ebi.ac.uk/pdbe/pisa/). The construct boundary for Naa30ΔC17 is shown in blue (ΔC17).  
 
 
Fig. S2 Sequence alignment of Naa38 orthologs. Sc, Saccharomyces cerevisiae; Kl, Kluyveromyces lactis; 
At, Arabidopsis thaliana; Tc, Tribolium castaneum; Dr, Danio rerio and Hs, Homo sapiens. Global sequence 
alignment with free end gaps (Blosum45) made with Geneious (https://www.geneious.com/) and visualized 
using ESPript3.0 (http://espript.ibcp.fr/). Completely conserved residues are highlighted with red boxes, highly 
conserved residues with yellow boxes. Secondary structures assignments of ScNaa38 are shown on top. The 
construct boundary for the Naa38 subunit in the crystallized NatC Complex is shown in blue (ΔC11). 
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Fig. S3 Sequence alignment of Naa35 orthologs. Selected species and alignment method are identical to the 
Naa38 alignment (Fig. S2). Two construct boundaries, that are described in section 4.4, are shown in blue 
(ΔN17 and ΔN44). +, substrate binding residues and ●, mutationally sensitive residues are annotated below the 
sequence alignment. Selected residues () in positively charged patches (Tip1, Tip2, Mid and Distal) were 
mutated to alanine in the ribosome sedimentation assay (section 4.12). 
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10.4 Phylogenetic tree of NatC orthologs 
 
Fig. S4 Phylogenetic tree of NatC orthologs. Shown are the 18 different species for which orthologs of all 
three NatC subunits (Naa30, Naa35 and Naa38) could be identified. The tree was generated for Naa35 amino 
acid sequences with the Geneious software, using a BLOSUM45 cost matrix. Orthologs were used to generate 
Multiple sequence alignments in order to calculate ConSurf conservation scores. 
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10.5 Unit cell content 
The NatC-apo and NatC-CoA, NatC-CoA-MFHLV and NatC-CoA-MLRFV structures crystallized in 
P212121 with very similar unit cell dimensions, containing one NatC complex per asymmetric unit. 
Four asymmetric units are present per unit cell (Z = 4), which are generated through general position 
operators.47 Two neighboring unit cells, with four NatC symmetry mates each, are shown in Fig. S5. 
 
Fig. S5 Two neighboring unit cells of the NatC complex in P212121.  Orthoscopic projection along the a-axis, 
showing unit cells (000) and (001) of the NatC-CoA structure. Each of the four asymmetric units contains one 
copy of the NatC-CoA complex (blue outline). The four NatC copies (1)-(4) in each unit-cell are symmetry-mates, 
which can be generated by applying the translation and rotation operations, listed under General positions. 
Twofold screw axes are shown either parallel to the plain of projection ( ) or pointing in the plane of projection 
( ).  
The structure of NatC_Naa30_L27A crystallized in P1 and its unit cell occupied approximately half 
the volume compared to the P212121 crystals. The asymmetric unit of NatC_Naa30_L27A contains 
two independent NatC copies (biological assemblies #1 and #2). The root-mean-square deviation of 
the Cα positions between the two biological assemblies is 0.893 Å (over 950 compared Cα atoms). 
To visualize the orientation of the two biological assemblies and crystal contacts of the two 
NatC_Naa30_L27A molecules, four neighboring unit cells are shown in Fig. S6. 
 
47 These operators can be found in the International Tables for Crystallography, Volume A (Hahn 2002) 
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Fig. S6 Four neighboring unit cells of the NatC complex in P1. Orthoscopic projection along the a-axis, 
showing four unit cells of the NatC_Naa30_L27A structure. The asymmetric unit contains two different copies 
of the NatC complex. Biological assembly #1 (on the left side of the unit cell) is colored in pale colors. Assembly 
#2 (on the right) is colored in saturated colors, with subunit Naa30 in yellow, Naa35 in pink and Naa38 in orange. 
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10.6 Pairwise comparison of the different NatC structures 
A total of six different NatC models were built — one model for each P212121 dataset and two models 
for the P1 datasets, which contains two NatC complexes (biological assembly #1 and #2) in the 
asymmetric unit. All six NatC complexes are compared in a pairwise structural superposition of 
matching Cα positions (Table S 1).  
Table S 1 Pairwise RMSDs of Cα positions between different NatC structures. The entire NatC complex or 
individual subunits of different NatC structures were superimposed (using PyMOL’s fit command) to compare 
the root-mean-square-deviations (RMSDs) of their Cα atom positions (in Å). The number of matching (i.e. 
compared) Cα atoms is given in brackets. For identical structures (grey boxes), this number corresponds to the 
structure’s Cα atom number. Cells are colored using a heat map gradient (with green = lowest RMSD and red 















Entire NatC complex 
NatC (SeMet) (953)      
NatC-CoA 0.231 (953) (961)     
NatC-CoA-MFHLV 0.435 (950) 0.381 (952)  (953)    
NatC-CoA-MLRFV 0.781 (948) 0.743 (950) 0.678 (949) (950)   
NatC_Naa30_L27A #1 0.546 (951) 0.584 (954) 0.614 (952) 0.951 (950) (955)  
NatC_Naa30_L27A #2 0.764 (950) 0.840 (953) 0.761 (950) 1.067 (948) 0.893 (950) (953) 
 
Naa30 subunit only 
NatC (SeMet) (159)      
NatC-CoA 0.218 (159)     
NatC-CoA-MFHLV 0.472 0.440 (159)    
NatC-CoA-MLRFV 0.855 0.825 0.679 (159)   
NatC_Naa30_L27A #1 0.513 0.595 0.479 0.812 (159)  
NatC_Naa30_L27A #2 0.478 0.527 0.414 0.777 0.352 (159) 
 
Naa35 subunit only 
NatC (SeMet) (719)      
NatC-CoA 0.205 (719) (725)     
NatC-CoA-MFHLV 0.391 (717) 0.341 (719) (720)    
NatC-CoA-MLRFV 0.732 (718) 0.685 (720) 0.628 (719) (720)   
NatC_Naa30_L27A #1 0.547 (719) 0.572 (722) 0.618 (720) 0.943 (720) (723)  
NatC_Naa30_L27A #2 0.781 (717) 0.88 (720) 0.774 (717) 1.050 (718) 0.933 (718) (720) 
 
Naa38 subunit only 
NatC (SeMet) (75)      
NatC-CoA 0.307 (75) (77)     
NatC-CoA-MFHLV 0.38 (74) 0.365 (74) (74)    
NatC-CoA-MLRFV 0.403 (71) 0.44 (71) 0.530 (71) (71)   
NatC_Naa30_L27A #1 0.394 (73) 0.438 (73) 0.442 (73) 0.461 (71) (73)  
NatC_Naa30_L27A #2 0.439 (74) 0.472 (74) 0.503 (74) 0.536 (71) 0.418 (73) (74) 
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10.7 Complete Michaelis-Menten kinetics 
 
Fig. S7 Michaelis-Menten kinetics for wild type NatC and Naa30 mutants (1/3). Kinetics for either acetyl-
CoA (top left – with a fixed yArl3 peptide concentration of 1340 µM) or the yArl3 peptide (top right – with 500 
µM acetyl-CoA). Middle and bottom row, Michaelis-Menten kinetics for NatC mutant constructs, with single point 
mutations in the Naa30 subunit, using the yArl3 (MFHLVGSRRR) substrate peptide (at 500 µM acetyl-CoA). 
Enzyme concentrations and catalytic parameters (𝑲𝐦, 𝒌𝐜𝐚𝐭), of all replicates (n ≥ 3) are shown above each plot. 
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Fig. S8 Michaelis-Menten kinetics for NatC–Naa30 mutants (2/3) Single point mutations were introduced in 
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Fig. S9 Michaelis-Menten kinetics for NatC–Naa30 mutants (3/3) and NatC–Naa35 mutants (1/2) Single 
point mutations were introduced in the Naa30 or Naa35 subunit. Kinetics were performed with the yArl3 
(MFHLVGSRRR) substrate peptide and 500 µM acetyl-CoA. 
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Fig. S10 Michaelis-Menten kinetics for NatC–Naa35 mutants (2/2) and NatCΔNaa38. Single point mutations 
were introduced in the Naa35 subunit. The NatCΔNaa38 construct is expressed and purified without the small 
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Fig. S11 Michaelis-Menten kinetics for wild type NatC, with various substrate peptides (1/2). Kinetics were 
performed with 500 µM acetyl-CoA. The N-terminal sequence of the corresponding substrate peptide is given 
in brackets above each plot.  
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Fig. S12 Michaelis-Menten kinetics for wild type NatC, with various substrate peptides (2/2). Kinetics were 
performed with 500 µM acetyl-CoA. The N-terminal sequence of the corresponding substrate peptide is given 
in brackets above each plot 
10.8 NatC-ribosome sedimentation assay replicate 
 
Fig. S13 NatC-ribosome sedimentation assay – Second Western blot. Western blot for the replication 
experiment of the sedimentation assay. 
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10.9 Pathlength determination for the acetyltransferase assay 
10.9.1 Dependency of the pathlength on the well shape 
The acetyltransferase assay (see methods section 3.6 and results section 4.9) employs a colorimetric 
read-out for the quantification of product formation. Coenzyme A thiol groups react with DTNB to 
produce the yellow 2-nitro-5-thiobenzoate (TNB2–) anion, which absorbs at 412 nm. The TNB2– 
concentration is determined using the Beer–Lambert law: 
 
The concentration of DTNB in solution can be directly determined from the absorbance of the dye, 
its molar extinction coefficient (ε= 14150 M–1 cm–1) and the pathlength, i.e. the length of the solution 
that the light passes through. In a cuvette, light passes horizontally through the solution and the 
pathlength is defined by the cuvette’s dimensions (typically 0.1–1 cm). However, in a microplate the 
light passes vertically and the pathlength depends on the volume of the solution to be measured. To 
precisely determine the concentration of an analyte with Beer–Lambert’s Law, the pathlength needs 
to be calculated as exact as possible. 
 
Fig. S14 Well dimensions (in millimeter) for the microplate (Cat. No. 781 162, Greiner Bio one) used in 
the acetyltransferase assays. The technical drawing is obtained from the Microplate Dimensions Guide.49 
The 384-well microplate used in the acetyltransferase assay (Cat. No. 781 162, Greiner Bio one) has 
a rounded square well profile, i.e. the top and bottom areas of the well represent a square with 
rounded corners. As illustrated in Fig. S14, the well diameter is 3.7 mm at the top and 3.3 mm at the 
bottom and the well height is 11.5 mm. No information is given for the radii of the rounded corners. 
The manufacturer specifies a working volume of 10 to 130 µL. Two different specifications are given 
for the well volume. The information “Total volume: 131 µL” is found in the plate’s datasheet48 and 
“Mathematical Volume: 138 µL” is found in the Microplate Dimensions Guide49. 
In a cylindrical or cubical well, the depth or height of a liquid (i.e. its pathlength) is linearly dependent 
on the volume of the liquid. However, the wells of the microplate used in the acetylation reaction 
 
48 https://shop.gbo.com/en/germany/files/10362809/781162.pdf 
49 Microplate_Dimensions_Guide, page 7 and p. 14-15 (www.gbo.com/fileadmin/user_upload/Downloads/ 
Brochures/Brochures_BioScience/F073027_Microplate_Dimensions_Guide.pdf) 
 𝐴 = 𝜀 × 𝑐 × 𝑙 (S1) 
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have a conical shape and thus this relation is not valid. The shape of the well represents a frustum: 
the portion of a cone or pyramid, which remains after its tip has been cut off by a plane parallel to its 
base (shown as a transparent green volume in Fig. S15, A-C). To be precise, the well corresponds to 
a frustum of an (upside-down) pyramid with rounded lateral edges. It is thus neither the frustum of a 
pyramid or a circular cone, but the frustum of a general cone, since a cone is defined as a three-
dimensional geometric shape that tapers smoothly from a flat base to a point called the apex or 
vertex.50 The liquid in a frustum-shaped well will also have the form of a frustum and the liquid 
height corresponds to the pathlength needed to calculate the concentration of the analyte. It is 
possible to calculate the liquid height, with the available parameters: Top and bottom well dimension, 
total well height and volume of the solution. 
 
Fig. S15 Drawing of a pyramid (A), a circular cone (B) and an inverted pyramid with rounded lateral 
edges (C), representing an approximation of the well shape for the microplate used in the 
acetyltransferase assay.  Base areas of the entire cone (𝑨𝐞) and tip (𝑨𝐭) are colored in grey. The edges of the 
square-shaped bases areas are labeled (𝒂𝐞, 𝒃𝐞) and (𝒂𝐭, 𝒃𝐭), respectively. The radii of the circular base areas 
are labeled 𝒓𝐞 and 𝒓𝐭. The corner radii of the rounded square bases are labeled 𝒓𝐜(𝐞) and 𝒓𝐜(𝐭). The heights are 
labeled: 𝒉𝐟, frustum height; 𝒉𝐭, tip height; 𝒉𝐞, entire cone/pyramid height; 𝒉𝐥, liquid height; 𝒉𝐢, imaginary height. 
The tip volume (𝑽𝐭) is filled with transparent red, the volume of the frustum is filled with transparent green (𝑽𝐟) 
and together they form the entire volume (𝑽𝐞).The liquid volume (𝑽𝐥) is colored in transparent blue and together 
with the tip volume it forms the imaginary volume (𝑽𝐢). The striped triangles represent similar triangles of the 
yellow or green colored triangles lying below. 
The names of the variables used in the calculations, are related to the geometrical objects illustrated 
in Fig. S15. Correspondingly, the top of a well from the 384-well plate represents the base of the 
entire (𝐴e) pyramid (which is also the base of the frustum) and the bottom of the well represents the 
base of the tip (𝐴t), which has been produced by cutting through the entire pyramid. The area of the 
well bottom and well top corresponds to a square with rounded corners. Since the manufacturer has 
not provided any information for the corner radii, a microscope photograph was taken to measure 
these (Fig. S16).  
 
50 https://en.wikipedia.org/wiki/Cone 
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Fig. S16 A microscope photograph of one well of the microplate used in the acetyltransferase assay. 
The shape of the well represents a frustum of a pyramid with rounded corners. The top of the plate represents 
the base of the entire pyramid (𝑨𝐞), and the bottom of the plate represents the base of the tip (𝑨𝐭). The diameters 
of the well top (𝒂𝐞 ≈ 𝒃𝐞 = 3.7 mm) and well bottom (𝒂𝐭 ≈ 𝒃𝐭 = 3.3 mm) were used to calibrate the images in order 
to obtain the corner radii 𝒓𝐜,𝐞 and 𝒓𝐜,𝐭. For the well top, the radius is 𝒓𝐜,𝐞≈ 1.0 mm. The bottom radius is a bit 
smaller, with 𝒓𝒄(𝒕),≈ 0.9 mm. Under the assumption, that the well shape represents an upside-down pyramid with 
rounded corners, the radii are linearly correlated with the base length and, taking 𝒓𝐜,𝐞≈ 1.0 mm as the reference, 
𝒓𝐜,𝐭 must have a length of ≈ 0.89 mm, which is in very good agreement with the measured length.  
The image dimensions were calibrated using the well diameters given by the manufacturer: 3.7 mm 
for the well top and 3.3 mm for the well bottom. The measurements of the images have shown that 
the horizontal and vertical dimensions of the well top (𝑎e, 𝑏e) and well bottom (𝑎t, 𝑏t) differ by only 
0.10 mm and 0.05 mm, respectively and thus the top and bottom well areas are approximated as 
square areas with side lengths 𝑎e or 𝑎t, respectively in further calculations. The corner radii were 
determined to be ≈ 1.0 mm for the top of the well (i.e. the base of the entire cone or frustum, 𝑟c,e) 
and ≈ 0.9 mm for the bottom of the well (i.e. the base of the tip 𝑟c,t). Under the assumption that the 
well shape represents an upside-down pyramid with rounded corners, the radii are proportional to 
the base lengths (equation (S2)) and, taking 𝑟c,e≈ 1.0 mm as the reference, 𝑟c,t must have a length of 
3.3 mm
3.7 mm
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10.9.2 The area of a rounded rectangle 
As shown in Fig. S16, a rounded rectangle (in this case a rounded square) is a rectangle, that is 
truncated at each corner (shown as a blue-striped area) and this truncation can be described by a 
corner radius 𝑟𝑐. Each truncated corner area (𝐴c) can be obtained by subtracting the area of a quarter 
circle with radius 𝑟c, from a square with the same side length:  




 π × 𝑟c
2 (S3) 
To obtain the area of the rounded rectangle 𝐴round.rect., 𝐴c needs to be subtracted four times (once 
for each corner) from the area of the untruncated rectangle Arect. (with side length arect. and brect.): 
 𝐴round.rect. = 𝐴rect. − 4 × 𝐴c (S4) 






 𝐴round.rect. = 𝑎rect. × 𝑏rect. − (4 𝑟c
2 − π × 𝑟c
2) (S6) 
 𝐴round.rect. = 𝑎rect. × 𝑏rect. − 𝑟c
2(4 − π) (S7) 
In case of a rounded square this simplifies to: 
 𝑨𝐫𝐨𝐮𝐧𝐝.𝐬𝐪. = 𝒂𝐬𝐪.
𝟐 − 𝒓𝐜
𝟐(𝟒 − 𝛑) (S8) 
10.9.3 The volume of a frustum 
Before deriving the equation for the volume (section 10.9.4) or height (section 0) of a liquid in a 
frustum it is a good idea to calculate the theoretical volume of the well-frustum (i.e. a completely 
filled well) and compare it with the manufacturer’s specification of the theoretical well volume.  
The volume of a cone (including the special case of a pyramid) is defined as: 
 𝑉 =  
1
3
× 𝐴 × ℎ  (S9) 
As mentioned earlier, a frustum is the portion of a cone, which remains after its tip has been cut off 
by a plane parallel to its base. Thus, the volume of a frustum of a cone (𝑉f) is simply the volume of 
the tip of the cone (𝑉t) subtracted from the volume of the entire cone (𝑉e): 





× (𝐴e × ℎe − 𝐴t × ℎt) (S11) 
The height of the entire cone (ℎe) corresponds to the sum of tip and frustum heights: 
 ℎe = ℎt + ℎf (S12) 
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The height of the frustum (ℎf) is given and the height of the tip ℎt can be readily calculated from 
similar triangles51. In case of the pyramid (Fig. S15, A) two similar triangles pairs can be drawn. The 
first pair of similar triangles lies parallel to the a-edges (𝑎e and 𝑎t) of the two bases. The triangle that 
expands between the apex and the base of the entire pyramid is similar to the triangle that expands 
between the apex and the base of the tip volume. Perpendicular to the first pair, a second pair of 
similar triangles lies parallel to the b-edges (𝑏e and 𝑏t) of the two bases. The halved lengths of the 
bases correspond to one site of the similar triangles and they are proportional to the heights of the 













 (S13) ,  (S14) 
The two equations can be combined, and the products of the base lengths can be substituted by the 

















In case of a circular cone (Fig. S15, B), one pair of similar triangles can be found, with the base radii 








The entire equation can be squared and the fraction on the left side of the equation can be expanded 
by π and the products in the numerator and denominator can be replaced by the areas of a circle 


















In case of a square pyramid with rounded lateral edges (Fig. S15, C) – in addition to the two similar 
triangles found in the pyramid – we can draw another pair of similar triangles. One side of the similar 
triangles corresponds to the corner radii, and the other side corresponds to the heights of the entire 
pyramid or pyramid tip, respectively (S20). Since the base lengths are proportional to the heights 













 (S20) , (S21) 
 
 
51 In geometry, two triangles △ ABC and △ A′B′C′ are similar (△ ABC ~ △ A′B′C′ ) if they have congruent (i.e. 
identical) angles. That is  ∠ABC = ∠A′B′C′ and ∠BAC = ∠B′A′C′ and ACB = ∠A′C′B′. The lengths of 
corresponding sides of similar triangles are proportional. 
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It was shown for both the pyramid and the circular cone, that the base areas are proportional to the 










In order to prove the above, the rounded square area (S8) of the entire pyramid (𝐴e) can be divided 







2 (4 − π)
𝑎t
2 − 𝑟c,t
2 (4 − π)
 (S23) 


























2 (4 − 𝜋)
 (S24) 

















2 (4 − 𝜋)
= 1 (S25) 




















(4 − 𝜋) (S26) 



















(4 − 𝜋) (S27) 






































(4 − 𝜋) (S29) 
Finally ℎ𝑒

















(4 − 𝜋) (S30) 
The left- and right-hand side of the above equation are equal and thus eq. (S22) is true. 
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It could be shown that the base areas are proportional to the squared heights for the geometrical shape 
of a pyramid (S16), as well as a cone (S19) and also for a pyramid with rounded lateral edges (S22). 
Solving this equation for ℎe gives: 
 









× (𝐴𝑒 × ℎ𝑡 ×
√𝐴𝑒
√𝐴𝑡





× ℎ𝑡 × (𝐴𝑒 ×
√𝐴𝑒
√𝐴𝑡





× ℎ𝑡 × (
𝐴𝑒 × √𝐴𝑒 − 𝐴𝑡 × √𝐴𝑡
√𝐴𝑡
) (S34) 
ℎ𝑒 in equation (S31) can be substituted by eq. (S12) and solved for ℎ𝑡: 





ℎ𝑓 = ℎ𝑡 ×
√𝐴𝑒
√𝐴𝑡
− ℎ𝑡 (S36) 
 
ℎ𝑓 = ℎ𝑡 × (
√𝐴𝑒
√𝐴𝑡
− 1) (S37) 
 









































× 𝒉𝒇 × (𝑨𝒆 + 𝑨𝒕 + √𝑨𝒆 × 𝑨𝒕) (S43) 
Substituting eq. (S43) with the area of a square gives the equation for the volume of a frustum of 












× ℎ𝑓 × (𝑎𝑒
2 + 𝑎𝑡
2 + 𝑎𝑒 × 𝑎𝑡) (S45) 
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Substituting eq. (S43) with the area of a circle, gives the equation for the volume of a frustum of 












× ℎ𝑓 × (𝜋𝑟𝑒
2 + 𝜋𝑟𝑡




× 𝒉𝒇 × (𝒓𝒆
𝟐 + 𝒓𝒕
𝟐 + 𝒓𝒆 × 𝒓𝒕) (S48) 




× 𝒉𝒇 × (𝒅𝒆
𝟐 + 𝒅𝒕
𝟐 + 𝒅𝒆 × 𝒅𝒕) (S49) 
10.9.4 Liquid volume in a frustum 
The volume of a liquid in a frustum can be calculated from the liquid height (ℎ𝑙) and the well 
dimensions (ℎ𝑓, 𝐴𝑒 and 𝐴𝑡). A liquid filled in a frustum represents another frustum itself. The top of 
the liquid corresponds to the base of that frustum. In order to obtain the volume of that liquid, the 
volume of the tip cone (shown in red) needs to be subtracted from the cone that is formed from the 
sum of the tip volume and the liquid volume (blue), which is here referred to as 𝑉𝑖, for imaginary 
(cone) volume: 





× (𝐴𝑙 × ℎ𝑖 − 𝐴𝑡 × ℎ𝑡) (S51) 
The height of the imaginary cone corresponds to the sum of the tip and liquid heights: 
 hi = hl + ht (S52) 
ht can be substituted using eq. (S39): 
 




The last variable in equation (S51), that still needs to be addressed, is the area of the imaginary cone 
which corresponds to the liquid surface area and is thus termed 𝐴𝑙. As established before, the base 
area of a cone is proportional to the squared height of the cone (S22). From another pair of similar 
triangles, with the first extending from the base of the entire pyramid and the second extending from 









Taking the square root and solving for √𝐴𝑙 gives: 
 




 𝑉𝑙 = 𝑉𝑖 − 𝑉𝑡 (S50) 
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Substituting ℎ𝑖 with eq. (S52) gives: 
 




Placing eq. (S39) into (S31) gives the equation for the height of the entire cone: 











Substituting ℎ𝑒 in the denominator of (S56) by eq. (S58) allows √𝐴𝑒 to be reduced: 
 √𝐴𝑙 = √𝐴𝑒 ×




(ℎ𝑙 + ℎ𝑡) × (√𝐴𝑒 − √𝐴𝑡)
ℎ𝑓
 (S60) 











ℎ𝑙 × (√𝐴𝑒 − √𝐴𝑡) + ℎ𝑓 × √𝐴𝑡
ℎ𝑓
 (S62) 
 √𝐴𝑙 = √𝐴𝑡 +
ℎ𝑙 × (√𝐴𝑒 −√𝐴𝑡)
ℎ𝑓
 (S63) 
 𝐴𝑙 = (√𝐴𝑡 +





Substituting eq. (S51) with equations (S39), (S53) and (S64) gives the equation for the volume of 









× (𝒉𝒍 + 𝒉𝒇
√𝑨𝒕
√𝑨𝒆 −√𝑨𝒕
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10.9.5 Liquid height in a frustum 
In order to obtain the pathlength, which corresponds to the height of the liquid in a frustum, eq. (S66) 




× ((𝐴𝑡 + 2√𝐴𝑡 ×
ℎ𝑙 × (√𝐴𝑒 −√𝐴𝑡)
ℎ𝑓
+ (



















(𝐴𝑡 + 2ℎ𝑙 ×





















× (ℎ𝑙𝐴𝑡 + 2ℎ𝑙
2 ×

































√𝐴𝑡 × (√𝐴𝑒 − √𝐴𝑡)
ℎ𝑓




































After expanding the equation, the resulting polynomial, consisting of the first four terms in the 





























































































53 (𝑎 + 𝑏)3 = 𝑎3 + 3𝑎2𝑏 + 3𝑎𝑏2 + 𝑏3 
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10.9.6 Calculation of the well volume 
Two contradictory specifications for the total well volume: 131 µL54 and 138 µL55, are given by the 
manufacturer. In the following, three different models describing the conical, frustum-shaped well 
are used to calculate the total well volume and compared with the manufacturer specifications, to 
identify the model that describes the well shape most accurately. In section 10.9.3, the equation (S43) 
for the volume of a general frustum (i.e. the complete well) is derived. The first model represents a 
frustum of a circular cone (S49). The variables are renamed in eq. (S78) to represent the shape of a 
well, rather than the corresponding geometrical object. With the given well dimensions (𝑑top =




× hwell × (𝑑top
2 + 𝑑bottom




× 11.5 mm × ((3.7 mm)2 + (3.3 mm)2 + 3.7 mm × 3.3 mm) (S79) 
 𝑉f,cone ≈ 110.76 mm
3 (S80) 
the well volume is approx. 110.7 µL. This volume is much smaller than the theoretical 131 µL or 
138 µL, provided by the manufacturer, because the well has a square profile and the volume of a 
circular cone is only 
π
4
 of the volume of pyramid with base lengths equal to the cones diameter. 
 𝑉cone = 
π
4
× 𝑉pyramid (S81) 
Thus, the second model represents a frustum of a square pyramid and is described by eq. (S45). 




× ℎwell × (𝑑top
2 + 𝑑bottom




× 11.5 mm × ((3.7 mm)2 + (3.3 mm)2 + 3.7 mm × 3.3 mm) (S83) 
 𝑉f,pyramid ≈ 141.03 mm
3 (S84) 
Now, the well volume is approx. 141.0 µL. This volume is much closer to the two mentioned 
theoretical volumes of 131 µL or 138 µL, but still too large. This deviation can be explained by the 
fact, that the well has a “rounded square design”, which means that the top and bottom areas of the 
well are truncated at all four corners. 𝑟c,top (≈ 1.0 mm ) was determined from a microscope 
photograph (Fig. S16) and 𝑟c,bottom (≈ 0.89 mm) is calculated with eq. (S2). Considering the rounded 
square profile of the well, the second model can be refined to yield the third and final model for the 
shape of the well: a frustum of a square pyramid with rounded lateral edges. The total well volume 




× ℎwell × (𝐴top + 𝐴bottom +√𝐴top × 𝐴bottom) (S85) 
 
54 Microplate datasheet (https://shop.gbo.com/en/germany/files/10362809/781162.pdf) 
55 Microplate_Dimensions_Guide, page 7 and p. 14-15 
https://www.gbo.com/fileadmin/user_upload/Downloads/Brochures/Brochures_BioScience/F073027_Microp
late_Dimensions_Guide.pdf 
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With the rounded rectangular area of the well top (𝐴top), 
 𝐴top = 𝑑top
2 − 𝑟c,top
2 (4 − π) (S86) 
 𝐴top = (3.7 mm)
2 − (1.0 mm)2(4 − π) (S87) 
 𝐴top = 12.83 mm
2 (S88) 
and the area of the well bottom (𝐴bottom),  






(4 −  π) (S89) 




× 1.0 mm)2(4 − π) (S90) 
 𝐴bottom = 10.21 mm
2 (S91)  




× 11.5 mm × (12.83 mm2 + 10.21 mm2 +√12.83 mm2 × 10.21 mm2) (S92) 
 𝑉well = 132.2 µL (S93) 
Under the assumption, that the well represent a frustum of a square pyramid with rounded lateral 
edges, the well volume is approx. 132.2 µL – a value that lies in between the two manufacturer-
specified well volumes of 131 µL or 138 µL. Thus, this model provides the closest approximation 
for the well shape and will be used to calculate the liquid height (i.e. the pathlength) for the 
microplates employed in the acetyltransferase assays.  
10.9.7 Calculation of the liquid height 
The derivation of the equation for the height of a liquid in a frustum-shaped well (S77) is described 
in sections 10.9.4 and 10.9.5. The variables in the eq. (S77) are renamed in eq. (S94) to represent the 
shape of a well, rather than the corresponding geometrical object. Combined with the equations for 
the rounded square areas of the top (S86) and bottom (S89) of the well, the liquid height (i.e. the 
pathlength) can be calculated for a well, shaped like a frustum of a square pyramid with rounded 
lateral edges. Using the interim results for the rounded square areas: 𝐴top = 12.83 mm
2 and 
𝐴bottom = 10.21 mm
2, the well height of ℎwell = 11.5 mm and an exemplary liquid volume of 𝑉l =
50 µL gives: 















3 × 50 mm3 × (11.5 mm)2 
(√12.83 mm2 − √10.21 mm2)
2 + (
11.5 mm × √10.21 mm2





11.5 mm × √10.21 mm2
√12.83 mm2 − √10.21 mm2
 
(S95)  
ℎl = 4.67 mm (S96)  
10.9  Pathlength determination for the acetyltransferase assay      145 
 
Using the model of a pyramidal frustum with rounded lateral edges, the pathlength for 50 µL analyte 
solution in one well of the microplate used in the acetyltransferase assay is 4.67 mm. In comparison, 
the model for a simple pyramidal frustum gives a 6% shorter pathlength of only 4.39 mm (Table S 
2). Instead of using the well dimension (𝑑top, 𝑑bottom , ℎwell), one could also calculate the liquid 




× ℎwell). However, this model assumes that the well is a rectangular cuboid and 
completely neglects the conical shape of the well. Depending on which value is used for 𝑉total, the 
calculated pathlengths for 50 µL analyte solution are 4.39 mm (𝑉total = 131 µL) or 4.17 mm 
(𝑉total = 138 µL), which is 5.9% or even 10.7% shorter, respectively, than the value obtained with 
the reference model of a pyramidal frustum with rounded lateral edges. 
Table S 2 Calculated liquid heights (𝒉𝒍) for four different well shapes and the percent height difference 
to the pyramidal frustum with rounded lateral edges. Both frustum liquid heights were calculated using eq. 
(S94), with square areas 𝐴top = 𝑑top
2  and 𝐴bottom = 𝑑bottom
2  for the pyramidal frustum and rounded square areas 
(eq. (S86) and (S89)) for the pyramidal frustum with rounded lateral edges, with ℎwell = 11.5 mm 𝑑top = 3.7 mm, 
𝑑bottom = 3.3 mm and rc,top = 1.0 mm. Liquid heights for the cuboids were calculated as ℎl =
𝑉l
𝑉total
× ℎwell, with 




ℎl, frustum, pyramid, 
round lateral edges (mm) 
(𝑉𝑡𝑜𝑡𝑎𝑙 = 132.2 µL) 
ℎl, frustum, pyramid 
(mm) 
(𝑉𝑡𝑜𝑡𝑎𝑙 = 141.0 µL) 
ℎl, right cuboid 
(mm) 
(𝑉𝑡𝑜𝑡𝑎𝑙 = 131 µL) 
ℎl, right cuboid 
(mm) 
(𝑉𝑡𝑜𝑡𝑎𝑙 = 138 µL) 
10 0.97 0.91 (-6.2%) 0.88 (-9.5%) 0.83 (-14.1%) 
20 1.92 1.80 (-6.2%) 1.76 (-8.6%) 1.67 (-13.2%) 
30 2.85 2.68 (-6.1%) 2.63 (-7.7%) 2.50 (-12.4%) 
40 3.77 3.54 (-6.0%) 3.51 (-6.8%) 3.33 (-11.5%) 
50 4.67 4.39 (-6.0%) 4.39 (-5.9%) 4.17 (-10.7%) 
100 8.93 8.41 (-5.8%) 8.78 (-1.7%) 8.33 (-6.7%) 
130 11.33 10.69 (-5.7%) 11.41 (0.7%) 10.83 (-4.4%) 
 
In summary, using the reference model of a pyramidal frustum with rounded lateral edges and the 
well dimensions given by the manufacturer, the total well volume was calculated as 132.2 µL. A 
value that lies in between the manufacturers specifications for the total well volume of 131 µL or 
138 µL. In comparison to the reference model, the calculated pathlengths, are about 6% shorter when 
neglecting the rounded edges (pyramidal frustum model) and differ widely in a range of -14.1% to 
+0.7% for the rectangular cuboid models, depending on the liquid volume and assumed total well 
height (131 µL or 138 µL). Thus, the model of a pyramidal frustum with rounded lateral edges was 
used to calculate the pathlength for all acetyltransferase assays. 
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10.10 Sequence alignments of secondary structure assignments 
NatC_CoA, subunit Naa30ΔC17 
--EEEEE--TT-HHHHHHHHHHHHHH-SS---HHHHHHHHHH-GGGEEEEEETTSSSSSSEEEEEEEEEEEETTTEEEEEEEEEEE-GGGTTSSHHHHHH    DSSP 
--EEEEE-TTTTHHHHHHHHHHHHH-TTTT--HHHHHHHHHHTTTTEEEEEETTTTTTTTEEEEEEEEEEEETTTEEEEEEEEEEETTTTTTT-HHHHHH    STRIDE 
--EEEEEE---HHHHHHHHHHHHHHH------HHHHHHHHHH---EEEEEEE---------EEEEEEEEEEE---EEEEEEEEEEEE------HHHHHHH    KAKSI 
--EEEEE-----HHHHHHHHHHHHHH------HHHHHHHHHH----EEEEEE------------EEEEEEEE--EEEEEEEEEE----------HHHHHH    PYMOL_DSS 





HHHHHHHHHTT-SEEEEEEETT-HHHHHHHHHTT-EEEEEETTTTGGG--EEEEEEE--    DSSP 
HHHHHHHHHH---EEEEEEETTTHHHHHHHHHH--EEEEEEEEEEGGGEEEEEEEEE--    STRIDE 
HHHHHHHHHHH-EEEEEEEE--HHHHHHHHHHH-EEEEEEEE-------EEEEEEEE--    KAKSI 
HHHHHHHHHH---EEEEEEE---HHHHHHHHHH--EEEEEE---------EEEEEEE--    PYMOL_DSS 






Fig. S17 Sequence alignment of the secondary structure estimations for the three subunits Naa30ΔC17, Naa38ΔC11 and Naa35 of the Coenzyme A bound NatC model 
(NatC-CoA). Assignments were performed using DSSP, STRIDE, PyMOLs default assignment algorithm dss (PYMOL_DSS) and an author provided assignment (AUTHOR). The 
secondary structure server (http://2struc.cryst.bbk.ac.uk/) was used for DSSP and STRIDE assignment. PYMOL_DSS and AUTHOR assignments were added manually. Original 
outputs were used for DSSP and STRIDE, with H = alpha helix, I = 5-helix (pi helix), G = 3-helix (3/10 helix), B = residue in isolated beta-bridge, E = extended conformation, T = 
hydrogen bonded turn, S = bend, - = other or ‘coil’). The three-state PYMOL_DSS output (H = Helix, S = beta sheet, L = loop) was converted to H, E, -, respectively, to match the 
DSSP/STRIDE assignment. The AUTHOR assignment uses the same three-state representation. The alignment for subunits Naa35 and Naa38 are shown on the following two 
pages. X = amino acids for which no model was built due to insufficient electron density and for which the coil/other (-) secondary structure class is assigned.  
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NatC_CoA, subunit Naa35 
--HHHHHHHHTTTTT-S-EEE-HHHHHHHHHHS-TT-EEE-SS--GGGGGG-EETT-TTT-GGG----HHHHH--TTS--SSHHHHHHHHHHHHHHHHHH    DSSP 
--HHHHHHHHHTTTTTTTEEEHHHHHHHHHHH-TTTTEEETTTT-GGGGTTTEETTTTTTTTTTT---HHHHH-TTTT-TTTHHHHHHHHHHHHHHHHHH    STRIDE 
-HHHHHHHHH-----------HHHHHHHHHHHH------------HHHHHH----------------HHHHHHH-------HHHHHHHHHHHHHHHHHHH    KAKSI 
--HHHHHHHHHHH-----EEE-HHHHHHHHHH-------------HHHHH------------------HHHHH---------HHHHHHHHHHHHHHHHHH    PYMOL_DSS 





HHTS---STTTGGGBHHHHHHHHHHHH------S---S-HHHHTHHHHHHHHHHHHHHHHHHHHHTTSS-BTTTB----SS---TTTS--HHHHHHHHHH    DSSP 
HHHH---GGG-GGGBHHHHHHHHHHHH------------HHHHHHHHHHHHHHHHHHHHHHHHHHH---TTTTTTT--TTTT-TTTT---HHHHHHHHHH    STRIDE 
HHHH----------HHHHHHHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHHHHHH-----------------------HHHHHHHHHHH    KAKSI 
HHHH---HHHHHHH-HHHHHHHHHHHH------------HHHHHHHHHHHHHHHHHHHHHHHHHHH------------------------HHHHHHHHHH    PYMOL_DSS 





HHHHHHH-SS--HHHHHHHHHHHHHHHHHGGGHHHHS-----HHHHHHHHHHHHHHHHGGGS-----TTSBSSHHHHHS---S---------SSSHHHHH    DSSP 
HHHHHHH-----HHHHHHHHHHHHHHHHHH-HHHHHH----HHHHHHHHHHHHHHHHHGGG-----TTTTBTHHHHHH----------------HHHHHH    STRIDE 
HHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHH-----------HHHHHH----------------HHHHHH    KAKSI 
HHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHH------HHHHHHHHHHHHHHHHHH------------HHHHH-----------------HHHHH    PYMOL_DSS 





HHHHHHHHHGGGG--SHHHHHHHHHHTTTSS---HHHHHHHHHHHB-TTSEETTTEEHHHHHHHHHHHHH-----------S-HHHHHHHHHHHHHHHHT    DSSP 
HHHHHHHHHGGGG---HHHHHHHHHHHTTTTT--HHHHHHHHHHHEETTTEETTTB-HHHHHHHHHHHHH--TTT----TTTTHHHHHHHHHHHHHHHHH    STRIDE 
HHHHHHHHHHHHH--HHHHHHHHHHHH------HHHHHHHHHHHHH----------HHHHHHHHHHHHHH------------HHHHHHHHHHHHHHHHHH    KAKSI 
HHHHHHHHHHHHH---HHHHHHHHHH--------HHHHHHHHHHH------------HHHHHHHHHHHHH-------------HHHHHHHHHHHHHHHHH    PYMOL_DSS 





TS-HHHHHHHHHHHHHHHHHHHHHHHHTT-HHHHHHHHHHHHHHHHHHHHHHHHTT-S-GGGHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH    DSSP 
---HHHHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHH----GGGHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH    STRIDE 
----HHHHHHHHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHH    KAKSI 
H---HHHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH    PYMOL_DSS 
H--HHHHHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHH----GGGHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH    AUTHOR 
SQNTCRYRQGFNRQLILWDSLQAQFESVNSQVYCSWTYFMKLSSMIEFSLKGFDLDIYKPFEAYSMFWYVYYLSHHLETFLKDSQNDIESNINAIHSMNK 
....:....|....:....|....:....|....:....|....:....|....:....|....:....|....:....|....:....|....:....| 





HHHH--SSHHHHHHHHHHHHHHHHTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTS--SS-SS--SS--HHHHHHHHTGGGTT-TTTT---    DSSP 
HHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH----------TTTT-HHHHHHHHHGGGTTTTTTT---    STRIDE 
HHHHH--HHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-------------HHHHHHHHH-HHHHH-------H    KAKSI 
HHHH----HHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---------------HHHHHHHHHHHHH---------    PYMOL_DSS 





HHHHHHHHHHHS----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-TTSSS-----GGGHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-    DSSP 
HHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTT------TTTTHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHT    STRIDE 
HHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-------------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH    KAKSI 
HHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH--------------HHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHH-    PYMOL_DSS 





SS---EEEEEE--TTS-TTS-EEEEEE---    DSSP 
TTT--EEEEEE-TTTTTTTTTEEEEEE---    STRIDE 
----EEEEEEEE--------EEEEEEEE--    KAKSI 
-----EEEEEE----------EEEEEE---    PYMOL_DSS 






NatC_CoA, subunit Naa38ΔC11 
-----HHHHTTSEEEEEESSS-EEEEEEEEEETT--EEEEEEEEEETTEEEEEEEEEE-TTTEEEEEEEHHHHHHH-    DSSP 
-----HHHHTTEEEEEEETTT-EEEEEEEEEETTT-EEEEEEEEEETTEEEEEETEEE-GGGEEEEEEEHHHHHHH-    STRIDE 
----HHHHHH-EEEEEEE---EEEEEEEEEEE---EEEEE-EEEEE---EEEE-EEEEE----EEEEE-HHHHHHH-    KAKSI 
-----HHHH-EEEEEEEE---EEEEEEEEEEE--EEEEEE-EEEEE--EEEEEE-EEE-HHH-EEEEEEHHHHHHH-    PYMOL_DSS 
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10.11 HELIX and SHEET records 
 
Fig. S 18 Manually added (author) HELIX records for the NatC-CoA structure. The numberings above the 
HELIX lines are not included in the PDB file and are only included to aid with column assignment: 1-6, Record 
name “HELIX”; 8-10, Serial number of the helix, starts at 1 and increases incrementally through all protein 
chains; 12-14, helix identifier (1= right-handed alpha, 3= right-handed pi, 5= right-handed 3-10). May contain 
any alphanumeric character; 16-18, Name of the initial residue (3-letter code); 20 and 32, chain identifier for the 
chain containing this helix; 22-25, Sequence number of the initial residue; 28-30, name of the terminal residue 
of the helix; 34-36, Sequence number of the terminal residue; 39-40, helix class (see below); 41-70, Comments 
about this helix; 72-76, Length of this helix. 
 
 
REMARK 650                                                             
REMARK 650 HELIX 
REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED 
         1         2         3         4         5         6         7         8 
12345678901234567890123456789012345678901234567890123456789012345678901234567890 
HELIX    1  A1 GLU A   13  ASP A   26  1                                  14 
HELIX    2  A2 ILE A   33  TRP A   43  1                                  11 
HELIX    3  A3 ILE A   95  GLU A  110  1                                  16 
HELIX    4  A4 SER A  124  MET A  133  1                                  10 
HELIX    5  B1 VAL B    3  SER B   11  1                                   9 
HELIX    6  B2 VAL B   22  LYS B   32  1                                  11 
HELIX    7  B3 LEU B   46  THR B   50  5                                   5 
HELIX    8  B4 ALA B   69  GLU B   73  1                                   5 
HELIX    9  B5 PRO B   83  ASP B  104  1                                  22 
HELIX   10  B6 LEU B  108  SER B  114  3                                   7 
HELIX   11  B7 ARG B  116  LYS B  127  1                                  12 
HELIX   12  B8 ILE B  140  LEU B  146  3                                   7 
HELIX   13  B8 GLY B  147  ALA B  166  1                                  20 
HELIX   14  B9 GLN B  191  ALA B  207  1                                  17 
HELIX   15 B10 LEU B  213  VAL B  229  1                                  17 
HELIX   16 B10 HIS B  230  GLU B  232  5                                   3 
HELIX   17 B10 ASP B  233  ASP B  237  1                                   5 
HELIX   18 B11 SER B  243  ILE B  258  1                                  16 
HELIX   19 B11 PHE B  259  GLN B  261  5                                   3 
HELIX   20 B12 TYR B  274  HIS B  278  1                                   5 
HELIX   21 B13 SER B  296  LEU B  309  1                                  18 
HELIX   22 B13 LEU B  310  LYS B  313  5                                   4 
HELIX   23 B14 ALA B  317  PHE B  327  1                                  11 
HELIX   24 B15 VAL B  335  ILE B  346  1                                  12 
HELIX   25 B16 TYR B  358  SER B  370  1                                  13 
HELIX   26 B17 GLU B  384  SER B  401  1                                  18 
HELIX   27 B18 THR B  404  VAL B  428  1                                  25 
HELIX   28 B19 GLN B  431  LEU B  455  1                                  25 
HELIX   29 B20 PRO B  460  GLU B  462  5                                   3 
HELIX   30 B20 ALA B  463  LYS B  504  1                                  42 
HELIX   31 B21 GLU B  509  ASN B  524  1                                  16 
HELIX   32 B22 MET B  526  PHE B  563  1                                  38 
HELIX   33 B23 GLU B  579  PHE B  587  1                                   9 
HELIX   34 B24 TYR B  601  PHE B  611  1                                  11 
HELIX   35 B25 GLY B  617  GLY B  651  1                                  35 
HELIX   36 B26 GLN B  666  LYS B  699  1                                  34 
HELIX   37  C1 LEU C    6  ILE C   10  1                                   5 
HELIX   38  C2 LYS C   70  LEU C   76  1                                   7 
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Fig. S 19 Manually added (author) SHEET records for the NatC-CoA structure. The numberings above the 
SHEET lines are not included in the PDB file and are only included to aid with column assignment: 1-6, Record 
name “SHEET”; 8-10 Strand number within a sheet. Starts at 1 for every sheet and increases by one; 12-14, 
Sheet identifier, which can be any alphanumeric character; 15-16, number of strands in sheet; Description of 
the initial residue in strand with 18-20, residue name; 22, chain ID and 23-26, sequence number; Description of 
the terminal residue in strand with 29-31, residue name; 33, chain ID and 34-37, sequence number; 39-40 Sense 
of the strand, with respect to previous strand in the sheet, with 0 = first strand, 1 = parallel and -1 = antiparallel; 
Registration of current strand with 42-45, Atom name; 46-48, residue name; 50, chain ID and 51-54, sequence 
number; Registration of previous strand with 57-60, Atom name; 61-63, residue name; 65, chain ID and 66-69, 
sequence number. 
REMARK 700 SHEET 
REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED 
REMARK 700 THE SHEET STRUCTURE OF THE MOLECULE NAA38 (CHAIN C) IS BIFURCATED. 
REMARK 700 IN ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, 
REMARK 700 TWO SHEETS ARE DEFINED. STRANDS 1, 2, 3 AND 4  
REMARK 700 OF SHEET *B* AND *C* ARE IDENTICAL. 
 
         1         2         3         4         5         6         7         8 
12345678901234567890123456789012345678901234567890123456789012345678901234567890 
SHEET    1   A 7 GLU A   2  LEU A   8  0 
SHEET    2   A 7 LEU A  46  ASN A  53 -1  N  ASN A  53   O  GLU A   2 
SHEET    3   A 7 ILE A  62  HIS A  72 -1  N  CYS A  67   O  LEU A  46 
SHEET    4   A 7 ARG A  76  GLU A  87 -1  N  GLU A  87   O  ILE A  62 
SHEET    5   A 7 ASP A 113  VAL A 121  1  O  MET A 116   N  ILE A  81 
SHEET    6   A 7 ASP A 150  LEU A 158 -1  N  LEU A 158   O  ASP A 113 
SHEET    7   A 7 ILE A 136  MET A 141 -1  N  MET A 141   O  ALA A 151 
SHEET    1   B 7 LEU B  53  VAL B  55  0 
SHEET    2   B 7 SER C  49  VAL C  58  1  O  SER C  57   N  VAL B  55 
SHEET    3   B 7 ASN C  36  MET C  46 -1  O  LEU C  37   N  VAL C  58 
SHEET    4   B 7 ARG C  22  ASP C  32 -1  N  VAL C  25   O  GLU C  43 
SHEET    5   B 7 GLY C  11  LEU C  18 -1  N  LEU C  18   O  ARG C  22 
SHEET    6   B 7 LYS C  64  ASP C  69 -1  O  MET C  67   N  ILE C  15 
SHEET    7   B 7 LEU B  19  ASP B  21 -1  N  VAL B  22   O  ILE C  68 
SHEET    1   C 5 LEU B  53  VAL B  55  0 
SHEET    2   C 5 SER C  49  VAL C  58  1  O  SER C  57   N  VAL B  55 
SHEET    3   C 5 ASN C  36  MET C  46 -1  O  LEU C  37   N  VAL C  58 
SHEET    4   C 5 ARG C  22  ASP C  32 -1  N  VAL C  25   O  GLU C  43 
SHEET    5   C 5 ILE B  38  LYS B  40 -1  N  VAL B  39   O  VAL C  31 
SHEET    1   D 2 GLU B 705  VAL B 711  0 
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